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INTRODUCTION 
Hypertension and the kidney 
Hypertension, or high blood pressure, is a major contributor to cardiovascular 
disease. It has been recently reported that approximately 25% of the adult population 
worldwide suffer from hypertension (Kearney et al. 2005). As many as 90-95% of all cases 
of hypertension are classified as essential (primary) hypertension with unknown cause of 
the disease (Chobanian et al. 2003). The remaining 5-10% of cases (secondary 
hypertension) are caused by known factors including endocrine disorders, kidney diseases 
and tumors (Taler 2008). This severe condition is associated with a significant increase in 
the risk for progression to heart failure, arrhythmias or sudden death (Levy et al. 1990; 
Lorell et al. 2000).  
The causes that underlie hypertension are complex, because both genetic and 
environmental factors participate in the pathogenesis of this disease (Moore et al. 2002; 
Coy 2005; Marteau et al. 2005; Kunes et al. 2006). It has been estimated, however, that 
30–50% of essential hypertension is heritable. Approximately 30–35% of subjects with 
normal blood pressure are salt-sensitive; in hypertensive patients, this percentage is as 
high as 50–70% (Burnier et al. 2006; Haddy 2006). Because the kidney is important in the 
long-term regulation of blood pressure and is the major organ involved in the regulation 
of sodium homoeostasis, many studies have focused on the abnormal renal handling of 
salt in the pathogenesis of hypertension. Moreover, several studies have shown that 
human essential hypertension is associated with increased sodium transport in the renal 
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proximal tubule (Ortiz et al. 2001; Hussain et al. 2003). Several rodent models of genetic 
hypertension have been established for experimental investigation of hypertension 
genetics and pathophysiology, including spontaneously hypertensive rats of the Okamoto-
Aoki strain (SHR), Dahl salt-sensitive rats, Milan hypertensive rats, and Prague 
hypertensive rats (Grisk et al. 2001). In these rats arterial hypertension can be transferred 
with a renal graft from the hypertensive strain to normotensive recipients. Furthermore, 
renal grafts from the respective normotensive control strains lowered arterial pressure in 
these genetically hypertensive rat strains (Bianchi et al. 1974; Dahl et al. 1974; Heller et al. 
1993; Grisk et al. 2001).  
SHR have been the most frequently used experimental animal models in research 
on genetics and pathology of arterial hypertension (Grisk et al. 2001). By the age of 3−6 
weeks, the pressure natriuresis and diuresis relationship in these animals has already 
shifted to elevated arterial pressure levels. Renal afferent arteriolar resistance and tubular 
sodium reabsorption is increased when compared with normotensive animals (Roman 
1987). These abnormalities in renal function are consistent with an involvement of renal 
mechanisms in the pathophysiology of hypertension in SHR. 
 
Renal systems controlling sodium homeostasis 
The renal renin-angiotensin-aldosterone system (RAAS) and dopaminergic system 
control renal electrolyte balance through various receptor-mediated pathways with 
counter-regulatory interactions. In order to conserve sodium during low sodium intake, 
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the RAAS is upregulated to produce angiotensin II (Ang II). Stimulation of the principal 
membrane bound cell surface receptor for Ang II, the AT1R, leads to sodium reabsorption. 
On the other hand, during high sodium intake the local renal production of dopamine is 
increased, leading to inhibition of sodium reabsorption (Felder et al. 2006).  
 
The renin-angiotensin-aldosterone system 
The RAAS plays an important role in regulating blood volume and systemic vascular 
resistance, which together influence cardiac output and arterial pressure (Covic et al. 
2009). Renin, which is primarily released by the kidneys, stimulates the formation of 
angiotensin in blood and tissues, which in turn stimulates the release of aldosterone from 
the adrenal cortex (Harrison-Bernard 2009). The release of renin is stimulated by 
sympathetic nerve activation (acting via β1-adrenoceptors), renal artery hypotension 
(caused by systemic hypotension or renal artery stenosis) and decreased sodium delivery 
to the distal tubules of the kidney (Paul et al. 2006; Covic et al. 2009). When renin is 
released into the blood, it acts upon a circulating substrate, angiotensinogen, that 
undergoes proteolytic cleavage to form angiotensin I. Angiotensin converting enzyme 
forms Ang II, which constricts resistance vessels (via Ang II AT1 receptors) thereby 
increasing systemic vascular resistance and arterial pressure (Paul et al. 2006; Harrison-
Bernard 2009). Ang II also acts on the adrenal cortex to release aldosterone, which in turn 
acts on the kidneys to increase sodium and fluid retention; stimulates the release 
of vasopressin from the posterior pituitary, which increases fluid retention by the kidneys; 
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facilitates noradrenaline release from sympathetic nerve endings and inhibits 
noradrenaline reuptake by nerve endings, thereby enhancing sympathetic adrenergic 
function and resulting in cardiac and vascular hypertrophy (Paul et al. 2006; Harrison-
Bernard 2009). 
Aldosterone plays a pivotal role in electrolyte and fluid homeostasis and thus in the 
control of blood pressure. The classical view of aldosterone action is that it targets 
epithelia of the distal colon and renal nephron to stimulate sodium reabsorption and 
potassium excretion (Laragh et al. 1964; Ngarmukos et al. 2001). The classical actions of 
aldosterone are mediated by the mineralocorticoid receptor (MR) that translocates to the 
nucleus upon ligand binding (Figure 1). The steroid-bound receptor modulates gene 
expression by functioning as a transcription factor (Yang et al. 2009; Ackermann et al. 
2010). The classical actions of aldosterone include increasing the expression and activity of 
the αENaC, Na+,K+-ATPase α1-subunit and sodium-hydrogen exchanger (NHE) (Loffing et al. 
2001; Fuller et al. 2005; Drumm et al. 2006; Pinto et al. 2008). However, other intrinsic 
proteins localized to the apical membrane of epithelia in the intestine and kidney are now 
also recognized as final effectors. 
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 Figure 1–Activation of the MR by aldosterone results in its dissociation from molecular 
chaperones, translocation into the nucleus and binding to hormone-response elements in the 
regulatory region of target gene promoters to enhance expression. Aldosterone enhances the 
gene expression of profibrotic molecules and stimulates inflammation through the generation of 
ROS by increasing the expression of NADPH oxidase. Abbreviations: MR, mineralocorticoid 
receptor; ROS, reactive oxygen species; SGK1, serine/threonine-protein kinase-1; TGF-β, 
transforming growth factor-β; NADPH oxidase, nicotinamide adenine dinucleotide phosphate-
oxidase; PAI1, plasminogen activator inhibitor-1 [Adapted from (Perico et al. 2008)]. 
 
Aldosterone increases activity of the luminal sodium-hydrogen exchanger type 3 
(NHE3) in the proximal portion of the colon and the apical thiazide-sensitive sodium-
chloride cotransporter (NCC) in the distal renal tubule (Cho et al. 1998; Kim et al. 1998). 
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Inappropriate aldosterone secretion leads to hypertension in the case of 
hyperaldosteronism, or to hypotension in the case of hypoaldosteronism (Epstein 2001). 
 
The renal dopaminergic system 
Intrarenal dopamine plays a central role in the regulation of sodium metabolism 
(Aperia 2000). Several clinical observations as well as studies on animals with various 
forms of genetic hypertension suggest that defects in the renal dopaminergic system may 
contribute to the development of hypertension, by causing salt retention (Hussain et al. 
2003). 
In the mammalian kidney, dopamine is primarily produced in the proximal tubule 
(Soares-da-Silva et al. 1998; Aperia 2000; Gomes et al. 2008). The dopamine precursor L-
dihydroxyphenylalanine (L-DOPA) is filtered at the glomerulus and is taken up by the 
proximal tubule and converted to dopamine by aromatic L-amino acid decarboxylase (L-
AADC), which is highly expressed in the proximal tubule (Soares-da-Silva et al. 1991). The 
regulation of this non-neuronal dopaminergic system depends mainly on the availability of 
L-DOPA, on its decarboxylation into dopamine and on cell outward amine transfer 
mechanisms (Soares-da-Silva et al. 1991; Pestana et al. 1994). In the kidney, dopamine is 
metabolized predominantly by catechol-O-methyl-transferase (COMT) and monoamine 
oxidase (MAO) to 3,4-dihydroxyphenylacetic acid (DOPAC), and to homovallinic acid 
(Soares-da-Silva et al. 1991; Pestana et al. 1994). Studies have shown the overexpression 
of sodium-independent and pH-sensitive amino acid transporter LAT2 (SLC7A8) in the SHR 
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kidney (Pinho et al. 2003), which might contribute to enhanced L-DOPA uptake in the 
proximal tubule and increased dopamine production, as an attempt to overcome the 
defect in D1 receptor function. In agreement with these findings, immortalized renal 
proximal tubular epithelial cells from the SHR also overexpressed LAT2. However, only 
25% of L-DOPA uptake in SHR cells occurred through LAT2; 50% of L-DOPA uptake 
occurred through LAT1 (SLC7A5) and the remaining 25% through sodium-dependent 
transport systems (Pinho et al. 2004). 
The effects of dopamine, in mammals, are mediated by five dopamine receptor 
subtypes. These five receptor subtypes differ in their primary structures and show distinct 
affinities for dopamine receptor agonists and antagonists (Zeng et al. 2007). The D1-like 
receptors are composed of the D1 and D5 receptor subtypes (D1A and D1B, for rodent 
homologues). The D1-like receptors couple to the stimulatory G-proteins Gs and Gq, and 
activate adenylate cyclase activity to increase cytosolic cAMP levels (Figure 2) (Hussain et 
al. 2003). The D2-like receptors are composed of the D2, D3 and D4 receptor subtypes, 
which couple to the inhibitory G-proteins Gi and Go and modulate ion channel activity 
and/or inhibit adenylate cyclase activity. All of the dopamine receptor subtypes have been 
shown to regulate, directly or indirectly, sodium transport in the proximal and distal 
nephron and blood pressure (Hussain et al. 2003; Zeng et al. 2004). The mechanisms 
through which renal dopamine is thought to produce natriuresis involve the activation of 
D1-like receptors that inhibit the activity of both apical (eg, NHE exchange and chloride-
bicarbonate exchange and Na-P cotransport) and basolateral (Na+,K+-ATPase and NaHCO3 
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cotransport) transporters (Aperia et al. 1987; Felder et al. 1990; Lokhandwala et al. 1991; 
Jose et al. 1992).  
 
 
Figure 2–Hypothetical scheme of dopamine synthesis and D1-like receptor signaling pathway that 
causes inhibition of sodium transporters in proximal tubles of rat kidney. Abbreviations: L-AADC, L-
aromatic amino acid decarboxylase; AC, adenylate cyclase; PLC, phospholipase C; PKA, protein 
kinase A; PKC, protein kinase C; PIP2, phosphatidylinositol bisphosphate; IP3, inositol 
trisphosphate; L-DOPA, L-dihydroxyphenylalanine; DAG, diacylglycerol. [Adapted from (Hussain et 
al. 2003)]. 
 
The SHR is a genetic model of hypertension characterized by the resistance to the 
natriuretic effect of dopamine and D1-like receptor agonists, as a result of a defective 
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transduction of the D1 receptor signal in renal proximal tubules (Sanada et al. 1999; Jose 
et al. 2010; Zeng et al. 2011). It has been suggested that increased oxidative stress in renal 
proximal tubules of the SHR could be a mechanism responsible for defective dopamine D1 
receptor/G-protein coupling (White et al. 1998).  
 
Oxidative stress: relation to aging and hypertension  
Oxidative stress is defined as an excess in the levels of oxidants over antioxidants 
within a biological system, and the direct consequence of this is a shift in the redox state 
of the biological compartment towards one that is more oxidizing. Reactive oxygen 
species (ROS), which include radical species such as superoxide anions and hydroxyl 
radicals, and non-radical oxidants such as hydrogen peroxide (H2O2), are particularly 
important effectors of cellular redox status. In the organism they can be produced by 
xanthine oxidase, nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase), 
mitrochondrial oxidative phosphorylation, lypoxygenase, cytochrome P450 mono-
oxygenase and heme-oxygenase. ROS can result in cell damage by reacting with various 
cellular constituents, including membrane lipids, proteins, and DNA (Wei et al. 2002). It is 
widely accepted that oxidative stress is closely linked to aging (Harman 1998; Kujoth et al. 
2007) and to a variety of pathological processes, including cancer, diabetes and 
cardiovascular and renal diseases (Spector 2000; Makino et al. 2003; Touyz et al. 2004). 
Presently, ROS are known to be normal products of cell metabolism and recognized for 
playing a dual role as both harmful and beneficial species to the organism (Valko et al. 
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2006; Valko et al. 2007). For example, ROS play a major physiological role in several 
aspects of intracellular signaling and regulation. Cells are capable of generating ROS 
endogenously and constitutively which are utilized in the induction and maintenance of 
signal transduction pathways involved in cell growth and differentiation (Droge 2002). 
There is an increase in the incidence of hypertension as well as an increase in the 
generation of ROS and inflammation with age. There is evidence that ROS can influence 
vascular reactivity either directly or through intermediate pathways such as reduction of 
nitric oxide (NO) availability or by oxidation of arachidonic acid with the generation of 
vasoactive lipid mediators (Schnackenberg et al. 1998). Thus oxidative stress may account 
for endothelial dysfunction, but it is unknown whether this abnormality is a primary event 
or a consequence of increased blood pressure. Furthermore, studies have indicated that 
an increase in oxidative stress within the renal medulla selectively reduces medullary 
blood flow resulting in chronic hypertension (Makino et al. 2002). Attempts to counteract 
the hypertensive effect of ROS have led to the use of exogenous administration of 
antioxidants thought to improve the vascular function and reduce the blood pressure in 
animal models (Chen et al. 2001; Hoagland et al. 2003) and in human hypertension (Duffy 
et al. 2001; Boshtam et al. 2002).  
 
The opposing effects of angiotensin and dopamine on the redox status 
Accumulating evidence suggests that Ang II stimulates intracellular formation of 
ROS such as the superoxide anion and H2O2 (Sachse et al. 2007). Ang II activates several 
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subunits of the membrane-bound NADPH oxidase and also increases ROS formation in the 
mitochondria (Sachse et al. 2007). Some of these effects may be induced by aldosterone 
and not directly by Ang II. For example, aldosterone has been shown to increase 
superoxide production and to induce cardiovascular injury in mineralocorticoid-induced 
hypertensive animals. These effects were blocked by the administration of MR 
antagonists, as well as by antioxidants and/or NADPH oxidase inhibitors (Beswick et al. 
2001; Schiffrin 2006). Moreover, in cultured rat aortic endothelial cells, aldosterone was 
shown to induce superoxide generation via MR activation of NADPH oxidase (Iwashima et 
al. 2008). Podocyte injury and proteinuria are enhanced in rats infused with aldosterone. 
An antioxidant, TEMPOL, and eplerenone, a MR antagonist, significantly reduced oxidative 
stress markers and prevented podocyte damage and proteinuria (Nagase et al. 2008). 
Several reports have indicated that aldosterone which causes serine/threonine-protein 
kinase-1 (SGK1) upregulation, increases ROS generation and podocyte injury (Figure 1) 
(Nishiyama et al. 2004; Nagase et al. 2006). Aldosterone-induced ROS production can 
activate extracellular signal–regulated kinase 1/2 (ERK 1/2), c-Jun N-terminal kinase (JNK), 
and big mitogen-activated protein kinase (BMK1) in rat renal cortex and cultured 
mesangial cells (Nishiyama et al. 2004; Nishiyama et al. 2005). 
The renal dopaminergic system can counteract the pro-oxidant effects of the RAAS 
(Yasunari et al. 2000; Gildea 2009). Recently, it was shown that age-related hypertension 
in rats may be reversed through the use of exercise which reduces ROS and inflammation 
in the kidneys from old rats, while simultaneously increasing the abundance of the D1 
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receptor (Asghar et al. 2007). Moreover, both D2 (Armando et al. 2007) and D5 receptor 
subtype (Yang et al. 2006) knock-out mice have increased ROS production. D1-like 
receptors were found to decrease NADPH oxidase activity and ROS production, mediated 
via PKA- and PKC-dependent mechanisms in human kidney cells (Yu et al. 2011). In 
addition, Han et al reported that D1-like receptors regulate NADPH oxidase activity 
through the redistribution of NOX2 and subunits (p22phox and Rac1) in membrane 
microdomains and intracellular vesicles (Han et al. 2008).  
In summary, although the cell signaling pathways of the dopamine receptor family 
are complex and interconnected, they work together to maintain normal blood pressure 
at least in part by inhibiting RAAS activity and ROS production. The availability of 
dopamine to activate its specific receptors is determined by factors affecting renal 
synthesis, mainly the amounts of L-DOPA and sodium delivered to the kidney and the 
degree of degradation of the amine (Soares-da-Silva et al. 1993).  Moreover, the activity of 
the amino acid transporters that promote L-DOPA uptake in renal epithelial cells is 
thought to rate-limit the synthesis of renal dopamine. 
 
Epithelial amino acid transporters  
Amino acid transporters are responsible for the uptake of amino acids derived 
from diet in the small intestine, the release into the blood, and subsequent uptake of 
amino acids from the blood into tissues such as liver or skeletal muscle or the 
reabsorption of amino acids from the urine along the kidney nephron. In the central 
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nervous system, amino acid transporters regulate the transport of amino acids across the 
blood-brain barrier or are involved in the reuptake of neurotransmitter amino acids such 
as glycine, aspartate, or glutamate from the synaptic cleft and are important for the 
metabolic coupling of astrocytes and neurons. Other amino acid transporters are involved 
in basic cellular functions such as cell volume regulation, the synthesis of glutathione 
(GSH), the provision of amino acids for protein synthesis and energy metabolism. 
In the kidney nephron, the proximal tubule is the major site of nutrient 
reabsorption. About 95–99% of all amino acids are reabsorbed in the proximal convoluted 
tubule and proximal straight tubule. All kidney cells express some amino acid transporters 
that are involved mostly in house-keeping functions. Some kidney cells also require 
additional uptake of amino acids, which are used as precursors for the synthesis of 
paracrine and/or endocrine substances such as NO (Verrey et al. 2009). As reviewed by 
Broer (Broer 2008), five transport activities in kidney and intestine were proposed: 1) the 
“neutral system” transporting all neutral amino acids; 2) the “basic system” transporting 
cationic amino acids together with cystine; 3) the “acidic system” transporting glutamate 
and aspartate; 4) the “iminoglycine system” transporting proline, hydroxyproline, and 
glycine; and 5) the β-amino acid system. The epithelial amino acid transport systems and 
their mediators are summarized in Table 1. 
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Table 1–Epithelial amino acid transport systems and their mediators (Broer 2008). 
 
NR, not reported; A, antiport; AA0, neutral amino acids; AA+, cationic amino acids; U, uniport; S, 
symport; S-AA0, symport together with neutral amino acids; K, kidney; I, intestine; AM, apical 
membrane; BM, basolateral membrane; Ub, ubiquitous. Amino acids are given in one-letter codes. 
O, ornithine; HO-P, hydroxyproline. Affinity: high, <100 μM; medium, 100 μM to 1 mM; low, >1 
mM. * Expression in epithelial cells of kidney and intestine. 
 
 
Luminal amino acid transporters of the proximal tubule 
Neutral amino acids represent more than 80% of the free plasma amino acids and 
are all transported by the luminal B0AT1 transporter (SLC6A19) (Figure 3), though with 
different apparent affinities (Broer et al. 2004; Verrey et al. 2009). This neutral amino acid 
cotransporter with broad selectivity is expressed in the luminal brush border membrane 
of the early segments of the kidney proximal tubule and similarly along the small intestine 
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(Romeo et al. 2006). Expressed in Xenopus oocytes, the B0AT1 cDNA induces a sodium-
dependent, chloride-independent uptake of neutral amino acids with an affinity for L-
leucine uptake (Broer et al. 2004). Its defect has been shown to cause Hartnup disorder, 
an autosomal recessive condition which is characterized by a urinary loss of neutral amino 
acids (Kleta et al. 2004). Another member of the same SLC6 amino acid transporter 
cluster, SLC6A20 in human, has been identified as the molecular correlate of system 
IMINO, mediating the cotransport of L-proline (Kowalczuk et al. 2005; Takanaga et al. 
2005). This transporter called SIT1 or IMINOB was shown to localize to the brush border 
membrane of the proximal tubule in mice by immunofluorescence (Romeo et al. 2006). As 
expected for system IMINO, it also transports hydroxy-L-proline and betaine but does not 
transport glycine. SIT1/IMINOB appears to require, as B0AT1 and B0AT3, the association 
with collectrin for its surface expression in kidney. This is suggested by the low brush 
border membrane expression of SIT1/IMINOB in collectrin knock-out mice and by the large 
urinary L-proline loss in these animals (Malakauskas et al. 2007). Collectrin (Tmem27) is a 
relatively short type I transmembrane protein (25 kDa) that is approximately 40% identical 
with the membrane anchor region of the RAS enzyme ACE2 (Danilczyk et al. 2006; 
Malakauskas et al. 2007). 
Cationic amino acids and the disulfide-linked L-cysteine dimmer enter the 
epithelial cells via the cystinuria transporter (b0,+AT) (Figure 3). This transporter is made of 
a catalytic subunit belonging to the SLC7 family and a disulfide linked accessory subunit 
referred to as heavy chain and called rBAT (SLC3A1) (Broer 2008). Similarly to the 
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basolateral heterodimeric exchangers of the SLC7/SLC3 family, it functions as an 
obligatory antiporter and specifically exchanges its cationic substrates or L-cystine against 
intracellular neutral amino acids. b0,1AT mRNA is expressed in kidney and small intestine, 
and, to a smaller extent, in heart, liver, placenta, and lung. rBAT protein was found in the 
apical membrane of the renal proximal tubule, increasing from the S1 to the S3 segment 
and in the microvilli of the small intestine. On the other hand, although b0,1AT protein is 
also expressed in the apical membrane of the proximal tubule, expression levels decrease 
from the S1 to the S3 segment (Wagner et al. 2001). 
The high-affinity transporter for anionic amino acids, referred to as EAAT3 
(SLC1A1) (Figure 3), is expressed in the intestine and kidney, as well as in the brain (Kanai 
et al. 1992; Hediger 1999). It is localized in the proximal tubule brush border membrane 
with an axial gradient: low amounts in S1 and highest levels in the later segments S2 and 
S3 (Hediger 1999). This transporter has been shown to cotransport its substrates with 
three sodium ions and one proton in exchange for one potassium ion (Zerangue et al. 
1996). Unlike the SLC6 and SLC7 transporters no SLC1 associated transmembrane protein 
has been identified.  
ASCT2 (SLC1A5) is a sodium -dependent exchanger of neutral amino acids that 
belongs to the SLC1 family and has been shown to be expressed at the mRNA level in 
kidney. ASCT transporters are sodium-dependent obligatory exchangers of amino acids (in 
particular alanine, serine, cysteine, and threonine) that are structurally related to the 
EAAT transporters. ASCT2 belongs to a restricted group of transporters that share 
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specificity for glutamine, since glutamine is the major precursor of urinary ammonia, thus 
playing a key role in acid-base homeostasis (Utsunomiya-Tate et al. 1996; Avissar et al. 
2001). 
Basolateral amino acid transporters of the proximal tubule 
The best characterized basolateral transporters of the proximal tubule amino acid 
reabsorption machinery function as obligatory exchangers (System L and system y+L) 
(Figure 3) and thus do not perform net basolateral amino acids export (Verrey et al. 2005). 
System L conveys the sodium-independent transport of large branched and aromatic 
neutral amino acids in almost all types of cells (Wagner et al. 2001). The first isoform of 
system L, LAT1 (SLC7A5), preferentially mediates the sodium-independent transport of 
large neutral amino acids such as leucine, isoleucine, valine, phenylalanine, tyrosine, 
tryptophan, methionine and histidine and is a major route for providing tumour cells with 
branched and aromatic amino acids (Kanai et al. 1998). LAT1 is widely expressed in 
nonepithelial cells such as brain, spleen, thymus, testis, skin, liver, placenta, skeletal 
muscle, and stomach and has a high affinity for amino acid substrates (Kanai et al. 1998; 
Prasad et al. 1999). Recent studies have demonstrated that LAT1 is a major L-type amino 
acid transporter in a variety of cancer cells including hepatic, oral, breast, bladder and 
colon (Storey et al. 2005). Although the transport of leucine by LAT1 in pig LLC-PK1 renal 
cells has been previously described (Soares-da-Silva et al. 2004), LAT1 has a very limited 
tissue distribution in the kidney (Pinho et al. 2007). The heavy subunit 4F2hc brings LAT1 
to the plasma membrane. In the absence of 4F2hc, LAT1 is found in intracellular 
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compartments, whereas 4F2hc can reach the plasma membrane independently 
(Nakamura et al. 1999). Moreover, 4F2hc interacts with several light chains to form 
system L (with LAT1 and LAT2), system y+L (with y+LAT1 and y+LAT2), system Xc- (with xCT), 
or system asc (with asc1) (Wagner et al. 2001).  
LAT2 (SLC7A8) is highly expressed in polarized epithelia (Segawa et al. 1999), 
suggesting an important role in transepithelial amino acid transport, but it has a lower 
affinity for amino acid substrates than LAT1 (Segawa et al. 1999; Wagner et al. 2001). LAT2 
is a major sodium-independent amino acid transporter and its functionality is dependent 
on the abundance of 4F2hc. The heterodimerization of LAT2 with 4F2hc is a prerequisite 
for the transporter to reach the cell surface. Moreover, 4F2hc may regulate the functional 
surface expression of the transporter (Nakamura et al. 1999; Pineda et al. 1999). 
Expression of LAT2 and 4F2hc induces amino acid transport with characteristics of system 
L, namely, sodium-independent transport of neutral amino acids sensitive to classic 
system L inhibitors (Pineda et al. 1999; Segawa et al. 1999). LAT2 also transports small 
neutral amino acids such as L-alanine, L-glycine, L-cysteine, and L-serine and glutamine, all 
of which are poor substrates for LAT1 (Pineda et al. 1999; Segawa et al. 1999; Wagner et 
al. 2001). 
System y+L was first functionally described in erythrocytes (Deves et al. 1992). 
However, its presence has also been revealed in placenta, liver, small intestine and kidney 
(Desjeux et al. 1980; Rajantie et al. 1981; Eleno et al. 1994; Furesz et al. 1997). It has an 
axial distribution along the kidney proximal tubule and small intestine similar to that of 
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LAT2-4F2hc (Bauch et al. 2003; Dave et al. 2004). y+LAT1 (SLC7A7) plays an important role 
for the transepithelial transport of its cationic substrates which it transports out of the 
cells in exchange for extracellular neutral amino acids and sodium (Torrents et al. 1998; 
Pfeiffer et al. 1999). The functional importance of this electroneutral exchange for 
transcellular cationic amino acid transport is demonstrated by the disease, lysinuric 
protein intolerance, that is caused by mutations of the y+LAT1 gene which is characterized 
by the urinary loss of L-arginine, L-ornithine, and L-lysine and by a poor intestinal 
absorption of these amino acids (Borsani et al. 1999; Torrents et al. 1999). This leads to 
low plasma concentrations of these amino acids and to an impaired function of the urea 
cycle and hyperammonemia (Tanner et al. 2007). 
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 Figure 3–Luminal and basolateral transporters belonging to the amino acid 
absorption/reabsorption machinery. Names of transporters and of the corresponding genes are 
indicated in rectangles. Recycling pathways are shown by dotted lines. AA, neutral amino acids; 
AA+, cationic amino acids; AA– anionic amino acids [Adapted from (Verrey et al. 2005)]. 
 
Modulation of amino acid transporters by oxidative stress 
Although the mechanisms responsible for the regulation of amino acid 
transporters are not fully understood, several factors have been shown to regulate their 
expression and/or activity. These factors include osmotic shock, growth factors, peptide 
hormones and protein phosphorylation (Fleck et al. 2003). Several evidence points 
towards the possible regulation of amino acid transport by oxidative stress. Oxidative 
stress has been found to stimulate the activity of NMDA receptors (Agostinho et al. 1995) 
and the calcium-independent, carrier-mediated release of glutamate and [3H]-D-aspartate 
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(Rego et al. 1996) from cultured retina cells. On the other hand, oxidative stress 
conditions induced by ascorbate/Fe2+ reduces significantly the activity of the excitatory 
amino acid (EAA) transporter, mainly by protein oxidation (Agostinho et al. 1997).  
The cystine/glutamate exchange system (Xc-) is another amino acid transport 
system that is regulated by oxidative stress. System Xc- transports one molecule of cystine, 
the oxidized form of cysteine, into cells and thereby releases one molecule of glutamate 
into the extracellular space. Cystine, a disulfide formed between two cysteine molecules, 
is the predominant form in the extracellular space, whereas cysteine is the prevailing form 
in cells due to highly reducing conditions. These amino acids are important not only as 
precursors for protein and antioxidant glutathione (GSH) biosynthesis, but also for the 
maintenance of physiological redox conditions inside/outside of the cell (Conrad et al. 
2011). One of most important features of system Xc- is that its activity is highly inducible 
by various stimuli, including electrophilic agents like diethyl maleate, cystine deprivation 
in the culture medium, oxidized low density lipoprotein and hydrogen peroxide (Conrad et 
al. 2011).  
Peroxynitrite generated from the reaction of nitric oxide with superoxide anion 
leads to alterations in cell signaling and function via the modification of cellular lipids and 
protein thiols (Beckman 1996). In bovine aortic endothelial cells, 3-
morpholinosydnonimine (SIN-1), a donor of nitric oxide and peroxynitrite, caused an 
increase in L-cystine transport and intracellular glutathione (GSH) levels. Induction of L-
cystine transport in both aortic endothelial and smooth muscle cells in response to SIN-1 
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was abolished by inhibitors of protein and RNA synthesis. It has been suggested that 
under conditions of overproduction of NO or peroxynitrite in inflammation, endothelial 
cells can adapt by increasing system Xc- transport activity and their GSH levels to 
counteract NO-mediated changes in cellular thiols (Li et al. 1999).  
More recently, exposure of Caco-2 cells to the S-nitrosothiol type nitric oxide 
donor, SNAP, was found to increase sodium-dependent alanine uptake mediated by 
ASCT2 (Uchiyama et al. 2005). Peroxynitrite stimulated sodium-dependent alanine 
transport, and the NADPH oxidase inhibitor DPI, and superoxide dismutase, partially 
inhibited SNAP induced sodium-dependent alanine transport which suggested that NO-
related radicals as well as NO itself might be responsible for stimulating ASCT2 (Uchiyama 
et al. 2005). 
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AIM 
The broad objective of this thesis is to gain further insight into the role of oxidative 
stress on the renal expression and regulation of the amino acid transporters potentially 
involved in the uptake of L-DOPA in hypertension and aging.  
 
The following questions were raised: 
CHAPTER I: Is the function and expression of sodium-dependent ASCT2 altered in 
hypertension? Does intracellular H2O2 play a role in the regulation of ASCT2 in 
immortalized renal proximal tubular epithelial (PTE) cells from WKY and SHR? Can H2O2 
modulate the activity of other transporters, such as NHE in PTE cells? 
CHAPTER II: What are the effects of aging on the renal oxidative stress status in WKY and 
SHR? 
CHAPTER III: How does aging affect the renal dopaminergic system and the regulation of 
LAT1, LAT2, 4F2hc, and ASCT2 in WKY and SHR? 
CHAPTER IV: Do age-related changes in the renal expression of amino acid transporters 
potentially involved in L-DOPA uptake parallel changes in the activation of the renal 
aldosterone/MR system? 
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CHAPTER I - H2O2 and the regulation of renal ASCT2 in hypertension 
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Pinho MJ, Pinto V, Serra˜o MP, Jose PA, Soares-da-Silva P.
Underexpression of the Na-dependent neutral amino acid transporter
ASCT2 in the spontaneously hypertensive rat kidney. Am J Physiol
Regul Integr Comp Physiol 293: R538–R547, 2007. First published
May 2, 2007; doi:10.1152/ajpregu.00906.2006.—This study exam-
ined the inward transport of L-[14C]alanine, an ASCT2 preferential
substrate, in monolayers of immortalized renal proximal tubular
epithelial (PTE) cells from Wistar-Kyoto (WKY) and spontaneously
hypertensive (SHR) rats. The expression of ASCT2 in WKY and SHR
PTE cells and kidney cortices from WKY and SHR was also evalu-
ated. L-[14C]alanine uptake was highly dependent on extracellular
Na. Replacement of NaCl by LiCl or choline chloride abolished
transport activity in SHR and WKY PTE cells. In the presence of the
system L inhibitor BCH, Na-dependent L-alanine uptake in WKY
and SHR PTE cells was inhibited by alanine, serine, and cysteine,
which is consistent with amino acid transport through ASCT2. The
saturable component of Na-dependent L-alanine transport under
Vmax conditions in SHR PTE cells was one-half of that in WKY PTE
cells, with similar Km values. Differences in magnitude of Na-
dependent L-alanine uptake through ASCT2 between WKY and SHR
PTE cells correlated positively with differences in ASCT2 protein
expression, this being more abundant in WKY PTE cells. Abundance
of ASCT2 transcript and protein in kidney cortices of SHR rats was
also lower than that in normotensive WKY rats. In conclusion,
immortalized SHR and WKY PTE cells take up L-alanine mainly
through a high-affinity Na-dependent amino acid transporter, with
functional features of ASCT2 transport. The activity and expression of
the ASCT2 transporter were considerably lower in the SHR cells.
L-alanine transport; hypertension; alanine-serine-cysteine-threonine
transporter-2
TRANSPORT OF NEUTRAL amino acids across membranes of mam-
malian cells proceeds through a variety of different transport
systems (reviewed in Refs. 4, 9, and 18). At the level of the
kidney and small intestine epithelia, distinct transporters are
located in the apical and basolateral membranes to ensure the
vectorial transport of amino acids across the epithelial cells
(13). Recently, several amino acid transporters have been
identified and shown to play a role in the cellular uptake and/or
basolateral extrusion of neutral amino acids. Indeed, it has been
proposed (13) that neutral amino acids are absorbed from the
luminal fluid via Na-dependent systems, like the proline
transporter IMINO/SIT (SLC6A20) (20, 37), the neutral amino
acid exchanger ASCT2 (SLC1A5) (16), or the broad specific
neutral amino acid transporter B0AT1 (SLC6A19), whose
molecular structure has been identified recently (7). The exit
path for neutral amino acids to the blood stream is supposed to
proceed through the system L. In kidney and small intestine
epithelial cells, type-2 L-amino acid transport (LAT2), together
with 4F2hc, was found to be present in basolateral membrane,
which is well suited for the exit path of intracellular amino
acids (28, 32). System yL, most likely yLAT1 (38, 45),
located at the basolateral membrane, is expected to mediate the
obligatory exchange of intracellular basic amino acids against
extracellular neutral amino acids, cotransported with sodium
ions (27). Because these two transport systems function as
obligatory exchangers, they cannot contribute to the net trans-
epithelial transport of amino acids but are thought to play a role
in extending the transport selectivity of putative parallel func-
tioning by unidirectional transporters.
System ASC transport activity is ubiquitous and character-
ized by its preference for small neutral amino acids including
alanine, serine, and cysteine. The system ASC of neutral amino
acid transporters (SLC1A4 and SLC1A5) belongs to the solute
carrier family-1 (SLC1), which also includes the high-affinity
glutamate transporters (13, 14, 40, 46). Human ATB0 was
identified by RT-PCR and enzymatic restriction analysis in the
human proximal tubule cell line HKPT (17) and corresponds to
rodent ASCT2. The two ASC transporters exhibit distinct
substrate selectivity. SLC1A4 encodes the Na-dependent
amino acid transporter ASCT1, which accepts L-alanine, L-
serine, L-theonine, and L-cysteine in a stereospecific manner.
ASCT2, the second isoform of the ASC transport system, is
encoded by SLC1A5. In the kidney and intestine, ASCT2 is
present in the brush-border membranes of the proximal tubule
cells and enterocytes, respectively (3). In addition to the typical
system ASC substrates, it also accepts L-glutamine and L-
asparagine at higher affinity as well as methionine, leucine, and
glycine with lower affinity. Both ASCT1 and ASCT2 mediate
the Na-dependent obligatory exchange of substrate amino
acids (5, 38, 46).
We previously reported that overexpression of Na-inde-
pendent LAT2 in the spontaneously hypertensive rat (SHR)
kidney is organ specific and precedes the onset of hyperten-
sion. This overexpression is accompanied by an enhanced
ability to take up L-3,4-dihydroxyphenylalanine (L-DOPA)
(29). These observations formed the basis for the hypothesis
that overexpression of renal LAT2 leads to enhanced renal
production of dopamine in the SHR in an attempt to compen-
sate for the decreased dopamine-mediated natriuresis generally
observed in this genetic model of hypertension. Furthermore,
we have demonstrated that immortalized renal proximal tubu-
lar epithelial (PTE) cells from Wistar-Kyoto rats (WKY) and
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SHR transport L-DOPA quite efficiently through the apical cell
border, in a Na-independent manner (30). LAT2 was almost
exclusively responsible for L-DOPA transport in WKY cells,
whereas in SHR cells, 25% of L-DOPA uptake was through a
Na-dependent system, 25% through LAT2, and the remaining
50% through LAT1. Differences in L-DOPA handling between
SHR and WKY cells may result from the overexpression of
LAT1 and LAT2 transporters in the former (30).
In an attempt to understand better differences in the handling
of L-amino acids in hypertension, the present study examined
the function and expression of ASCT2. The inward transport of
L-[14C]alanine, an ASCT2 preferential substrate, was evaluated
in monolayers of immortalized renal PTE cells from the SHR
and its normotensive control, WKY. The quantification of
ASCT2 mRNA and ASCT2 protein was performed in immor-
talized renal PTE cells and kidney cortices from WKY
and SHR.
METHODS AND MATERIALS
Cell culture. Immortalized renal PTE cells from WKY and SHR
(44) were maintained in a humidified atmosphere of 5% CO2-95% air
at 37°C. SHR and WKY PTE cells were grown in DMEM Nutrient
Mixture-Ham’s F-12 (Sigma, St. Louis, MO) supplemented with 100
U/ml penicillin G, 0.25 g/ml amphotericin B, 100 g/ml streptomy-
cin (Sigma), 5% fetal bovine serum (Sigma), and 25 mM HEPES
(Sigma). For subculturing, the cells were dissociated with 0.10%
trypsin-EDTA, split 1:4, and subcultured in Costar flasks with 75- or
162-cm2 growth areas (Costar, Badhoevedorp, The Netherlands). The
cell medium was changed every 2 days, and the cells reached
confluence after 3–5 days of incubation. For 24 h before each
experiment, the cells were maintained in fetal bovine serum-free
medium. Experiments were generally performed 2–3 days after cells
reached confluence and 6–8 days after the initial seeding; each
squared centimeter contained 80–100 g of cell protein.
Uptake of L-amino acids. Flux measurements in immortalized renal
PTE cells from the WKY and SHR were performed as previously
described (30). Briefly, on the day of the experiment, growth medium
was aspirated, and the cell monolayers were preincubated for 15 min
in Hanks’ medium at 37°C. The Hanks’ medium had the following
composition (in mM): NaCl 137, KCl 5, MgSO4 0.8, Na2HPO4 0.33,
KH2PO4 0.44, CaCl2 0.25, MgCl2 1.0, Tris HCl 0.15, and sodium
butyrate 1.0, pH  7.4. Uptake was initiated by the addition of 1 ml
of Hanks’ medium with a given concentration of the substrate. Time
course studies were performed in experiments in which cells were
incubated with 0.25 M L-[14C]alanine for 1, 3, 6, 12, 30, and 60 min.
Saturation experiments were performed in cells incubated for 6 min
with 0.25 M radiolabeled amino acid in the absence and in the
presence of increasing concentrations of the unlabeled substrate. To
achieve Na-free and Cl-free conditions, NaCl was replaced by LiCl
or sodium gluconate (NaGlu). In experiments performed to determine
the Na dependence of transport, sodium chloride was replaced by an
equimolar concentration of choline chloride. To determine whether
L-[14C]alanine transport is an electrogenic process, cells were depo-
larized by the addition of 50 mM KCl or NH4Cl (5); in these
experiments, 100 mM sucrose added to Hanks’ balancing for the
increased osmolarity represented the control situation. In inhibition
studies, test substances were applied from the apical side and were
present during the incubation period only. During preincubation and
incubation, the cells were continuously shaken and maintained at
37°C. Uptake was terminated by the rapid removal of uptake solution
by means of a vacuum pump connected to a Pasteur pipette followed
by a rapid wash with cold Hanks’ medium. Subsequently, cells were
solubilized by 0.1% vol/vol Triton X-100 (dissolved in 5 mM
Tris HCl, pH 7.4), and radioactivity was measured by liquid scintil-
lation counting.
Immunoblotting. Cell monolayers and renal cortical membranes
from the WKY and SHR were washed with PBS and then lysed in
RIPA buffer containing 150 mM NaCl, 50 mM Tris HCl, pH 7.4, 5
mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS,
100 g/ml PMSF, 2 g/ml leupeptin, and 2 g/ml aprotinin. Protein
concentration was determined using a protein assay kit (Bio-Rad
Laboratories, Hercules, CA), with bovine serum albumin as standard.
Cell lysates were boiled in sample buffer (35 mM Tris HCl, pH 6.8,
4% SDS, 9.3% dithiothreitol, 0.01% bromophenol blue, 30% glyc-
erol) at 95°C for 5 min. Samples containing 60 g of protein were
separated by SDS-PAGE with 10% polyacrylamide gel and then
electroblotted onto nitrocellulose membranes (Bio-Rad). Blots were
blocked for 1 h with 5% nonfat dry milk in PBS (10 mmol/l PBS) at
room temperature with constant shaking. Blots were then incubated
with anti-ASCT2 polyclonal antibody (1:800; Chemicon Interna-
tional) in 5% nonfat dry milk in PBS-T (0.01% Tween 20-PBS)
overnight at 4°C. The immunoblots were subsequently washed and
incubated with fluorescently labeled goat anti-rabbit (1:10,000; IRDye
800, Rockland) or the fluorescently labeled goat anti-mouse secondary
antibody (1:5,000; AlexaFluor 680, Molecular Probes) for 60 min at
room temperature and protected from light. The membrane was
washed and imaged by scanning at both 700 and 800 nm with an
Odyssey Infrared Imaging System (LI-COR Biosciences).
RT-PCR. One microgram of total RNA was reverse transcribed to
cDNA with SuperScript First Strand Synthesis System for RT-PCR
(Invitrogen) according to manufacturer’s instructions. The reverse
transcription was performed at 50°C and with the use of 5 g/l
random hexamers. The ASCT2 cDNA was amplified by PCR using
the following set of rat-specific primers: forward 5-GCC TGA TCG
GAG GTG CAG CC-3 and reverse 5-CGG GTA AAG AGG AAG
TAG ATG-3, corresponding to nucleotides 334 and 983 of the rat
cDNA (GenBank accession no. AJ132846). The B0, cDNA was
amplified by PCR using the following set of primers: forward 5-AAC
AGT ATT GGG ATA AAG TGA-3 and reverse 5-TAA TGG CAT
CAG AGT AAC AG-3, corresponding to nucleotides 755 and 1136
of the rat B0, mRNA sequence (GenBank accession no.
NM_001037544). PCR was performed with Platinum TaqPCRx DNA
Polymerase (Invitrogen). Amplification conditions were as follows:
hot start of 2 min at 94°C; 30 cycles of denaturing (94°C for 30s),
annealing (55°C for 30 s), and extension (72°C for 45 s); and a final
extension of 7 min at 72°C. The PCR products were separated by
electrophoresis in a 2% agarose gel and visualized under UV light in
the presence of ethidium bromide.
Real-time PCR quantification of rat ASCT2. Kidney cortices from
WKY and SHR (4 and 12 wk of age) and immortalized renal PTE
WKY and SHR cells were homogenized (Diax, Heidolph) in Trizol
reagent (75 mg/ml; Invitrogen), and total RNA was extracted accord-
ing to the manufacturer’s instructions. All animal interventions were
performed in accordance with the European Directive no. 86/609 and
the rules of the Guide for the Care and Use of Laboratory Animals,
7th ed, Washington, DC. Instittue for Laboratory Animal Research
(ILAR), 1996. The RNA preparation was further treated with DNase
(Ambion), to eliminate potential genomic DNA contamination. Re-
verse transcription was performed with SuperScript First Strand
System for RT-PCR (Invitrogen), using 5 g/l random hexamers as
primers at 50°C, according to the manufacturer’s instructions. cDNA
was synthesized from 1 g of total RNA in a total volume of 20 l.
Standards for ASCT2 and GAPDH were obtained by conventional
PCR amplification, using Platinum TaqPCRx DNA Polymerase (Life
Technologies) and the following rat-specific primers: rASCT2 for-
ward primer 5-CGT CCT CAC TCT TGC CAT CAT-3 and reverse
primer 5-CCA AAA GCA TCA CCC TCC AC-3 (nucleotide posi-
tions 1298 and 1427 in rat ASCT2 sequence NM_175758); rGAPDH
forward primer 5-GGC ATC GTG GAA GGG CTC ATG AC-3 and
reverse primer 5-ATG CCA GTG AGC TTC CCG TTC AGC-3
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(nucleotide positions 1348 and 1512 in rat GAPDH sequence
M17701). PCR products were gel purified with Qiaex II (Qiagen),
quantified by spectrophotometry at 260 nm, and further diluted ac-
cordingly in serial steps. All PCR fragments were cloned and se-
quenced. Real-time PCR was carried out using a LightCycler (Roche,
Mannheim, Germany). Each RT-PCR reaction mixture (50 l) in-
cluded reverse transcription products corresponding to 50 ng of total
RNA or standard DNA, 1 SYBR Green I master mix (LightCycler
FastStart DNA MasterPLUS SYBR Green I, Roche), and 0.5 M each
forward and reverse primer, mentioned above. Cycling conditions
were as follows: denaturation (95°C for 1 min), amplification and
quantification (95°C for 10 s, 60°C for ASCT2 and 62°C for GAPDH
for 10 s, and 72°C for 5 s, with a single fluorescence measurement at
the end of the 72°C for 5 s segment) repeated 35 times, a melting
curve program (65–95°C with a heating rate of 0.1°C/s and continu-
ous fluorescence measurement), and a cooling step to 40°C. Ampli-
fication specificity was checked using melting curves, following the
manufacturer’s instructions. In addition, PCR products were separated
by electrophoresis in a 2% TBE agarose gel to confirm that correct
band sizes were obtained. Target mRNAs were quantified by measur-
ing the threshold cycle (when fluorescence is statistically significantly
above background) and reading against a calibration curve. Results
were analyzed with LightCycler Software v.3.5 (Roche Applied
Science, Mannheim, Germany) using the second derivate maximum
method. The relative amount of each mRNA was normalized to the
housekeeping gene (GAPDH) mRNA. Each sample was tested in
duplicate.
Drugs. L- and D-Amino acids, 2-aminobicyclo-(2,2,1)-heptane-2-
carboxylic acid (BCH), and N-(methylamino)-isobutyric acid were
purchased from Sigma Chemical (St. Louis, MO). L-[14C]alanine
(specific activity 152 mCi/mmol) was purchased from Amersham
Pharmacia Biotech (Little Chalfont, UK).
Data analysis. Km and maximum velocity (Vmax) values for the
uptake of L-[14C]alanine were determined from a competitive uptake
inhibition protocol (10) and calculated from nonlinear regression
analysis using the GraphPad Prism statistics software package (21).
For calculation of the IC50, the parameters of the equation for one-site
inhibition were fitted to the experimental data (21). Arithmetic means
are given with SE. Statistical analysis was performed by one-way
analysis of variance (ANOVA) followed by Newman-Keuls test for
multiple comparisons. A P value  0.05 was assumed to denote a
significant difference.
RESULTS
Inward transfer of L-alanine. To determine the initial rates of
uptake, SHR and WKY PTE cells were incubated with a
nonsaturating (0.25 M) concentration of L-[14C]alanine for 1,
3, 6, 12, 30, and 60 min. In both types of cells, uptake of
nonsaturating concentration of L-[14C]alanine was linear with
time up to 60 min of incubation (Fig. 1). As depicted in Fig. 1,
the initial rate for L-[14C]alanine uptake was significantly lower
in SHR than in WKY PTE cells.
Since transfer of neutral amino acids across the plasma
membrane can be mediated by both Na-dependent and Na-
independent transport systems, a set of experiments was per-
formed replacing NaCl with an equimolar concentration of
choline chloride to determine a potential Na dependence of
L-[14C]alanine apical uptake. Na removal from the uptake
solution almost completely abolished transport activity in both
SHR and WKY PTE cells (Fig. 2A). Complete Na activation
curves are shown in Fig. 2B. Linearization of data according to
the Hill equation yielded a Hill coefficient of 0.98 and 1.0 for
SHR and WKY PTE cells, respectively. A more detailed
analysis of the Na-dependent L-[14C]alanine uptake using
Fig. 1. Time course of L-[14C]alanine transport in immortalized Wistar-Kyoto
(WKY) and spontaneously hypertensive rat (SHR) proximal tubular epithelial
(PTE) cells. Values represent means of 4–6 experiments per group, and error
bars show SE. Significantly different from values for WKY PTE cells
(*P  0.05).
Fig. 2. A: effect of sodium chloride replacement by an equimolar concentra-
tion of choline chloride on 0.25 M [L-14C]alanine transport. Columns
represent the mean of 4 experiments per group; vertical lines show SE.
B: [L-14C]alanine transport as a function of extracellular sodium concentration
in immortalized WKY and SHR PTE cells. Symbols represent means of 4
experiments per group; error bars show SE. Significantly different from
corresponding control values (*P  0.05) and corresponding values for WKY
PTE cells (#P  0.05).
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Lineweaver-Burk plots revealed the presence of high- and
low-affinity uptake processes in both WKY and SHR PTE cells
(Fig. 3, A and B). The kinetic parameters (Km and Vmax) for the
high- and low-affinity Na-dependent L-[14C]alanine uptake in
WKY and SHR PTE cells are given in Table 1. The effect of
BCH on high- and low-affinity Na-dependent L-[14C]alanine
uptake was also evaluated. In the WKY PTE cells, BCH
induced a decrease in the affinity for Na without changes in
Vmax values, in both low- and high-affinity components, thus
behaving as a competitive inhibitor (Table 1). In the SHR PTE
cells, the effects of BCH on Km and Vmax for the high- and
low-affinity components of Na-dependent L-[14C]alanine up-
take did not attain a statistical significance (Table 1).
The replacement of NaCl by LiCl reduced the transport
activity by 90% in both SHR and WKY PTE cells (Fig. 4A).
Replacing NaCl with NaGlu produced a significant reduction
in L-alanine uptake in both WKY and SHR PTE cells, this
being more marked in the latter (Fig. 4A). The addition of 50
mM KCl, but not of 50 mM NH4Cl, to the uptake solution, a
manipulation that reduces cell membrane potential, resulted in
a slight but statistically significant (P  0.05) reduction
(13% decrease) in L-[14C]alanine uptake (Fig. 4B), suggest-
ing that alanine uptake occurs mainly through nonelectrogenic
transporters.
In the presence of extracellular 140 mM Na, the system A
inhibitor N-(methylamino)-isobutyric acid (MeAIB) had no
inhibitory effect on L-alanine accumulation in both types of
cells (WKY, 91 	 8%, and SHR, 115 	 7% of control).
Subsequent experiments were designed to determine the
apparent kinetics of L-alanine transporters under Na Vmax
experimental conditions (extracellular 140 mM Na). Cells
were incubated for 6 min in the absence or presence of
increasing concentrations of unlabeled substrate (3–3,000
M). The effect of BCH on the kinetic parameters was also
investigated. In both types of cells, the accumulation of
L-[14C]alanine was found to be concentration dependent and a
saturable process (Fig. 5). The apparent kinetic parameters of
L-[14C]alanine uptake, determined by nonlinear analyses of the
inhibition curves, are given in Table 2. The transport capacity
of the saturable component of L-[14C]alanine transport in SHR
was lower than that for WKY PTE cells, at all substrate
concentrations with similar Km values (Table 2). Experiments
were also conducted in the presence of BCH to reduce the
contribution of L-type amino acid transport. In the presence of
BCH, Km values for L-[14C]alanine uptake in SHR PTE cells
were markedly increased without changes in Vmax, whereas Km
values in WKY PTE cells changed only slightly (Table 2).
Substrate selectivity of L-alanine uptake was investigated by
inhibition experiments in which the accumulation of 0.25 M
L-[14C]alanine was measured in the presence of 1 mM unla-
beled amino acids and selective analogs (Fig. 6A). In both cell
lines, L-alanine uptake was markedly (
80%) inhibited by
L-isomers of neutral amino acids, such as alanine, serine,
threonine, and cysteine, which is consistent with amino acid
transport through ASCT2. Nevertheless, the profile of inhibi-
tion differs considerably in the case of other neutral and
aromatic amino acids, such as leucine, isoleucine, phenylala-
nine, methionine, tyrosine, and histidine, which, in WKY PTE
cells, produced moderate inhibition (10–50%). By contrast, in
SHR PTE cells, neutral and aromatic amino acids produced a
high degree of inhibition (75–90%) on L-[14C]alanine uptake.
The basic amino acids lysine and arginine also reduced the
accumulation of L-[14C]alanine in SHR PTE cells. In WKY
Table 1. Na-Km and Vmax values for uptake of
L -[14C]alanine in immortalized WKY and SHR PTE cells
WKY SHR
Na-Km Vmax Na-Km Vmax
Vehicle
High affinity 18	1 59	2 9	1 15	1
Low affinity 55	4† 105	3† 182	14† 111	23†
BCH, 3 mM
High affinity 29	3* 58	2 23	8 14	4
Low affinity 155	12*† 118	5† 105	33† 58	18†
Values are means 	 SE of 6 experiments/group; Na-Km (mM). Vmax,
maximum velocity (pmol  mg protein1  6 min1); WKY, Wistar Kyoto rats;
SHR, spontaneously hypertensive rats; PTE cells, proximal tubular epithelial
cells; BCH, 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid. *Significantly
different from corresponding control values (P  0.05); †significantly differ-
ent from corresponding values for the high-affinity state (P  0.05).
Fig. 3. Lineweaver-Burk reciprocal plots of velocity (V) and substrate con-
centrations ([S]) are presented for L-[14C]alanine transport as a function of
extracellular sodium concentration in immortalized WKY (A) and SHR (B)
PTE cells. Lines were derived from a weighted least squares analysis of the
data points. Inset: Lineweaver-Burk reciprocal plots of velocity and substrate
for the low-affinity component.
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PTE cells, L-alanine uptake was also inhibited by glutamine
and asparagine.
To prove that the uptake of L-[14C]alanine occurs through
system ASC, substrate specificity was examined in the pres-
ence of BCH 3 mM. As shown in Fig. 6B, the SHR cell profile
of inhibition changed considerably, becoming less sensitive to
glycine, isoleucine, phenylalanine, methionine, tyrosine, and
histidine (0–35% inhibition) as well as to cationic amino acids.
By contrast, glutamine was able to reduce significantly
L-[14C]alanine uptake in SHR PTE cells. WKY PTE cells were
less affected by the presence of 3 mM BCH in the uptake
solution.
These results indicate that L-alanine transport in SHR and
WKY PTE cells is largely promoted through a high-affinity,
Na-dependent, Li-sensitive amino acid transporter, insensi-
tive to amino acid analog MeAIB, with specificity for alanine,
serine, and cysteine. These are features of ASC-like activity.
As evidenced by Vmax values, the Na-dependent and Li-
sensitive transport of L-[14C]alanine was lower in SHR than in
WKY PTE cells. However, in SHR PTE cells, L-alanine trans-
port was sensitive to BCH as well as to basic amino acids, and
the absence of Cl in the media inhibited the uptake. These
observations suggest that, in SHR PTE cells, the Na-depen-
dent component might be the combination of system B0, and
ASCT2.
Expression of ASCT2. The presence of ASCT2 protein in
SHR and WKY PTE cells was studied by means of immuno-
blotting using an antibody raised against ASCT2. As shown in
Fig. 7, antibodies against ASCT2 recognized the presence of
the protein in immortalized WKY and SHR PTE cells and in
renal cortical membranes from WKY and SHR. The abundance
of ASCT2 (corrected for -actin) was lower in SHR than in
WKY PTE cells (Fig. 7A). The reduced ASCT2 protein ex-
pression in SHR PTE cells correlates positively with the lower
transport capacity observed in SHR PTE cells compared with
WKY PTE cells. The reduced ASCT2 protein expression in the
SHR was also observed in renal cortical membranes in both 4-
and 12-wk-old rats (Fig. 7, B and C).
ASCT2 transcript abundance. Detection of ASCT2 tran-
script in immortalized PTE cells and kidney cortices from
WKY and SHR at 12 wk of age was performed by conven-
tional RT-PCR, using rat-specific primers. As depicted in
Fig. 8A, all samples amplified the expected 650-bp fragment.
Transcript abundance of ASCT2 was measured by quantitative
real-time PCR in immortalized PTE cells and kidney cortices
from WKY and SHR. The expression of the ASCT2 transcript
was normalized to that of the housekeeping gene GAPDH,
which was identical in WKY and SHR. Data are presented as
Fig. 4. Ion dependence of L-[14C]alanine transport in immortalized WKY and
SHR PTE cells. A: replacement of NaCl with equimolar concentrations of
lithium chloride and sodium gluconate. B: addition of 50 mM KCl or 50 mM
NH4Cl; the control medium contained 100 mM sucrose to maintain osmolarity.
Columns represent the mean of 4–6 experiments per group; error bars show
SE. Significantly different from corresponding control values (*P  0.05).
Fig. 5. Effect of increasing concentrations of L-alanine ([Ala]; 3, 10, 30, 100,
300, 1,000 and 3,000 M) on the uptake of L-[14C]alanine (0.25 M) in WKY
(A) and SHR (B) PTE cells in the absence and in the presence of 2-aminobi-
cyclo-(2,2,1)-heptane-2-carboxylic acid (BCH; 1 and 3 mM). Symbols repre-
sent means of 4–8 experiments per group; vertical lines show SE.
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the ratio of ASCT2 to GAPDH. The mRNA expression of
ASCT2 was lower (P  0.05) in WKY than in SHR PTE cells
(Fig. 8B), which is not consistent with higher ASCT2 protein
in WKY than in SHR PTE cells. Posttranscriptional events
may be responsible for the low expression of ASCT2 protein in
SHR cells, as previously reported by Tailor et al. (36). As
depicted in Fig. 8C, the expression of ASCT2 transcript was
markedly lower in SHR than in WKY rat kidney cortices, at
both 4 and 12 wk of age, which correlated well with differ-
ences in ASCT2 protein expression between WKY and SHR.
ASCT2 mRNA decreased with age in both WKY and SHR.
Detection of B0, transcript. To explore the possible in-
volvement of system B0,, a Na- and Cl-dependent amino
acid transporter sensitive to BCH as well as neutral and basic
amino acids (35, 41), conventional RT-PCR was performed in
immortalized PTE cells and kidney cortices from WKY and
SHR. A specific primer set, designed based on the rat B0,
sequence NM_00103744, was used. As shown in Fig. 9, the
expected 400-bp fragment corresponding to B0, was present
only in the SHR immortalized PTE cells.
DISCUSSION
The present study shows that renal WKY and SHR PTE cells
take up L-[14C]alanine mainly through the high-affinity Na-
dependent amino acid transporter system ASCT2. The SHR
PTE cells were found to be endowed with lower expression
level and function of ASCT2. Furthermore, findings described
here in immortalized WKY and SHR PTE cells are consistent
with that occurring in vivo in WKY and SHR. In fact, the
abundance of ASCT2 transcript and protein in kidney cortices
was also markedly lower in SHR than in normotensive WKY.
Although the expression of ASCT2 in renal epithelial cells
has been reported previously (3, 11, 15), it was only recently
that functional evidence for ASC-like activity in the apical
membrane of kidney epithelial cells was observed. Oppedisano
and co-workers observed transport activity with characteristics
of ASCT2 (22, 23) in liposomes obtained from rat renal apical
plasma membranes. The immortalized renal PTE cells from
WKY and SHR are well-established models in our laboratories
(25, 26, 29, 30) that have been used to evaluate both the
diversity and the regulation of amino acid transport systems
(29). In the present study, L-alanine was used to assess the
presence of ASCT2, one of the transport systems responsible
for the Na-dependent inward transfer of this amino acid.
Fig. 6. L-Amino acid inhibition of the uptake of 0.25
M L-[14C]alanine in immortalized WKY and SHR
PTE cells in the presence of 140 mM NaCl (A) and 140
mM NaCl with 3 mM BCH (B). Columns represent the
mean of 4–6 experiments per group; error bars
show SE.
Table 2. Kinetic parameters for uptake of L-[14C]alanine in
immortalized WKY and SHR PTE cells
WKY SHR
Km Vmax Km Vmax
L-Alanine 110	11 32,554	2,766 60	3* 13,816	628*
L-Alanine 1 mM
BCH 152	13† 32,862	2,573 141	20† 18,657	2,861*
L-Alanine 3 mM
BCH 152	8† 29,979	1,491 208	16†* 15,961	1,492*
Values are means	 SE of 16 experiments/group; Km (M); Vmax (pmol  mg
protein1  6 min1). Significantly different from WKY cells (*P  0.05) and
without BCH (†P  0.05).
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However, transport systems B0 and ASCT2 are most likely to
be responsible for the Na-dependent uptake of alanine in
kidney brush border membranes. WKY and SHR PTE cells
transport quite efficiently L-alanine through the apical cell
border, and several findings suggest that this uptake process is
a facilitated mechanism and proceeds through ASCT2. Most of
L-[14C]alanine entered the cells in a Na-dependent manner,
and only a minor component of L-[14C]alanine uptake (10–
15%) was found not to require extracellular Na. The Na
activation Hill coefficient of unity indicates a 1:1 Na-to-
alanine activation stoichiometry for secondary active transport
in both cell lines. However, in-depth analysis of this process
revealed the presence of high- and low-affinity states for the
Na-dependent L-[14C]alanine uptake in both cell lines. Al-
though this could be interpreted as the presence of two trans-
porter entities, it is likely that this is not the case. In fact, at low
extracellular Na concentrations, the Na-dependent L-[14C]
alanine uptake in both WKY and SHR PTE cells is a high-
affinity, low-capacity process, and increases in extracellular
Na reduced the affinity for the substrate but increased the
capacity to take up L-[14C]alanine. Another finding that sup-
ports this suggestion is that BCH decreases the affinity of the
transporter but does not affect the Na-dependent L-[14C]ala-
nine uptake, this being particularly evident for WKY PTE
cells. It is also likely that differences in the Na-dependent
L-[14C]alanine uptake between WKY and SHR cells may be
related to the presence of two different Na-dependent
L-[14C]alanine transporters in the latter, as discussed below.
The L-[14C]alanine uptake was unaffected by MeAIB, sug-
gesting that inward transfer in WKY and SHR PTE cells was
not promoted by the system A. BCH only reduced L-[14C]
alanine uptake 25%; this low level of sensitivity to BCH
supports the view that L-alanine transport is mediated by an
ASC-like transporter. Furthermore, L-[14C]alanine uptake was
also found to be markedly inhibited by Li. Small neutral
amino acids such as alanine, serine, and cysteine significantly
inhibited the uptake of L-[14C]alanine in both cell lines. System
B0 is largely electrogenic, with high affinity for phenylalanine
(7). The uptake of L-[14C]alanine in WKY and SHR PTE cells
was largely nonelectrogenic. In the presence of BCH (to
Fig. 7. Immunoblot analysis of ASCT2 amino
acid transporter in immortalized WKY and
SHR PTE cells (A) and in kidney cortices from
WKY and SHR [at 4 wk (B) and 12 wk of age
(C)]. Each lane contains an equal amount of
protein (60 g). Western blot analysis was
repeated 3 times. Significantly different from
corresponding values for WKY PTE cells (*P
0.05).
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exclude the role of system L), L-[14C]alanine uptake in SHR
and WKY PTE cells was less sensitive to phenylalanine than to
alanine. Taken together, these results indicate that the Na-
dependent alanine uptake in SHR and WKY cells proceeds
mainly through the Na-dependent neutral amino acid ASCT2
transporter and not by systems B0 and A. This suggestion
agrees with data in previous reports that characterized the
Na-dependent alanine uptake in renal epithelial cells (19, 34).
In SHR PTE cells, the ability of the transporter to take up
L-[14C]alanine appeared to be lower than that observed in
WKY PTE cells. As shown in time course experiments, the
initial rate of L-[14C]alanine uptake in SHR PTE cells was
already two times lower than that in WKY PTE cells. In
addition, the saturable component of Na-dependent
L-[14C]alanine transport under Vmax conditions in SHR was
one-half that in WKY PTE cells. In the presence of BCH, the
system L inhibitor, Km values for transport increased and
became similar in both cell lines. The Km values reported here
are in close agreement with those described previously for
human ASCT2 expressed in Xenopusoocytes (169.7 M)
(24) and for the pig kidney epithelial cell line LLC-PK1 (380
M) (19). Furthermore, differences in the magnitude of Na-
dependent L-[14C]alanine uptake through ASCT2 between
WKY and SHR PTE cells correlated positively with differ-
ences in the expression of ASCT2 protein, this being more
abundant in WKY than in SHR PTE cells. The discrepancy
between mRNA concentration and protein expression observed
in SHR PTE cells might be related to posttranscriptional
events. Several levels of nuclear posttranscriptional events can
be regulated, such as the control of splicing efficiency, precur-
sor RNA stability, polyadenylation, or RNA transport (2).
Whether this overproduction in SHR involves a cis- or trans-
regulatory mechanism or whether any labile protein factor
affected the regulation is unknown. Studies to elucidate the
molecular mechanism of mASCT2 overproduction in SHR
PTE cells are required.
Different routes for alanine uptake are present in SHR PTE
cells. SHR cells, but not WKY cells, were also found to take up
L-[14C]alanine in a Cl-dependent manner (45% of L-alanine
uptake) that, in the absence of BCH, was sensitive to inhibition
by leucine, isoleucine, phenylalanine, methionine, tyrosine,
and histidine and to the cationic amino acids lysine and
arginine. The Na- and Cl-dependent L-[14C]alanine trans-
porter most likely involved corresponds to system B0,, a
transporter sensitive to BCH, neutral and basic amino acids
(35, 41). Thus the major Na-dependent L-alanine transporter
in WKY cells is ASCT2, contributing to 85% of the total
L-alanine uptake. By contrast, in SHR cells Na-dependent
component may result of ASCT2 (55%) and system B0,
(45%). A minor contribution to L-alanine uptake by Na-
independent transporters is also observed in both cell lines.
To determine whether the findings obtained in immortalized
WKY and SHR PTE cells might reflect the in vivo situation, a
set of experiments was conducted in renal cortices from SHR
Fig. 8. A: RT-PCR detection of ASCT2 in total RNA extracted from WKY
and SHR PTE cells and kidney cortices from WKY and SHR (12 wk of age).
MW, GeneRuler DNA Ladder Mix (MBI, Fermentas). B and C: abundance of
ASCT2 transcript in WKY and SHR PTE cells (B) and in kidney cortices from
WKY and SHR (4 and 12 wk of age) (C). Results are expressed as ratio to
GAPDH, as determined by quantitative real-time PCR. Arithmetical mean
values were used to calculate the percentage of control levels. Data are
means 	 SE. *Significantly different from WKY (P  0.05) and significantly
different from 4 wk of age (P  0.05).
Fig. 9. RT-PCR detection of system B0, in total RNA extracted from WKY
and SHR PTE cells and kidney cortices from WKY and SHR (12 wk of age).
MW, GeneRuler DNA Ladder Mix (MBI, Fermentas).
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and WKY rats of 4 and 12 wk of age. An ASCT2-specific
fragment was detected in the mRNA samples from the rat
kidney, suggesting that this transporter was also expressed in
renal cortices. The quantitative real-time PCR experiments
correlated positively with data from immunoblots, which indi-
cated that the expression of ASCT2 in renal cortices from SHR
was lower than that in the WKY. This suggests that immortal-
ized SHR and WKY PTE cells constitute a good experimental
model for the study of ASCT2.
Neutral amino acid transporter ASCT2 displays substrate-
induced Na antiport activity; therefore, as an obligatory
exchanger, it cannot mediate net amino acid uptake (6). Thus
the role of ASCT2 in proximal tubule homeostasis is that of a
mechanism for the delivery of glutamine for ammoniagenesis
(4, 8) and for the removal of other small neutral amino acids
from the extracellular space, maintaining their low extracellu-
lar levels. ASCT2 belongs to a restricted group of transporters
that share specificity for glutamine, since glutamine is the
major precursor of urinary ammonia, thus playing a key role in
acid-base homeostasis. Interestingly, however, glutamine was
higher in muscle and plasma of SHR at 6 wk of age and
thereafter (12). These differences, because they occurred most
strikingly in SHR during the prehypertensive state, were sug-
gested to be related to the development of hypertension (12).
However, ammonium urinary excretion was identical in WKY
and SHR (31). The possibility that the SHR uses less glutamine
in renal ammoniagenesis because of underexpression of
ASCT2 needs to be evaluated.
Another interesting observation is that ASCT2 has been
shown to be regulated by nitric oxide (NO) in the human
intestinal cell line Caco-2 (39). NO is inactivated by reaction
with superoxide (O2) to produce peroxynitrite. In the kidney of
SHR the regulation of renal oxygen consumption by NO is
impaired (1), due to the increased superoxide production ob-
served in this model of hypertension (33, 42, 43). NO avail-
ability in the kidney is decreased in SHR, resulting in increased
oxygen consumption. By lowering intrarenal oxygen levels,
reduced NO may contribute to susceptibility to renal injury (1).
Taken together, these observations and those described in the
present study suggest that, in SHR, oxidative stress might be
downregulating ASCT2 by decreasing intrarenal NO availabil-
ity. Therefore, the modulation of renal ASCT2 transporter in
hypertension is worthy of further attention.
In conclusion, immortalized SHR and WKY PTE cells take
up L-alanine mainly through a high-affinity Na-dependent
amino acid transporter, with functional features of ASCT2
transport. The activity and expression of the ASCT2 trans-
porter were considerably lower in the SHR cells. As a com-
pensatory mechanism, in SHR cells, L-alanine is also trans-
ported by other amino acid transport systems, namely B0,,
that account for 45% of total Na-dependent L-[14C]alanine
uptake. Finally, findings obtained in immortalized cells match
those in vivo: ASCT2 is underexpressed at the kidney cortex
level in the SHR.
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The presence of high and low sodium affinity states for the Na+-dependent [14C]-L-alanine uptake in
immortalized renal proximal tubular epithelial (PTE) cells was previously reported (Am. J. Physiol. 293
(2007) R538–R547). This study evaluated the role of H2O2 on the Na+-dependent [14C]-L-alanine uptake
of ASCT2 in immortalized renal PTE cells from Wistar Kyoto rat (WKY) and spontaneously hypertensive
rat (SHR). Na+ dependence of [14C]-L-alanine uptake was investigated replacing NaCl with an equimolar
concentration of choline chloride in vehicle- and apocynin-treated cells. Na+ removal from the uptake
solution abolished transport activity in both WKY and SHR PTE cells. Decreases in H2O2 levels in the
extracellular medium significantly reduced Na+-Km and Vmax values of the low-affinity high-capacity
component in SHR PTE cells, with no effect on the high-affinity low-capacity state of the Na+-dependent
[14C]-L-alanine uptake. After removal of apocynin from the culture medium, H2O2 levels returned to basal
values within 1 to 3 h in both WKY and SHR PTE cells and these were found stable for the next 24 h.
Under these experimental conditions, the Na+-Km and Vmax of the high-affinity low-capacity state were
unaffected and the low-affinity high-capacity component remained significantly decreased 1 day but
not 4 days after apocynin removal. In conclusion, H2O2 in excess is required for the presence of a low-
affinity high-capacity component for the Na+-dependent [14C]-L-alanine uptake in SHR PTE cells only. It
is suggested that Na+ binding in renal ASCT2 may be regulated by ROS in SHR PTE cells.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Renal absorption of amino acids is accomplished by at least
three different types of Na+-dependent transporters for neutral
amino acids [1]: the proline transporter IMINO/SIT (SLC6A20),
the broad specific neutral amino acid transporter B0AT1 (SLC6A19)
and the neutral amino acid exchanger ASCT2 (SLC1A5). ASCT2 is
present in the brush-border membranes of the proximal tubule
cells and enterocytes in the kidney and intestine, respectively [2].
In addition to its preference for small neutral amino acids (alanine,
serine, and cysteine), it also accepts L-glutamine and L-asparagine
at higher affinity, as well as methionine, leucine and glycine with
lower affinity [3,4]. Additionally, because of its specificity for glu-
tamine, the major precursor of urinary ammonia, ASCT2 plays
and important role in acid–base homeostasis [5]. Recently it has
been shown that the activity and expression of the glutamine/ami-
no acid transporter (ASCT2) were significantly lower in SHR PTEll rights reserved.
rmacology and Therapeutics,
22 5513643.
a@netcabo.pt (P. Soares-da-
37cells, which matched the in vivo findings; ASCT2 was under-ex-
pressed at the kidney cortex level in the SHR [6].
Several lines of evidence point towards the possible regulation
of amino acid transport by oxidative stress [7–10]. Studies by our
group have show that immortalized renal PTE SHR cells generate
more hydrogen peroxide (H2O2) than WKY cells [11]. In SHR cells,
the NADPH oxidase inhibitor apocynin reduced their increased
ability to generate H2O2 and reverted differences in receptor-med-
iated events between WKY and SHR cells [11–13]. Differences be-
tween WKY and SHR PTE cells in their sensitivity to angiotensin II
correlate with the higher H2O2 generation that accompanies an en-
hanced expression of glycosylated and nonglycosylated AT1 recep-
tor forms in lipid rafts [12]. Likewise, the increased generation of
H2O2 was found responsible for the amplification of the response
downstream to alpha2-adrenoceptor activation in SHR PTE cells
[13] as well as the aldosterone-induced stimulation of NHE1 activ-
ity [11].
Although crystallographic studies of Na+-coupled secondary
transporters have greatly advanced the understanding of the struc-
tural principles that underlie transporter function [14–16], the
mechanisms by which these transporters couple substrate and so-
dium transport are still largely unknown. We have previously
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Fig. 1. Effect of sodium chloride replacement by an equimolar concentration of
choline chloride on 0.25 lM [14C]-L-alanine transport. Cells were incubated for
6 min with 0.25 lM [14C]-L-alanine in the presence of BCH (3 mM). Significantly
different from corresponding control values (*P < 0.05) and corresponding values
for WKY PTE cells (#P < 0.05). Symbols represent the mean of four experiments per
group; error bars show S.E.M.
554 V. Pinto et al. / Biochemical and Biophysical Research Communications 398 (2010) 553–558shown that WKY and SHR PTE cells transport L-alanine efficiently
through the apical cell border and several findings suggested this
uptake process is a facilitated mechanism that proceeds through
ASCT2. The Na+ activation Hill coefficient of unity indicates a 1:1
Na+/alanine activation stoichiometry for secondary active trans-
port in both cell lines [6]. At low extracellular Na+ concentrations,
the Na+-dependent [14C]-L-alanine uptake in both WKY and SHR
PTE cells is a high-affinity low-capacity process. Increments in
extracellular Na+, reduced the affinity for the substrate, but in-
creased the capacity to take up [14C]-L-alanine [6].
The aim of this study was, therefore, to determine the role of
H2O2 on the kinetic parameters for Na+-dependent [14C]-L-alanine
uptake and on ASCT2 expression in immortalized renal PTE cells
from WKY and SHR.
2. Methods and materials
2.1. Cell culture
Immortalized renal PTE cells from the WKY and SHR [17] were
maintained as previously described [6]. The cell mediumwas chan-
ged every 2 days, and the cells reached confluence after 3–5 days of
incubation. For 24 h prior to each experiment, the cells were main-
tained in fetal bovine serum-free medium. Experiments were
generally performed 2–3 days after cells reached confluence and
6–8 days after the initial seeding; each cm2 contained about
80–100 lg of cell protein.
2.2. Uptake of L-amino acids
Flux measurements in immortalized renal PTE cells from the
WKY and SHR were performed as previously described [18]. All
experiments were carried out in the presence of BCH (3 mm), to
minimize the contribution of L-type amino acid transports. Satura-
tion experiments were performed in cells incubated for 6 min with
0.25 lM radiolabeled amino acid. In experiments performed to
determine the Na+-dependence of transport, sodium chloride was
replaced by an equimolar concentration of choline chloride. Radio-
activity was measured by liquid scintillation counting.
2.3. Measurement of H2O2
H2O2 was measured fluorometrically using the Amplex™ Red
Hydrogen Peroxide Assay Kit (Molecular Probes, Inc., Eugene,
OR), as described previously [11].
2.4. Immunoblotting
Western blot was performed as previously described [6]. Blots
were incubated anti-ASCT2 polyclonal antibody (1:800; Chemicon
International) or mouse anti-b-Actin (Santa Cruz Biotechnology).
After incubation with fluorescently-labeled goat anti-rabbit
(1:10,000; IRDye™ 800, Rockland) or the fluorescently-labeled
goat anti-mouse secondary antibody (1:5000; AlexaFluor 680,
Molecular Probes) the membrane was washed and imaged by scan-
ning at both 700 and 800 nm, with an Odyssey Infrared Imaging
System (Li-COR Biosciences).
2.5. Drugs
L- and D-Amino acids, 2-aminobicyclo (2,2,1)-heptane-2-carbox-
ylic acid (BCH) and apocynin were purchased from Sigma Chemical
Company, St. Louis, Mo, USA. [14C]-L-alanine (specific activity
152 mCi/mmol) was purchased from Amersham Pharmacia Bio-
tech (Little Chalfont, UK).382.6. Data analysis
Km and Vmax values for the uptake of [14C]-L-alanine, were deter-
mined from a competitive uptake inhibition protocol [19], and cal-
culated from non-linear regression analysis using the GraphPad
Prism statistics software package [20]. For calculation of the IC50
the parameters of the equation for one site inhibition were fitted
to the experimental data [20]. Arithmetic means are given with
S.E.M. Statistical analysis was performed by one-way analysis of
variance (ANOVA) followed by Newman–Keuls test for multiple
comparisons. A P value <0.05 was assumed to denote a significant
difference.
3. Results
3.1. H2O2 and the sodium kinetic parameters for the high and low-
affinity Na+-dependent [14C]-L-alanine uptake
The effect of H2O2 availability on the Na+ dependence of [14C]-L-
alanine uptake was investigated replacing NaCl with an equimolar
concentration of choline chloride in the absence and presence of
apocynin. Na+ removal from the uptake solution almost completely
abolished transport activity in both WKY and SHR PTE cells (Fig. 1).
The sodium concentrations and alanine uptake data were trans-
formed using the Eadie–Hofstee equation. The low- and high-affin-
ity components in both WKY and SHR PTE cells were identified and
subsequently plotted as a double reciprocal Lineweaver–Burk plot
as previously reported [6]. The sodium kinetic parameters (Na+-Km
and Vmax) for the high- and low-affinity Na+-dependent [14C]-L-ala-
nine uptake in WKY and SHR PTE cells are given in Table 1. Treat-
ment with apocynin (100 lM) for 4 days decreased H2O2 levels
[11], but had no effect on the high- and low-affinity states of
Na+-dependent [14C]-L-alanine uptake in WKY PTE cells (Fig. 2A
and B) or on the high-affinity state of SHR PTE cells (Fig. 2C). How-
ever, apocynin significantly decreased the low-affinity high-capac-
ity state (Fig. 2D). Treatment with apocynin (100 lM) for 4 days
significantly reduced Na+-Km and Vmax values of the low-affinity
high-capacity component of Na+-dependent [14C]-L-alanine uptake
(from 361 ± 7 to 48 ± 6 mM, and 137 ± 2 to 40 ± 2 pmol/mg/6 min,
respectively) in SHR PTE cells only. The high-affinity low-capacity
sodium Km and Vmax values of ASCT2 were unaffected by apocynin
treatment.
Table 1
Sodium Km (mM) and Vmax (pmol/mg protein/6 min) values for uptake of [14C]-L-
alanine in immortalized WKY and SHR PTE cells in the presence of BCH (3 mM).
WKY SHR
Na+-Km Vmax Na+-Km Vmax
Vehicle High
affinity
16 ± 1 53 ± 2 21 ± 5 26 ± 3
Low
affinity
111 ± 1# 101 ± 1# 361 ± 7# 137 ± 2#
Apocynin
(100 lM)
High
affinity
15 ± 6 47 ± 7 29 ± 4 32 ± 2
Low
affinity
138 ± 15# 104 ± 7# 48 ± 6*,# 40 ± 2*,#
Values are means ± S.E.M. of eight experiments per group.
* Significantly different from corresponding vehicle values (P < 0.05).
# Significantly different from corresponding values for the high-affinity state
(P < 0.05).
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for the high and low-affinity Na+-dependent [14C]-L-alanine uptake
To evaluate the nature of the relationship between H2O2 avail-
ability and the effects of apocynin on the low-affinity high-capacity
Na+-dependent [14C]-L-alanine uptake, it was decided to determine
whether these effects could be reversed after return of H2O2 pro-
duction to basal values. H2O2 levels were measured before and
after (1, 3, 6 and 24 h) apocynin treatment for 4 days in WKY
and SHR cells. Treatment with apocynin reduced H2O2 levels in-0.12 -0.08 -0.04 0.00 0.04 0.08 0.12
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Fig. 2. Lineweaver–Burk reciprocal plots of velocity and substrate concentrations for
immortalized (A and B) WKY PTE cells, (C and D) SHR PTE cells. Lineweaver–Burk recipro
components in the presence of BCH (3 mM). Points: mean of two observations within a
weighted least-squares analysis of the data points.
39the extracellular medium by 20% in WKY PTE cells and 30% in
SHR PTE cells (Fig. 4A and B). H2O2 levels returned to control values
1 and 3 h after apocynin removal in both WKY and SHR PTE cells,
respectively. Thereafter, H2O2 levels were kept stable up to 24 h
after apocynin withdrawal (Fig. 4A and B). Therefore, in this new
set of experiments the Na+-dependent [14C]-L-alanine uptake was
evaluated 1 and 4 days after apocynin removal in SHR PTE cells
treated for 4 days with the antioxidant. Despite apocynin removal
and the return of H2O2 levels to control values, Lineweaver–Burk
plots show that the high-affinity low-capacity Na+-dependent
[14C]-L-alanine uptake was not affected in apocynin-treated cells
(Fig. 3A), whereas the low-affinity high-capacity component of
Na+-dependent [14C]-L-alanine uptake was markedly reduced in
apocynin-treated cells (Fig. 3B). However, 4 days after apocynin re-
moval (Fig. 3C and D) the low-affinity high-capacity Na+-depen-
dent [14C]-L-alanine uptake was restored (Fig. 3D). Sodium
kinetic parameters for the high- and low-affinity Na+-dependent
[14C]-L-alanine uptake were determined and results show that
1 day after H2O2 levels were restored, sodium Km and Vmax values
of the low-affinity high-capacity component were still reduced,
but not 4 days later (Table 2), indicating that the effect of apocynin
is not long lasting and that H2O2 in excess is required to maintain
normal sodium Km and Vmax values in SHR PTE cells.
3.3. Expression of ASCT2
The presence of ASCT2 protein in WKY and SHR PTE cells was
studied by means of immunoblotting using an antibody raised-0.12 -0.08 -0.04 0.00 0.04 0.08 0.12
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Fig. 3. Lineweaver–Burk reciprocal plots of velocity and substrate concentrations for [14C]-L-alanine transport as a function of extracellular sodium concentration in
immortalized SHR PTE cells after treatment with apocynin (100 lM) for 4 days and without apocynin for 1 and 4 days before each experiment. Lineweaver–Burk reciprocal
plots of velocity and substrate for the (A and C) high and (B and D) low-affinity components in the presence of BCH (3 mM). Points: mean of two observations within an
experiment, representative of six separate experiments. Lines were derived from a weighted least-squares analysis of the data points.
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the protein in immortalized WKY and SHR PTE cell lines. The abun-
dance of ASCT2 (corrected for b-actin) in SHR PTE cells was lower
than in WKY PTE cells (Fig. 4C), which correlates positively with
the lower transport capacity observed in SHR PTE cells when com-
pared to WKY PTE cells. Treatment with apocynin (100 lM) for
4 days had no effect on ASCT2 expression in both cell lines
(Fig. 4C).
4. Discussion
In the present study inhibition of H2O2 production by apocynin
during cell growth was shown to significantly reduce Na+-Km and
Vmax values of the low-affinity high-capacity component of Na+-
dependent [14C]-L-alanine uptake in immortalized SHR PTE cells.
The evaluation of several amino acid transport systems using
immortalized renal PTE cells from WKY and SHR has been well
documented in our group [6,18,21,22]. Recent studies indicate that
WKY and SHR PTE cells take up [14C]-L-alanine mainly through the
high-affinity Na+-dependent amino acid transporter system ASCT2.
Moreover, SHR PTE cells were found to have a lower expression
level and function of ASCT2 [6]. The System A and System N trans-
porters of the SLC38 family each mediate Na+-dependent transport
of small, zwitterionic (net neutral) amino acids and exhibit marked
inhibition at low extracellular pH [23]. The uptake of L-alanine in
the SHR cells was not sensitive to pH. In the presence of extracel-
lular 140 mM Na+, system A inhibitor N-(methyamino)-isobutyric
acid (MeAIB), had no inhibitory effect on the L-alanine accumula-
tion in both types of cells (WKY, 97 ± 8% and SHR, 115 ± 7% of40control) [6]. This suggests that the inward transfer of L-alanine in
WKY and SHR cells is not promoted by SNAT’s (SLC38). On the
other hand, system B (SLC6) is highly electrogenic, with high affin-
ity for phenylalanine [24]. Contrasting, L-alanine uptake in the
WKY and SHR cells was significantly inhibited by small amino
acids, such as alanine, serine and cysteine. Besides, the uptake of
L-alanine in WKY and SHR cells was largely non-electrogenic [6].
Since the imbalance between NO and reactive ROS production is
an important factor in the development of hypertension [25,26],
we hypothesised whether oxidative stress could have an effect
on ASCT2 regulation and function. The effect of decreased avail-
ability of H2O2 on [14C]-L-alanine uptake was determined using
apocynin. Apocynin has antioxidant properties and reduces ROS
production in vivo and in vitro [27]. It inhibits the membrane
recruitment of regulatory cytosolic NADPH oxidase subunits such
as p47phox, p67phox, and rac-1 by direct interaction with p47phox
[28]. Previous studies have shown that SHR PTE cells are endowed
with an increased capacity to generate H2O2 when compared with
WKY PTE cells and treatment with apocynin for 4 days reduces sig-
nificantly the rate of H2O2 production in WKY and SHR PTE cells
[11]. The experiments described here were designed to evaluate
the effect of H2O2 availability on the sodium high- and low-affinity
states for the Na+-dependent [14C]-L-alanine uptake in WKY and
SHR PTE cells. As previously described [6], Lineweaver–Burk plots
from data obtained in the present study also revealed the presence
of high- and low-affinity states for the Na+-dependent [14C]-L-ala-
nine uptake processes in both cell lines. At low extracellular Na+
concentrations, the Na+-dependent [14C]-L-alanine uptake in both
WKY and SHR PTE cells is a high-affinity low-capacity process
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Fig. 4. Extracellular H2O2 in A) WKY and B) SHR PTE cells in the presence of
apocynin (4 days after seeding) and after 1, 3, 6 and 24 h following apocynin
removal. Each column represents the mean of six experiments per group; vertical
lines indicate SEM. Significantly different from values for control (*P < 0.05). (C)
ASCT2 protein expression in immortalized WKY and SHR PTE cells and effect of
apocynin (100 lM) for 4 days on ASCT2 protein expression. Each lane contains
equal amount of protein (60 lg), Western blotting was repeated 6. b-Actin was
used as a control. Significantly different from corresponding control values
(*P < 0.05).
Table 2
Sodium Km (mM) and Vmax (pmol/mg protein/6 min) values in the presence of BCH
(3 mM) for uptake of [14C]-L-alanine in immortalized SHR PTE cells after treatment
with apocynin 100 lM for 4 days and subsequent removal for 1 and 4 days.
1 day 4 days
Na+-Km Vmax Na+-Km Vmax
Vehicle High
affinity
16 ± 3 23 ± 2 14 ± 2 28 ± 1
Low
affinity
218 ± 26# 96 ± 8# 274 ± 8# 105 ± 2#
Apocynin
(100 lM)
High
affinity
16 ± 1 19 ± 1 18 ± 5 24 ± 3
Low
affinity
55 ± 8*,# 27 ± 2*,# 320 ± 38# 107 ± 10#
Values are means ± S.E.M. of eight experiments per group.
* Significantly different from corresponding vehicle values (P < 0.05).
# Significantly different from corresponding values for the high-affinity state
(P < 0.05).
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strate, but increased the capacity to take up [14C]-L-alanine. Apocy-
nin treatment during cell growth (4 days) had no effect on the
high- and low-affinity states of Na+-dependent [14C]-L-alanine up-
take in WKY PTE cells or on the high-affinity state of SHR PTE cells.
However, the reduction in H2O2 levels significantly decreased the
Na+-Km and Vmax of the low-affinity high-capacity component of
[14C]-L-alanine uptake in SHR PTE cells. These results suggest that
when H2O2 levels are reduced after apocynin treatment the Na+-
dependent [14C]-L-alanine uptake by ASCT2 in SHR PTE cells func-
tions predominantly as a high-affinity low-capacity transporter.
We have previously found (data not shown) that treatment with41a non toxic concentration (100 lM) of exogenous H2O2 (for
21 min or 1 day) failed to change the Na+-Km and Vmax values for
the Na+-dependent [14C]-L-alanine uptake, possibly due to the
rapid decomposition of H2O2 by catalase.
There have been recent crystallographic advances relating to
Na+-coupled transporters specifically about the coupling of sub-
strates to ions, the conformational state of the transporter at differ-
ent stages of the transport cycle and how the substrate and ion
pathway is alternately opened and closed, or gated, to maintain a
tightly coupled transport mechanism [29–31]. Sodium ions have
been shown to be ‘gate-keepers’ of aspartate transporter GltPh
and other members of this Na+-coupled transporter family, includ-
ing ASCT2, which has a similar structural fold [16]. In the present
study ROS have been shown to be important in modulating sodium
coupling in SHR PTE cells. The mechanism by which this occurs is
still not known. However, it is possible that oxidative stress may
have an effect on the conformations of ASCT2 in SHR PTE cells as
they proceed through the transport cycle, which may result in dif-
ferential sodium binding and unbinding. ROS may also have an ef-
fect on steric, chemical and electrical properties of the sodium
binding site. Nevertheless, ROS has shown to regulate other amino
acid transport systems in different cell models. Oxidative stress
was shown to stimulate NMDA receptor activity [8,32] and the
Ca2+-independent carrier-mediated release of glutamate and
aspartate from cultured retina cells [33,34]. On the other hand,
reuptake of glutamate in astrocytes, a critical mechanism involved
in the maintenance of physiological excitatory amino acid neuro-
transmission, is inhibited by ROS [35].
The results show that the apocynin effects were long lasting but
reversible. The reversal process is not immediate and an adaption
period is needed in order to restore basal Na+-Km and Vmax values.
As previously suggested, H2O2 may affect steric, chemical and elec-
trical properties of the sodium binding site as well as the confor-
mational state of the transporter. Though H2O2 production is
recovered within 1 day after apocynin removal the apocynin-asso-
ciated changes of the Na+-dependent [14C]-L-alanine uptake take
longer (at least 4 days) to return to its initial state of activity.
Apocynin was also found not to alter ASCT2 protein expression in
either WKY or SHR PTE cells. ASCT2 expression was found to be
lower in SHR than WKY PTE cells as previously described [6].
5. Conclusions
It is concluded that ROS production during growth of the cell
monolayer is essential for maintaining a low-affinity high-capacity
component of Na+-dependent [14C]-L-alanine uptake in immortal-
ized SHR PTE cells. Finally, data gathered here suggest that the
558 V. Pinto et al. / Biochemical and Biophysical Research Communications 398 (2010) 553–558modulation of Na+ binding to ASCT2 is dependent on increased
hydrogen peroxide production exclusively in SHR PTE cells.
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Abstract This study evaluated the effects of aldosterone
upon Na+/H+ exchange (NHE) activity in immortalized
proximal tubular epithelial (PTE) cells from the sponta-
neously hypertensive rat (SHR) and the normotensive
controls (Wistar Kyoto rat; WKY). Increases in NHE
activity after exposure to aldosterone occurred in time- and
concentration-dependent manner in SHR PTE cells, but not
in WKY PTE cells. The aldosterone-induced increases in
NHE activity were prevented by spironolactone, but not by
the glucocorticoid receptor antagonist Ru 38486. The
presence of the mineralocorticoid receptor transcript was
confirmed by PCR and NHE1, NHE2, and NHE3 proteins
were detected by immunoblot analysis. Cariporide and
EIPA, but not S3226, inhibited the aldosterone-induced
increase in NHE activity, indicating that NHE1 is the most
likely involved NHE isoform. Pretreatment of SHR PTE
cells with actinomycin D attenuated the aldosterone-
induced increases in NHE activity. The SHR PTE cells had
an increased rate of H2O2 production when compared with
WKY PTE cells. Treatment of cells with apocynin, a
NADPH oxidase inhibitor, markedly reduced the rate of
H2O2 production. The aldosterone-induced increase in
NHE activity SHR PTE cells was completely prevented by
apocynin. In conclusion, the aldosterone-induced stimula-
tion of NHE1 activity is a genomic event unique in SHR
PTE cells, which involves the activation of the mineralo-
corticoid receptor, but ultimately requires the availability
of H2O2 in excess.
Keywords Na+/H+ exchanger  NHE1  Aldosterone 
H2O2  Hypertension  SHR  WKY
Introduction
Aldosterone is a steroid hormone secreted by the adrenal
cortex. This mineralocorticoid is the final endocrine signal
in the rennin–angiotensin–aldosterone system that is
responsible for Na+ reabsorption and K+ secretion in the
kidney and colon [1]. Consequently, it plays a pivotal role
in the control of blood volume and thus blood pressure. The
classical final effectors of aldosterone action are the apical
ENaC, the basolateral Na+–K+–ATPase and the Na+/H+
exchanger 3 (NHE3) located in the proximal tubule [2].
Aldosterone was shown to have short- and long-term
effects on the Na+-K+-ATPase and on the ENaC. The
transcriptional effects on these ion transporters occur after
4 h [3]. Aldosterone enters the cell by diffusion through the
cellular membrane and once in the cytoplasm it binds to an
intracellular receptor, the mineralocorticoid receptor (MR).
As has been shown, in the collecting duct, long-term
effects are dependent on the activation of the serum-and-
glucocorticoid-regulated kinase (SGK) which occurs after
aldosterone binds to the MR [4]. Other studies have also
shown that aldosterone also stimulates epidermal growth
factor receptor (EGFR) expression in the kidney [5].
Steroid hormones, however, have the ability to act
through non-genomic mechanisms as well as genomic. The
V. Pinto  M. J. Pinho  P. Soares-da-Silva (&)
Faculty of Medicine, Institute of Pharmacology
and Therapeutics, Porto 4200, Portugal
e-mail: psoaresdasilva@netcabo.pt
U. Hopfer
Department of Physiology and Biophysics, Case Western
Reserve School of Medicine, Cleveland, OH, USA
P. A. Jose
Department of Pediatrics, Georgetown University, Washington,
DC, USA
123
Mol Cell Biochem
DOI 10.1007/s11010-007-9680-6
43
non-genomic action is characterized by a rapid onset
(within seconds to minutes) after aldosterone administra-
tion and by the lack of sensitivity to transcription and
translation inhibitors [6]. In Madin–Darby canine kidney
(MDCK) cells aldosterone makes use of the EGFR-ERK1/
2 cascade to bring out its rapid effects [7, 8].
Recent studies have shown that aldosterone stimulates
surface expression of NHE3 in rat renal proximal tubular
brush borders [9]. Furthermore, aldosterone stimulates not
only the surface expression but also the activity of NHE3 in
human primary renal proximal tubular epithelial (PTE) cells
[10]. The NHE is a protein found in many mammalian cell
types responsible for intracellular pH and cell volume reg-
ulation by exchanging protons localized in the cell for
sodium ions. Seven isoforms of NHE have already been
identified and cloned [11]. NHE1, 2 and 3 have been local-
ized in the kidney [11, 12] and in MDCK-C11 cells.
Aldosterone is thought to activate NHE1 activity through
non-genomic stimulation [8, 13]; however, information
concerning the long-term effect of aldosterone on NHE1 is
scarce.
Abnormal aldosterone signaling or hyperactivity of its
final effectors has been associated to steroid hypertension in
humans [14]. Hypertension has also been linked to oxida-
tive stress. Oxidative stress has been observed in a number
of models of hypertension including in the spontaneous
hypertensive rat (SHR) [15] and in the mineralocorticoid
hypertensive rat [16]. Studies have shown that aldosterone
directly induces reactive oxygen species (ROS) generation
through the activation of NADPH oxidase in the salt-loa-
ded, aldosterone-infused hypertensive rats [17], as well as
in rat mensagial cells [18]. In mineralocorticoid hyperten-
sive rats prolonged antioxidant administration normalizes
superoxide accumulation and attenuates hypertension [19].
The aim of this study was to investigate the effects of
aldosterone on NHE activity in immortalized renal PTE cells
from the SHR and its normotensive control, the Wistar–
Kyoto rat (WKY), and to determine whether oxidative stress
is involved in aldosterone actions on NHE activity.
Materials and methods
Cell culture
Immortalized renal PTE cells from 4- to 8 week-old WKY
and SHR animals [20] were maintained in a humidified
atmosphere of 5% CO2-95% air at 37C. WKY and SHR
PTE cells were grown in Dulbecco’s modified Eagle’s
medium nutrient mixture F-12 Ham (Sigma Chemical
Company, St. Louis, MO, USA) supplemented with 100
U/ml penicillin G, 0.25 lg/ml amphotericin B, 100 lg/ml
streptomycin (Sigma), 4 lg/ml dexamethasone (Sigma),
5 lg/ml transferrin (Sigma), 5 lg/ml insulin (Sigma), 5
ng/ml selenium (Sigma), 10 ng/ml epidermal growth factor
(Sigma), 5% fetal bovine serum (Sigma) and 25 mM N-2-
hydroxyethylpiperazine-N0-2-ethanosulfonic acid (HEPES;
Sigma). For subculturing, the cells were dissociated with
0.10% trypsin-EDTA, split 1:4 and subcultured in Costar
plates with 21-cm2 growth areas (Costar, Badhoevedorp,
The Netherlands). For pHi measurement experiments, cells
were grown in 96 well plates (Costar). On the day of each
experiment, the cells were maintained in fetal bovine
serum-free medium for 2 h. Experiments were generally
performed 1–2 days after cells reached confluence and
4–5 days after the initial seeding; each cm2 contained
about 50 lg of cell protein.
NHE activity
NHE activity was assayed as the initial rate of intracellular
pH (pHi) recovery after an acid load imposed by 20 mM
NH4Cl followed by removal of Na
+ from the Krebs’
modified buffer solution (in mM: NaCl 140, KCl 5.4,
CaCl2 2.8, MgSO4 1.2, NaH2PO4 0.3, HEPES 10, glucose
5, and pH 7.4) in the absence of CO2/HCO3. In these
experiments NaCl was replaced by an equimolar concen-
tration of tetramethylammonium chloride (TMA). In
intracellular pH measurement experiments, WKY and SHR
PTE cells were grown in 96 well plates. The cell culture
medium was aspirated and the cell monolayers were
incubated for 30 min with 10 lM BCECF/AM, the mem-
brane-permeant acetoxymethyl ester derivative of 20,70-bis
(carboxyethyl)-5,6-carboxyfluorescein (BCECF) at 37C in
5% CO2–95% air atmosphere. Cells were placed in the
sample compartment of a dual-scanning microplate spec-
trofluorometer (Spectramax Gemini XS, Molecular
Devices, Sunnyvale, USA), and fluorescence was measured
every 17 s alternating between 440 and 490 nm excitation
at 535 nm emission, with a cutoff filter of 530 nm. The
ratio of intracellular BCECF fluorescence at 490 and
440 nm was converted to pHi values by comparison with
values from an intracellular calibration curve using the
nigericin (10 lM) and high-K+ method [21, 22].
Intracellular buffering capacity was determined from the
pHi response to the removal of NH3/NH4
+ using the following
formula: intracellular buffering capacity (bI)=K[NH4
+]i/KpHi
where [NH4
+]i is the intracellular concentration just before
NH3/NH4
+ removal, calculated as [NH4
+]i =[NH4
+]0 9 10
(7.4-pHi)
and KpHi is the pHi change on removal of NH4
+ [23].
In experiments aimed to evaluate the sensitivity of the
Na+-dependent pHi recovery to selective inhibitors of NHE
isoforms, cells were treated with increasing concentrations
of 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) or vehicle for
0.5 h before starting the Na+-dependent pHi recovery.
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Reverse transcription (RT)-PCR
To identify the presence of the MR, immortalized renal
PTE WKY and SHR samples were examined by Reverse
trancriptase-PCR analysis. Cells were homogenized (Diax,
Heidolph) in Trizol Reagent (75 mg/ml; Invitrogen) and
total RNA was extracted according to manufacturer’s
instructions. The RNA preparation was further treated with
DNase (Ambion), to eliminate potential genomic DNA
contamination. Reverse transcription was performed with
SuperScript First Strand System for RT-PCR (Invitogen),
using 5 lg/ll random hexamers as primers at 50C,
according to manufacturer’s instructions. cDNA was syn-
thesized from 1 lg of total RNA in a total volume of 20 ll.
PCR was performed on 5 ll of cDNA using degenerate
pairs of primers (Sigma Genosys) based on rattus and canis
sequences (for MR DQ195096 and NP_037263) as
described in Table 1. PCR reactions were carried out in
50-ll final solutions (5 ll of 109 PCR buffer, 1.5 mM
MgCl2, 0.2 mM dNTPs, 0.4 lM of each primer, 2.5 units
of Taq polymerase (Invitrogen)). Cycling conditions were
as follows: (1) denaturation: 94C, 2 min; (2) denaturation:
94C, 30 s; annealing: 55C (for MR) and 57C (for
11b-HSD1), 30 s; and extension: 72C, 30 s for 35 cycles;
and (3) final extension: 72C, 7 min.
NHE expression
In order to determine the expression of NHE1, NHE2, and
NHE3 in WKY and SHR PTE cells, cells were cultured to
90% of confluence were washed twice with PBS and total
cell protein extracted. Cells were lysed by brief sonication
(15 s) in lysis buffer with protease inhibitors (150 mM
NaCl, 50 mM Tris–HCl pH 7.4, 5 mM EDTA, 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 100 lg/ml
PMSF aprotinin and leupeptin 2 lg/ml each) and incubated
on ice for 1 h. After centrifugation (14,000 r.p.m., 30 min,
4C), the supernatant was mixed in 69 sample buffer
(0.35 M Tris–HCl, 4% SDS, 30% glycerol, 9.3% DTT, pH
6.8, 0.01% bromphenol blue) and boiled for 5 min. The
proteins (30 lg) were subjected to SDS-PAGE (10%
SDS-polyacrylamide gel) and electrotransfered onto nitro-
cellulose membranes. The transblot sheets were blocked
with 5% of non-fat dry milk in Tris.HCl 25 mM pH 7.5,
NaCl 150 mM and 0.1% Tween 20, overnight at 4C.
Then, the membranes were incubated with appropriately
diluted antibodies: rabbit anti-NHE1, rabbit anti-NHE2
polyclonal isoform specific antibodies (Chemicon Interna-
tional) or the rabbit polyclonal anti-NHE3 antibody [24] and
mouse anti-Actin (Santa Cruz Biotechnology). The immu-
noblots were subsequently washed and incubated with
0.5 lg/ml of fluorescently labeled goat anti-rabbit or goat
anti-mouse secondary antibody (IRDyeTM 800 or IRD-
yeTM 680, Rockland Immunochemicals, Gilbertsville, PA)
for 1.30 h at room temperature and protected from light.
Membranes were washed and imaged by scanning at 800 or
700 nm with an Odyssey Infrared Imaging System (LI-COR
Biosciences). Protein concentration was measured using the
DC protein assay kit (Bio-Rad Laboratories, Hercules, CA)
and bovine serum albumin as standard.
Measurement of H2O2
H2O2 was measured fluorometrically using the Amplex
TM
Red Hydrogen Peroxide Assay Kit (Molecular Probes, Inc.,
Eugene, OR). AmplexTM Red is a fluorogenic substrate with
very low background fluorescence that reacts with H2O2 with
a 1:1 stoichiometry to produce a highly fluorescent reagent
[25]. Measurement of H2O2 was evaluated both directly by
H2O2 released form the WKY and SHR monolayer cultured
in 96 well plates or by H2O2 accumulated in the extracellular
medium during 24 h after cells achieved confluence. Fluo-
rescence intensity was measured in multiplate reader
(Spectromax Gemini, Molecular Devices) at an excitation
wavelength of 530 nm and emission wavelength of 590 nm
at room temperature. After subtracting background fluores-
cence, the concentration of H2O2 was calculated using a
resorufin-H2O2 standard calibration curve generated from
experiments using H2O2 and Amplex
TM Red.
Data analysis
Geometric means are given with 95% confidence limits and
arithmetic means are given with SEM. Statistical analysis
was performed by one-way analysis of variance (ANOVA)
followed by the Student’s t-test or the Newman–Keuls test
for multiple comparisons. A P value less than 0.05 was
assumed to denote a significant difference.
Drugs
Aldosterone, apocynin, spironolactone, Ru 38486, actino-
mycin D, cytochalasin B, and EIPA were purchased from
Table 1 Sequences of the degenerated oligonucleotides used for RT-PCR
Target gene (Rat) GeneBank accession no Primer Sequence (50–30) Position Product
MR NP_037263 Forward 50CCA GAT GG(A/G) GCT TT(C/T) AG30 1006 732
Reverse 50GCA (A/G)TC ATT TCT TCC AGC ACA 30 1738
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Sigma Chemical Company, St. Louis, MO, USA. Acetoxy-
methyl ester of 20,70-bis(carboxyethyl)-5(6)-carboxyfluo-
rescein (BCECF-AM) nigericin and the AmplexTM Red
Hydrogen Peroxide Assay Kit were obtained from Molecular
Probes (Eugene, OR). S3226 and Cariporide were kindly
provided by Dr. Jurgen Punter (Aventis Pharma).
Results
NHE activity and expression
NHE activity was assayed as the initial rate of pHi recovery
measured after an acid load imposed by 20 mM NH4Cl
followed by removal of Na+ from the Krebs modified
buffer solution, in the absence of CO2/HCO3. The cells
were incubated in Krebs solution for 15 min, then an acid
load was imposed during 5 min and subsequently the
NH4Cl was aspirated and the cells were placed into TMA
solution for an additional 5 min. As shown in Fig. 1a, the
Na+-dependent recovery of pHi in SHR cells was more
pronounced than that observed in WKY cells. The pHi
recovery rates (in dpHi/dt, pH units/s) during the linear
phase of pHi recovery after intracellular acidification in
SHR were greater than in WKY cells (Fig. 1b).
The sensitivity of NHE to inhibition by EIPA, an
effective NHE1 inhibitor and moderate NHE2, and NHE3
inhibitor, was evaluated in SHR and WKY immortalized
PTE cells (Fig. 1c). The inhibition produced by EIPA was
found to be more potent in SHR than in WKY. At the
concentration of 100 nM, EIPA did not affect pHi recov-
ery, therefore being able to inhibit NHE1 and leave NHE2,
and NHE3 unaltered.
The expression of NHE1, 2 and 3 was also evaluated in
immortalized renal PTE cells from SHR and WKY. As
shown in Fig. 2c, the level of expression of NHE3 in the SHR
cells was greater than in WKY. However, in both cell lines
NHE1 and NHE2 expression was equal (Fig. 2a and b).
Effect of aldosterone on NHE activity
Since NHE activity is an important mechanism for the
maintenance and regulation of pHi in the proximal tubules
we next examined the effects of aldosterone on the NHE
transporter. Cells were exposed to control DMEM or
aldosterone-supplemented DMEM at various concentra-
tions (0.01, 0.1, and 1 lM) for 72 h. As shown in Fig. 3a,
Fig. 1 Assessment of (a) delta intracellular pH and (b) NHE activity
under Vmax conditions as the initial rate of Na
+-dependent pHi recover
after an acid load imposed by exposure to NH4Cl followed by Na
+
removal of the perfusion medium in immortalized WKY and SHR
PTE cells. Influence of (c) EIPA (0.001–10 lM) on NHE activity in
WKY and SHR PTE cells. Traces represent means of 9–14
experiments per group. Columns represent the mean of 9–15
independent determinations: vertical lines show SEM. Significantly
different from values in WKY cells (*P \ 0.05)
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the aldosterone-induced increase in NHE activity was a
concentration-dependent effect; treatment with aldosterone
0.1 and 1 lM significantly increased NHE activity (19 ± 5
and 22 ± 6% increase, respectively) in SHR PTE cells;
however, no stimulation was observed in immortalized
WKY PTE cells (Fig. 3b). We next examined the time-
dependent effects in the NHE activity induced by aldo-
sterone (1 lM) in SHR and WKY PTE cells. Cells were
exposed to aldosterone (1 lM) for 6, 24, and 72 h. Sig-
nificant stimulatory effects on NHE activity were observed
for 24 and 72 h (16 ± 6 and 21 ± 6% increase, respec-
tively) in SHR PTE cells but not in WKY PTE cells
(Fig. 4a and b).
There were no significant differences on the intrinsic
buffering capacity at pHi of 7.6 between the two conditions
(vehicle, 16.02 ± 0.97 mM/H+, pH, n = 8 and aldosterone
(72 h) 14.09 ± 0.68 mM/H+, pH, n = 7) in SHR PTE
cells. Therefore, the Na+-dependent pHi recovery after acid
load appears to be dependent on the NHE activity and the
aldosterone-induced increases in the Na+-dependent pHi
recovery after acid load may not relate changes in differ-
ences on the intrinsic buffering capacity, but rather on
increases in NHE activity.
Detection of MR
To confirm the presence of the mineralocorticoid receptor,
MR in immortalized WKY and SHR PTE cells, a con-
ventional RT-PCR was performed. Degenerate primer sets,
designed based on the MR canine and rattus sequences,
were used. As shown in Fig. 5, the expected 732-bp
fragment corresponding to MR was present in both cell
lines.
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Fig. 2 Immunoblot analysis of (a) NHE1, (b) NHE2, and (c) NHE3
in immortalized WKY and SHR PTE cells. Each lane contains equal
amount of protein (30 lg). Significantly different from corresponding
values for WKY PTE cells (*P \ 0.05)
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Fig. 3 Effect of aldosterone (0.01, 0.1, and 1 lM) for 72 h on NHE
activity in (a) SHR PTE cells and (b) WKY PTE cells. In WKY PTE
cells, the pHi values in vehicle- and aldosterone-treated were,
respectively, 7.51 ± 0.01 and 7.48 ± 0.02. In SHR PTE cells the
pHi values in vehicle- and aldosterone-treated were, respectively,
7.63 ± 0.02 and 7.66 ± 0.03. Each column represents the mean of
7–8 experiments per group; vertical lines indicate SEM. Significantly
different from values for control (*P \ 0.05)
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Effects of spironolactone and Ru 38486 on
aldosterone-induced increase in NHE activity
To determine whether the stimulatory effects of aldoste-
rone on NHE activity occurred via the MR and/or the
glucocorticoid receptor (GR), SHR PTE cells were exposed
to the MR antagonist spironolactone (100 lM) or the GR
antagonist Ru 38486 (10 lM) for 24 h. The concentrations
of spironolactone and Ru 38486 used were those previously
described in the literature [26]. Results are shown in
Fig. 6a for spironolactone-treated SHR PTE cells and
Fig. 6b for Ru 38486-treated SHR PTE cells. Spironolac-
tone or Ru alone caused no effect on NHE activity. The
addition of Ru 38486 produced no effect on the long term
stimulatory effect of aldosterone on NHE activity whereas
spironolactone completely inhibited the aldosterone-
induced stimulation.
Determination of the NHE transporter isoform involved
in the aldosterone-induced increase in activity
In order to identify the NHE transporter isoform involved
in the aldosterone-induced increase in activity SHR cells
were incubated with aldosterone (1 lM) for 24 h and EIPA
(100 nM), cariporide (1 lM), a selective NHE1 inhibitor or
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Fig. 4 Effect of aldosterone (1 lM) for 6, 24, and 72 h on NHE
activity in (a) SHR PTE cells (b) and WKY PTE cells. Each column
represents the mean of 7–8 experiments per group; vertical lines
indicate SEM. Significantly different from values for control
(*P \ 0.05)
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Fig. 5 PCR detection of MR in total RNA extracted from WKY and
SHR PTE cells; MW—GeneRulerTM DNA Ladder Mix (MBI,
Fermentas)
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Fig. 6 Effects of the mineralocorticoid receptor antagonist sipiron-
olactone or the glucocorticoid receptor antagonist Ru 38486 on
aldosterone-induced increase in NHE activity in SHR PTE cells. (a)
Cells were exposed to control DMEM or aldosterone (1 lM)
supplemented DMEM for 24 h in the absence or presence of
spironolactone (100 lM). (b) Cells were exposed to control DMEM
or aldosterone (1 lM) supplemented DMEM for 24 h in the absence
or presence of Ru 38486 (10 lM). Each column represents the mean
of 7–8 experiments per group; vertical lines indicate SEM. Signif-
icantly different from values for control (*P \ 0.05)
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S3226 (1 lM), a NHE3 inhibitor for 30 min. EIPA and
cariporide completely reversed the effects of aldosterone
upon the NHE activity (Fig. 7a and b), but not S3226
(Fig. 7c), indicating that NHE1 is the most likely involved
exchanger isoform.
Effects of actinomycin D and cytochalasin B
on aldosterone-induced increase in NHE activity
To determine whether gene transcription is required for
aldosterone-induced increase in NHE activity, SHR cells
were incubated with actinomycin D (400 nM), an inhibitor
of gene transcription and aldosterone (1 lM) for 24 h.
Recent studies demonstrate that the interaction between the
cytoskeleton and the plasma membrane regulates the
activity of many ion channels and transport proteins,
including the NHE transporters. To determine whether the
cytoskeleton is involved in the aldosterone stimulation of
the NHE, SHR cells were incubated with cytochalasin B
(1 lM), a disruptor of filamentous actin (F-actin). For this
purpose, SHR cells were treated during 24 h with aldoste-
rone (1 lM) and cytochalasin B for 3 h. As shown in Fig. 8,
actinomycin D (Fig. 8a) and cytochalasin B (Fig. 8b) had
no influence on NHE activity. However, both drugs atten-
uated the stimulatory effect of aldosterone upon NHE
activity, though this did not attain statistical significance.
Aldosterone effect on NHE1 protein expression
Protein expression of NHE1 in SHR PTE cells treated for
24 h with aldosterone (1 lM) and aldosterone (1 lM) plus
spironolactone (10 M) was evaluated by immunoblot
analysis. The protein expression levels of NHE1 from
aldosterone-treated cells were not significantly different
from control (Fig. 9a and b).
Role of oxidative stress in the mediation of aldosterone-
induced increase in NHE activity
H2O2 generation was measured in SHR and WKY PTE
cells and the involvement of H2O2 in the regulation of
NHE by aldosterone was determined. The SHR PTE cells
revealed an increased rate of H2O2 formation when com-
pared with WKY PTE cells (22.4 ± 0.9 vs.
7.9 ± 0.3 nmoles/min) (Fig. 10a). Cells were also treated
with apocynin (0, 10, 30, and 100 lM) for 4 days and the
rate of H2O2 production was determined. WKY PTE cells
were less sensitive to apocynin than SHR PTE cells
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Fig. 7 Effects of (a) EIPA (100 nM), (b) Cariporide (1 lM) and (c)
S3226 (1 lM) on NHE activity in the absence and presence of
aldosterone (1 lM) for 24 h in SHR PTE cells. Each column
represents the mean of 7–8 experiments per group; vertical lines
indicate SEM. Significantly different from values for control
(*P \ 0.05)
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(Fig. 10b); inhibition of H2O2 production in WKY PTE
cells was only obtained at 100 lM apocynin, whereas in
SHR PTE cells 30 lM apocynin was enough to inhibit this
production in SHR PTE cells (Fig. 10c). Treatment of cells
with apocynin (100 lM), an inhibitor of the NADPH
oxidase complex, for 4 days reduced the rate of H2O2
production in WKY and SHR PTE cells, but did not change
the NHE activity in both WKY (0.0065 ± 0.0002 vs.
0.0054 ± 0.0005 pH units/s) and SHR (0.0075 ± 0.0002
vs. 0.0081 ± 0.0002 pH units/s) PTE cells. However,
treatment of SHR PTE cells with apocynin (100 lM)
completely blocked the ability of aldosterone to increase
NHE activity (Fig. 11). Treatment of cells with aldosterone
(1 lM) for 24 h did not change the rate of H2O2 production
(Fig. 12). Differences in the inhibitory effect apocynin
(100 lM) on the production of H2O2 in the absence and the
presence of aldosterone (1 lM) did not attain statistical
significance (Fig. 12).
Discussion
The present study was designed to evaluate the effects of
aldosterone on NHE activity in immortalized renal PTE cells
from SHR and WKY and to determine the mechanisms
whereby aldosterone regulates NHE activity in these cells.
The aldosterone-mediated increase in NHE activity was a
concentration- and time-dependent phenomenon in SHR
PTE cells. The data presented here also demonstrates that the
aldosterone-induced increase in NHE1 activity in immor-
talized renal PTE cells from SHR, but not in WKY, occurs as
early as 24 h and is sustained effect for up to 72 h. The
effects of aldosterone upon NHE1 activity occur through the
activation of genomic mechanisms involving the stimulation
of the MR, but require the availability of H2O2 in excess.
In order to explain the differences in sensitivity to
aldosterone in WKY and SHR immortalized PTE cells, it
was hypothesized that oxidative stress could be involved in
such differences. In the present study, the generation of
H2O2, a marker of oxidative stress, was evaluated in WKY
and SHR PTE cells. SHR PTE cells were found to have an
increased rate of H2O2 production. Apocynin specifically
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Fig. 8 Effects of (a) actinomycin D (400 nM) and (b) cytochalasin B
(1 lM) on aldosterone-induced increase in NHE activity in SHR PTE
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experiments per group; vertical lines indicate SEM. Significantly
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NHE1 in immortalized SHR
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treatment with aldosterone
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inhibits the activity of NAD(P)H oxidase by interfering
with the assembly of the cytosolic NAD(P)H oxidase
components (p40phox, p47phox, and p67phox) with the
membranous components gp91phox and p22phox [27]. The
concentration of apocynin that reduced the extracellular
levels of H2O2 in SHR was lower (30 lM) than that in
WKY (100 lM), which fits well the observation that the
level oxidative stress in SHR may be higher than in WKY
PTE cells. In SHR PTE cells, treatment with apocynin
abolished the stimulation of aldosterone upon the NHE1
activity in SHR PTE cells. According to these results, the
effects of aldosterone upon NHE1 activity in SHR PTE
cells are a consequence of the oxidative stress, resulting
from increases in the generation of H2O2. Although pre-
vious studies have indicated that aldosterone directly
induces ROS generation through the activation of NADPH
oxidase [17, 18], we gathered evidence that aldosterone did
not increased the production of H2O2.
The results presented here show that aldosterone-
induced increase in NHE1 activity in SHR PTE cells was
partially inhibited by actinomycin D, an inhibitor of gene
transcription and cytochalasin B, a disruptor of filamentous
actin (F-actin). This data suggests that the long-term effect
of aldosterone on NHE1 activity might be related to a
genomic effect. On the other hand, it is likely that aldo-
sterone might facilitate a ‘‘shuttle’’ process where NHE1 is
translocated to the plasma membrane. Since the aldoste-
rone-induced increase in NHE1 activity was prevented by
apocynin, it is likely that increases in H2O2 production may
promote the translocation of NHE1 to the plasma mem-
brane induced by aldosterone or facilitate the intracellular
events induced by the activation of the MR. These aspects
are currently under evaluation in our laboratory.
Aldosterone enters the cell by diffusion through the
cellular membrane and once in the cytoplasm it binds to the
intracellular MR receptor. In the present study, mRNA of
MR was detected in WKY and in SHR PTE cells indicating
that aldosterone has the potential to bind to the MR, and
activate NHE; however, only SHR PTE cells responded to
aldosterone. It is clear that the mechanism responsible for
the activation of NHE by aldosterone in SHR PTE cells is
different from WKY PTE cells. The long term effect of
aldosterone was inhibited by the MR antagonist spirono-
lactone, which indicates that the effect of aldosterone
occurs through the MR. High concentrations of aldosterone
(1 lM) may activate both the MR and the GR, as reported
Fig. 10 (a) Rate of H2O2 (nM/min) released from WKY or SHR cell
culture when cells reached confluence (4 days after of seeding).
Levels of extracellular H2O2 (nM) in (b) WKY and (c) SHR PTE cells
in control cell culture conditions or in the presence of apocynin
(4 days after seeding). Each column represents the mean of 4
experiments per group; vertical lines indicate SEM. Significantly
different from values for control (*P \ 0.05)
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by Ebata et al. [26]. However, in the present study aldo-
sterone (1 lM) most likely was devoid of effects upon the
GR, as revealed by the finding that Ru 38486 did not
prevent the aldosterone-induced stimulation of NHE.
WKY and SHR PTE cells were found to express all three
NHE isoforms. NHE1 expression was identical in both cell
lines, whereas NHE3 in SHR cells was more abundant than
in WKY PTE cells, which fits well the data by Kelly et al.
[28] in freshly isolated PTE cells from SHR and WKY.
However, according to Pedrosa et al. [29], NHE1 in
immortalized SHR PTE cells is significantly more abundant
than in WKY PTE cells. Recent studies have shown that
serum deprivation leads to an increase in NHE1 mRNA and
protein expression in immortalized PTE cells [30], which
may offer an explanation for this apparent discrepancy. It is
possible that immortalized SHR PTE cells are more affected
by serum deprivation than WKY PTE cells and, therefore,
have a high expression of NHE1 in serum deprivation
conditions. NHE2 was also detected in WKY and SHR PTE
cells and its expression was identical in both cell lines.
NHE2 is also expressed in other proximal tubular cell lines
for example MCT and RKPC2 [30].
Previous studies in other cell types, namely vascular
smooth muscle cells, have reported genomic effects of
aldosterone through NHE1 [26]. In order to identify the
NHE isoform involved, 100 nM EIPA was used to selec-
tively inhibit the NHE1 isoform. This concentration of
EIPA completely reversed the stimulatory effects of aldo-
sterone upon NHE activity. To confirm this result,
cariporide, a selective NHE1 inhibitor and S3226, a NHE3
inhibitor, were also used. As predicted, cariporide inhibited
the stimulation produced by aldosterone, whereas S3226
was devoid of effects. In hypertension, there is evidence
that NHE1, the isoform most frequently studied, exhibits
increased activity in a large variety of cell types. In several
examples of increased NHE1 activity, the primary change is
not in NHE1 expression, but in post-translational regulation
of activity. In immortalized cells from hypertensive
patients, enhanced NHE1 activity appears to reflect
increased Vmax rather than increased NHE1 mRNA [31].
Similarly, vascular smooth muscle cells from SHR were
found to be endowed with increased NHE1 activity as
evidenced by increases in Vmax, compared to WKY, without
changes in NHE1 mRNA levels or protein abundance [32].
These observations are in agreement with the results pre-
sented here. The present study shows that total protein
levels of NHE1 were not increased in the presence of
aldosterone. It has also been reported that increased extra-
cellular sodium concentration together with the prolonged
treatment with aldosterone may contribute to the increase in
NHE1 activity. In fact, Yamamuro et al. [33] showed an
apparent cardiomycocyte hypertrophy caused by long term
exposure to aldosterone in the presence of elevated extra-
cellular sodium concentration which is thought to occur via
NHE1 with the involvement of the MR. The medium used
in the present study was the ideal for SHR and WKY cells;
however, it is possible that the aldosterone-stimulated
increase of NHE1 activity in SHR PTE cells may be also
effected by extracellular sodium concentration.
In conclusion, we demonstrate that aldosterone increases
NHE1 activity under Vmax conditions through the activa-
tion of the MR in immortalized SHR PTE cells, but not in
WKY PTE cells. This activation occurs through genomic
mechanisms and requires the availability of H2O2 in
excess. High blood pressure is a major clinical issue in
patients afflicted with primary or secondary aldosteronism.
However, the precise mechanisms of blood pressure ele-
vation in mineralocorticoid excess are still unclear. The
present findings, together with previous reports, show that
enhanced NHE1 activity might have an important role in
the pathogenesis of hypertension.
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Fig. 11 Effect of apocynin treatment (4 days) on aldosterone-
induced NHE activity in SHR PTE cells. Each column represents
the mean of 8 experiments per group; vertical lines indicate SEM.
Significantly different from values for control (*P \ 0.05) or values
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Fig. 3 Effect of aldosterone (0.01, 0.1, and 1 lM) for 72 h on NHE
activity in (a) SHR PTE cells and (b) WKY PTE cells. In WKY PTE
cells, the pHi values in vehicle- and aldosterone-treated were,
respectively, 7.51 ± 0.01 and 7.48 ± 0.02. In SHR PTE cells, the
pHi values in vehicle- and aldosterone-treated were, respectively,
7.63 ± 0.02 and 7.66 ± 0.03. Each column represents the mean
of 7–8 experiments per group; vertical lines indicate SEM. Signif-
icantly different from values for control (*P \ 0.05)
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Aging is a degenerative process affecting all living organisms.
Among the many theories that have been put forward to explain the
aging process, the free radical theory has received widespread
attention in recent years. This theory postulates that endogenous
oxygen radicals cause a pattern of cumulative damage that is
responsible for the functional deterioration associated with aging
(Harman, 1956). The current view is that oxidative stress, resulting
from excessive production of reactive oxygen species (ROS) and/or
inadequate antioxidant defense mechanisms, may be mechanistically
linked to some aspects of aging and a multitude of age-associateddisorders (Finkel and Holbrook, 2000; Kregel and Zhang, 2007). ROS
can either be generated exogenously or produced intracellularly from
several different sources. Enzymatic systems contributing to oxidative
stress include, among others, the superoxide-generating enzyme,
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
(Griendling et al., 2000; Li et al., 2001). However, under physiological
conditions, the burden of ROS production is largely neutralized by an
intricate antioxidant defense system that includes low molecular
weight antioxidants like glutathione, vitamins E, C and A, the
enzymatic scavengers superoxide dismutase (SOD), catalase and
glutathione peroxidase (GPx) (Finkel and Holbrook, 2000; Kregel and
Zhang, 2007).
The spontaneously hypertensive rat (SHR) is a genetic model of
naturally developing hypertension that appears to be similar in many
aspects to human essential hypertension (Trippodo and Frohlich, 1981).
It is becoming increasingly recognized that hypertension in SHR is
associatedwith enhanced oxidative stress (Touyz, 2004;Wilcox, 2002).
This assumption results from multiple lines of evidence, including
measurements of oxidative stressmarkers in plasma, urine and tissue or
protein levels and activity of oxidant and antioxidant enzymes in the
kidney and vascular tissues of SHR in comparison with their genetic
normotensive controls, the Wistar Kyoto (WKY) rats (Biswas et al.,
2008; Kerr et al., 1999; Schnackenberg and Wilcox, 1999; Ulker et al.,
2003; Zhan et al., 2004a). Nevertheless, experimental studies have
provided conflicting resultswhen the aforementioned parameterswere
469S. Simão et al. / Experimental Gerontology 46 (2011) 468–474analyzed. For example, Zhan et al. (2004a) reported a marked increase
in immunodetectable p22phox subunit of NADPH oxidase in the renal
cortex of SHR comparedwith that in theWKY; by contrast, Chabrashvili
et al. (2002) reported that there was no detectable difference for
p22phox. On the other hand, data on the expression of oxidant and
antioxidant enzymes in the aged SHR kidney are scarce.
The aim of the present study was, therefore, to assess oxidative
stress and renal expression of oxidant and antioxidant enzymes in
SHR and WKY and whether or not the expression of these enzymes
may change in the kidney during aging.
2. Materials and methods
2.1. Animal preparation and experimental design
Five-week old male Wistar Kyoto (WKY) and spontaneously
hypertensive rats (SHR) were obtained from Harlan-Interfauna
Ibérica (Barcelona, Spain). Animals were housed under controlled
conditions (12 h light/dark cycle and room temperature at 22±2 °C)
and had free access to tap water and standard rat chow (PANLAB,
Barcelona, Spain). The animals were carefully maintained and
monitored until 12 months of age. Blood pressure (systolic and
diastolic) and heart rate were measured in conscious animals using a
photoelectric tail–cuff detector (LE 5000, Letica, Barcelona, Spain). A
minimum of 5 measures were made each time and the mean values
were used for further calculations. Both body weight and blood
pressure measurements were performed at 4 to 6 week intervals.
2.2. Metabolic study
Two days before the start of experiments, 3- and 12-month old rats
were placed in metabolic cages (Tecniplast, Buguggiate, Italy) for a 24 h
urine collection. The urine sampleswere collected in sterilized vials that
were stored at−80 °C until assayed. After completion of this protocol,
rats were anesthetized with sodium pentobarbital (60 mg/kg, i.p.). The
animals were then sacrificed by exsanguination using cardiac puncture
and the blood collected into tubes containing K3 EDTA for later
determination of plasma biochemical parameters. Before excising the
kidneys, the right ventricle of the heart was perfused with ice-cold
saline (0.9% NaCl) to remove all blood from the kidneys. The kidneys
were then excised, weighed, decapsulated, and the renal cortex and
medulla rapidly separated by fine dissection. Tissue pieces were
immediately frozen in liquid nitrogen and stored at−80 °C until use.
2.3. Plasma and urine biochemistry
The quantification of sodium was performed by an ion-selective
electrode. The analysis of non-fasting plasma creatinine, urinary
creatinine, urinary proteins and serum lactate dehydrogenase (LDH)
was performed on the Cobas Mira Plus automated analyzer (Roche
Diagnostics, Germany) using standardized procedures (ABXDiagnostics
for Cobas Mira, Switzerland). Creatinine clearance was calculated using
24-h urine creatinine excretion in absolute values (ml/min).
2.4. Quantification of adiposity levels
Adiposity of all rats was evaluated by the Lee index, which is well
correlated with the percentage of body mass (Li et al., 1998; Ricci
et al., 2006). The Lee index is calculated through the cubic root of body
weight (g) divided by the naso-anal length (mm) times 104.
2.5. H2O2 production by renal cortex
Fresh renal cortex was cut into square pieces and incubated at 37 °C
in Krebs–HEPES buffer (in mM: NaCl 118, KCl 4.5, CaCl2 2.5, MgCl2 1.20,
K2HPO4 1.2, NaHCO3 25.0, Na–HEPES 25.0, and glucose 5; pH 7.4) for5890min. The supernatant was then used in the Amplex Red Hydrogen
PeroxideAssay kit (Molecular Probes Inc., Eugene, OR) in order to detect
H2O2 released from the tissue, as previously described (Furukawa et al.,
2004). Amplex Red is a fluorogenic substratewith very low background
fluorescence that reactswithH2O2with a 1:1 stoichiometry toproducea
highly fluorescent reagent. Fluorescence intensity was measured in a
multiplate reader (Spectromax Gemini; Molecular Devices, Sunnyvale,
CA) at an excitation wavelength of 530 nm and emission wavelength of
590 nm at room temperature. After subtracting background fluorescence,
the concentration of H2O2 (in nmol/mg tissue) was calculated using a
resorufin–H2O2 standard calibration curve generated from experiments
using H2O2 and Amplex Red.2.6. Measurement of TBARS
As a marker of lipid peroxidation, we measured thiobarbituric acid
reactive substances (TBARS) according to the method of Ohkawa et al.
(1979), with some modifications. Briefly, urine samples were
combined with 8.1% SDS for 10 min. Equal volumes of 28% TCA and
0.6% TBAwere added and heated at 95 °C for 1 h. After cooling at room
temperature, a mixture of chloroform/methanol (2:1) was added and
centrifuged at 5000 rpm for 10 min. Supernatant absorbance was
measured at 532 nm. A calibration curve was prepared with
malondialdehyde (MDA) as a standard and results were expressed
as μmol MDA/24 h urine volume. All samples gave results which were
within the linear range of the MDA standard curve.2.7. Western blotting
Renal cortices were lysed in RIPA buffer containing 150 mM NaCl,
50 mM Tris–HCl, pH 7.4, 5 mM EDTA, 1% Triton X-100, 0.5% sodium
deoxycholate, 0.1% SDS, 100 μg/ml PMSF, 2 μg/ml leupeptin and 2 μg/ml
aprotinin. Protein concentrationwas determined using a protein assay kit
(Bio-Rad Laboratories, Hercules, CA), with bovine serum albumin as
standard. Homogenates were boiled in 2x sample buffer (62.5 mM Tris–
HCl pH 6.8, 2% SDS, 10% glycerol, 2% 50 mM DTT, 0.1% w/v bromophenol
blue) at 95 °C for 5 min. Samples containing 25–100 μg of protein were
separated by SDS-PAGE with 10% polyacrylamide gel and then electro-
blotted onto nitrocellulose membranes (Bio-Rad Laboratories, Hercules,
CA). Blots were blocked for 1 h with 5% non-fat dry milk in TBS at room
temperature with constant shaking. Blots were then incubated with
antibodies goat polyclonal anti-Nox4 (1:400, Santa Cruz Biotechnology,
Santa Cruz, CA); rabbit polyclonal anti-p22phox (1:800, Santa Cruz
Biotechnology); rabbit polyclonal anti-SOD1 (1:2000, Santa Cruz Biotech-
nology); goat polyclonal anti-SOD2 (1:100, Santa Cruz Biotechnology);
goat polyclonal anti-SOD3 (1:500, Santa Cruz Biotechnology); rabbit
polyclonal anti-catalase (1:2000, Calbiochem, Nottingham, UK); mouse
monoclonal anti-glutathione peroxidase (1:1000, Calbiochem) and
mouse monoclonal anti-GAPDH (1:60,000, Santa Cruz Biotechnology) in
5% non-fat dry milk in TBS-T overnight at 4 °C. The immunoblots were
subsequently washed and incubatedwith fluorescently labeled goat anti-
rabbit (1:20,000; IRDyeTM800, Rockland, Gilbertsville, PA), fluorescently
labeled donkey anti-goat (1:20,000; IRDyeTM 800, Rockland), or the
fluorescently labeled goat anti-mouse secondary antibody (1:20,000;
AlexaFluor 680, Molecular Probes, Paisley, UK) for 60 min at room
temperature and were protected from light. The membranes were
washed and imaged by scanning at both 700 and 800 nm, with an
Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE).2.8. Drugs
All chemicals were obtained from Sigma (St. Louis, MO) unless
otherwise stated.
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C3. Results
3.1. General data
Body weight increased with age in both rat strains, but this
increment wasmore pronounced inWKY than in SHR (70% versus 40%
increase) (Table 1). In addition, body weight inWKYwas significantly
higher than in age-matched SHR (Table 1). Tibia length is an index of
growth that remains constant after maturity. As shown in Table 1,
tibia length was slightly higher in 12-month old rats, indicating that
3-month old rats were reaching full body growth. In contrast, the
increase in body weight/tibia length ratio in WKY (58%) was greater
than in SHR (18%), suggesting that aged WKY accumulate fat mass.
Additionally, the obesity Lee index was augmented in 12-monthWKY
rats when compared with 3-month WKY rats, whereas no differences
were observed in the SHR rats during aging. Fractional urinary
excretion of sodium (FE Na+) and creatinine clearance were
considered as markers of renal function. In WKY, FE Na+ and
creatinine clearance were unaffected by age. FE Na+ in 12-month
SHR was lower than in 3-month SHR and 12-month WKY (Table 1).
On the other hand, creatinine clearance was slightly higher in
12-month SHR than in 3-month SHR (Table 1). We have also
evaluated urinary protein excretion and serum lactate dehydrogenase
(LDH) levels as markers of renal injury. Urinary protein excretion was
not affected by age in WKY. By contrast, urinary protein excretion in
12-month SHR was higher than in 3-month SHR. Urinary protein
excretion in both SHR groups was also significantly higher than in
age-matched WKY (Table 1). Following a similar pattern, serum LDH
levels were higher in SHR than in age-matched WKY rats and no
age-related changes were observed, although statistical significance
was not reached (Table 1).0
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As expected, the systolic anddiastolic bloodpressures (SBPandDBP)
determined by the tail–cuff method were significantly higher in both
3- and 12-month old SHR than in age-matched WKY (Fig. 1A and 1B).
Moreover, a significant increase in both SBP and DBP was observed in
12-month versus 3-month SHR (Fig. 1A and 1B). Heart rate in SHR was
higher than in WKY (Fig. 1 C).Table 1
Physiological parameters in 3- and 12-month old WKY and SHR.
WKY SHR
Parameter 3-months 12-months 3-months 12-months
Body weight (g) 332±9 565±10a 272±5 380±5a,b
Tibia length (cm) 4.00±0.09 4.30±0.02 3.30±0.01 3.90±0.03
Body weight/tibia
length (g/cm)
83.0±2.9 131.4±2.5a 82.4±1.4 97.4±0.9a,b
Lee index 297.7±3.1 308.2±1.8a 301.8±3.0 303.4±1.7
FE Na+ (%) 0.36±0.04 0.40±0.03 0.37±0.04 0.20±0.04a,b
Creatinine clearance
(ml/min)
2.6 ±0.3 3.4±0.3 1.9±0.2 2.7 ±0.2a
Proteinuria (mg/24 h) 14.0±0.8 13.9±1.2 26.0±1.6b 34.0±3.3a,b
LDH (U/L) 248±72 337±44 436±70 410±93
Data are means±SEM of 5–11 rats per group.
a Pb0.05 compared with corresponding 3-months old rats.
b Pb0.05 compared with corresponding WKY rats.
3-months 12-months
Fig. 1. Changes in systolic (A), diastolic blood pressure (B), and heart rate (C) of 3-and
12-month old WKY and SHR. Each bar represents the mean±SEM of 6–12 rats.
Significantly different from corresponding WKY values (* Pb0.05) and significantly
different from values in 3-month old rats (# Pb0.05) using the Newman–Keuls test.
593.3. Markers of oxidative stress
To evaluate oxidative stress during aging in both WKY and SHR, we
measured the production of hydrogen peroxide (H2O2), a hazardous
ROS against tissues and cells, in renal cortex tissue samples, and
assessed lipid peroxidation through the quantification of TBARS in urine
samples. H2O2 production by the renal cortex of 3-month SHR was
increased in comparison with age-matched WKY (Fig. 2A). In contrast,
no changes in urinary TBARS were detected in this age group (Fig. 2B).
H2O2 production in the renal cortex increasedmarkedly (4–5 fold)with
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Fig. 2. Production of H2O2 by renal cortex of 3- and 12-month old WKY and SHR (A).
Urinary levels of lipid peroxidation (TBARS) in 3- and 12-month old WKY and SHR (B).
Each bar represents the mean±SEM of 3–7 rats. Significantly different from values in
3-month old WKY (* Pb0.05) and significantly different from corresponding values in
3-month old rats (# Pb0.05) using the Newman–Keuls test.
Fig. 3. Expression of the NADPH oxidase protein subunits p22phox (A) and Nox4 (B) in
the renal cortex of 3- and 12-month oldWKY and SHR. Representative immunoblots are
depicted on top of the bar graphs. Values are normalized to the level of GAPDH
expression in each condition and expressed as % of 3-month old WKY rats. Each bar
represents the mean±SEM of 4 independent immunoblots. Significantly different from
values in 3-month old WKY (* Pb0.05) and significantly different from corresponding
values in 3-month old rats (# Pb0.05) using the Newman–Keuls test.
471S. Simão et al. / Experimental Gerontology 46 (2011) 468–474age in both WKY and SHR, though no significant differences were
observed between rat strains of the same age group (Fig. 2A). Similar to
the results shown for oxidant production, a significant increase (2 fold)
was observed in urinary TBARS in 12-month WKY and SHR when
compared with 3-month rats (Fig. 2B).
3.4. Pro-oxidant enzymes
Because the NADPH oxidases are predominant sources of ROS
leading to oxidative stress (Griendling et al., 2000; Li et al., 2001), the
levels of two major subunits of NADPH, Nox4 and p22phox, were
evaluated by Western blotting in the renal cortex of 3- and 12-month
old WKY and SHR. The abundance of Nox4 in 3-month SHR, as well as
in 12-month WKY and 12-month SHR, was higher than in 3-month
WKY (Fig. 3B). No significant differences in p22phox protein
expression were found between age-matched groups of WKY and
SHR strains. However, the abundance of p22phox in both 12-month old
WKY and SHRwas higher than in 3-month oldWKY and SHR (Fig. 3A).
3.5. Antioxidant enzymes
Protein expression of superoxide dismutase isoforms (SOD1, SOD2
and SOD3) was determined in renal cortex of 3- and 12-month WKY
and SHR (Fig. 4). Expression of SOD1 in 3-month SHRwas significantly
lower than in age-matched WKY (Fig. 4A). In 12-month SHR the
expression of SOD1 was higher than in 3-month SHR, though no
differences were detected between aged WKY and SHR (Fig. 4A). The60abundance of SOD2 did not differ in 3-month WKY and SHR. In
contrast, the abundance of SOD2 in 12-month WKY and SHR was
higher than in the 3-month rats (Fig. 4B). SOD3 expression levels in 3-
months SHR were significantly lower than in 3-month WKY. In 12-
month WKY and SHR the abundance of SOD3 was higher than in the
3-month rats (Fig. 4 C). In addition, expression of catalase and GPx,
the enzymes responsible for H2O2 catabolism, were also evaluated in
the renal cortex of all groups of animals (Fig. 5). The abundance of
catalase in 3-month SHR, as well as in 12-month WKY and SHR, was
higher than in 3-month WKY (Fig. 5A). By contrast, GPx expression
remained unchanged in all groups (Fig. 5B).
4. Discussion
The main findings of this study were that both SHR and WKY
exhibited increased levels of oxidative stress in renal tissue with age
and this was accompanied by similar expression profile of oxidant and
antioxidant enzymes.We hypothesize that the findings reported here,
which apparently conflict with the current view that hypertension is a
state of oxidative stress, might arise from the fact that normotensive
WKY developed obesity with aging. Common mechanisms leading to
oxidative stress may, therefore, underlie hypertension and obesity.
Fig. 4.Expression of SOD1 (A), SOD2 (B) and SOD3 (C) in the renal cortex of 3- and12-month
oldWKY and SHR. Representative immunoblots are depicted on top of the bar graphs. Values
are normalized to the level of GAPDH expression in each condition and expressed as % of
3-month oldWKY rats. Each bar represents themean±SEMof 4 independent immunoblots.
Significantly different from values in 3-month oldWKY (* Pb0.05) and significantly different
from corresponding values in 3-month old rats (# Pb0.05) using the Newman–Keuls test.
Fig. 5. Expression of catalase (A) and glutathione peroxidase (B) in the renal cortex of 3- and
12-month old WKY and SHR. Representative immunoblots are depicted on top of the bar
graphs. Values are normalized to the level of GAPDH expression in each condition and
expressed as % of 3-month old WKY rats. Each bar represents the mean±SEM of 4
independent immunoblots. Significantly different from values in 3-month old WKY
(* Pb0.05) and significantly different from corresponding values in 3-months old rat
(# Pb0.05) using the Newman–Keuls test.
472 S. Simão et al. / Experimental Gerontology 46 (2011) 468–474Oxidative stress is assumed to be an important factor in aging and in
many age-related diseases (Finkel andHolbrook, 2000; Kregel and Zhang,
2007), including essential hypertension (Touyz, 2004;Wilcox, 2002). This61view isbasedon thepresenceof increasedproductionof superoxideanion
and H2O2, reduced NO synthesis, and decreased bioavailability of
antioxidants, which have been verified in experimental and human
hypertension. As it concerns the SHRmodel, the majority of studies have
been conducted in young/adult animals, ranging from 10 to 24 weeks of
age. Additionally, several conflicting results have been reported in what
concerns themeasurementofdifferentoxidative stressparameters inSHR
and WKY. In the present study, we further confirmed the presence of
oxidative stress in young SHR. The production of H2O2 in the renal cortex
was significantly increased in 3-month old SHR although no differences
were detected in urinary lipid peroxidation products. Oxidative stress in
3-month old SHR might be explained by the upregulation of NADPH
oxidase subunit Nox4 and down-regulation of antioxidant SOD1 and
SOD3enzymes. Previous studies reported similar observations confirming
that at the age of 10 to 12 weeks these rats develop oxidative stress (Adler
and Huang, 2004; Biswas et al., 2008). Overexpression of catalase in
3-month old SHRmight be an attempt to compensate for increased levels
of oxidative stress.
To the best of our knowledge, no previous study has examined the
effects of aging on oxidative stress in kidneys of SHR and WKY. A
473S. Simão et al. / Experimental Gerontology 46 (2011) 468–474recent work evaluated oxidant handling and energy metabolism in
chronic kidney disease using 3- and 21–24-month old WKY, SHR and
Wistar rats, although with a different approach regarding oxidative
stress measurement. In this study, the expression of hemeoxygenase-
1 was used as a renal marker of oxidative stress. The authors observed
an increased expression of hemeoxygenase-1 in old Wistar and SHR
rats as compared with the young rats (Percy et al., 2009).
Furthermore, in the study of Alvarez et al., comparisons of oxidative
stress levels were made during aging in hearts of Wistar and SHR rats.
These authors reported increased levels of oxidative stress in aged
SHR (Alvarez et al., 2008).
In the present study, we found a significant increase in H2O2
production by the renal cortex of 12-month old SHR. Moreover, these
rats also exhibited a significant increase in urinary TBARS, a frequently
used index of cell lipid peroxidation. Several reports have shown an
age-associated increase in the concentrations of lipid peroxidation
products (Pratico, 2002). Unexpectedly, WKY at the age of 12 months
displayed similar oxidative stress levels as the age-matched SHR. It is
suggested that the increased levels of H2O2 found in the renal tissue of
aged SHRandWKYmay be, at least in part, responsible for the increased
urinary lipid peroxides in these rats. Altogether, the results presented
here indicate that aged rats have increased levels of oxidative stress
compared with young ones. In contrast, recent work demonstrated an
increase in plasma (Zhan et al., 2004a) and urinary (Suzuki et al., 2008)
H2O2 levels in 22/24-week-old SHR compared with age-matchedWKY.
Furthermore, the study of de Cavanagh et al. (2006) reports an increase
in renal mitochondrial H2O2 production in 8-month old SHR compared
with age-matchedWKY. The discrepancy between our study and those
mentioned before in terms of H2O2 production might be explained by
the marked increase in bodyweight of agedWKY, even after correction
for tibia length, suggesting the accumulation of fat in these rats. In fact,
numerous reports have shown that oxidative stress is increased in
animal models of obesity and that the adipose tissue is a major
contributor to ROS production (Davi et al., 2002; Furukawa et al., 2004;
Urakawa et al., 2003). Several studies demonstrated that dietary
restriction is an efficient approach to confront age-related oxidative
damage indifferent rat tissues, decreasingROSandF2-isoprostane levels
as well as the activities of proinflammatory transcription factors (Jung
et al., 2009; Opalach et al., 2010; Ward et al., 2005). It would be of
interest, in future studies, to determine the importance of diet intake
upon oxidative stress parameters in the aged kidney of SHR and WKY.
The NADPH oxidase complex has been described as the main
source of ROS in the kidney, although other ROS-generating enzymes
are also present in this organ (Paravicini and Touyz, 2008; Touyz,
2004). The NAPDH oxidase catalyzes the conversion of molecular
oxygen into superoxide anion and is composed by p22phox and Nox2/
gp91phox membrane subunits and the cytosolic proteins p40phox,
p47phox, p67phox and Rac (Bedard and Krause, 2007; Paravicini and
Touyz, 2008). Nox4 is the most highly expressed NADPH oxidase in
the kidney and does not require cytosolic subunits for its activation
(Bedard and Krause, 2007). Oxidative stress in aged SHR and WKY
was accompanied by increases in the abundance of p22phox and Nox4
proteins, which provides additional support for increased ROS
production in the kidney of aged rats.
The primary lines of defense preventing biological macromolecules
from ROS attack are the antioxidant enzymes. SODs are an ubiquitous
family of enzymes that catalyze the conversion of superoxide anion into
H2O2. In the subsequent step of the detoxifying cascade,H2O2 previously
produced is converted to water and molecular oxygen by catalase or
GPx, which uses reduced glutathione as the hydrogen donor. Increased
levels of ROS in cells and tissues may act as a signal to enhance the
activity and expression of antioxidant enzymes. According to this
hypothesis, an increase in antioxidant enzymes activity and/or
expression with age would be expected, this being an adaptation to
help cells and tissues protect fromoxidative stress. Here,we reported an
increased renal expression of SOD2, SOD3 and catalase in both aged SHR62and WKY. This finding may occur in response to the increased H2O2
production in aged rats. In addition, the increased levels of H2O2 present
in these rats might modulate mRNA levels of antioxidant enzymes
through activation of redox-sensitive transcription factors such as AP-1
and NF-κB, which can lead to the overexpression of these enzymes in
aged rats. In contrast, expression of GPx remained unaltered during
aging in both SHR and WKY rats, suggesting that this enzyme may be
dysregulateddespite thepresence of oxidative stress. Somestudies have
showndecreases in activity and/or expressionof catalase andGPx,while
other studies showed the opposite trend. Fortepiani and Reckelhoff
(2005) reported a decrease in the expression of both catalase andGPx in
17/19-week old SHR. In contrast, Zhan et al. (2004b) reported increases
in the expression of catalase and GPx in the renal cortex of 24-week old
SHR without changes in enzymatic activity. In the study of Zhan et al.
(2004b), and similar to the present work, a significant increase in body
weight ofWKYwas reported. The cause of the discrepancy between the
results of Fortepiani and Reckelhoff (2005), Zhan et al., (2004b) and the
present study remains at present unclear. It is possible that it rests
simply on the fact that animals of different ages and bodyweights were
used and this is an important aspect to consider. Recent studies carried
out in WKY and Fischer-344 rats (21 to 24 months old) also described
increases in the activity of major antioxidant enzymes with age (Judge
et al., 2005; Lambertucci et al., 2007).
In conclusion, aged SHR and WKY display increased levels of
oxidative stress in renal tissue with similar expression profile of
oxidant and antioxidant enzymes, suggesting the existence of
common mechanisms in hypertension and obesity leading to
oxidative stress. It is suggested that oxidative stress levels in aged
WKY might arise from increased fat mass accumulation which is
operating as a confounding factor.
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A B S T R A C T
This study examined age-related changes in renal dopaminergic activity and expression of amino acid
transporters potentially involved in renal tubular uptake of L-DOPA in Wistar Kyoto (WKY) and
spontaneously hypertensive rats. Aging (from 13 to 91 weeks) was accompanied by increases in systolic
blood pressure (SBP) in both WKY and SHR. The sum of urinary dopamine and DOPAC and the urinary
dopamine/L-DOPA ratio were increased in aged SHR but not in aged WKY. The urinary dopamine/renal
delivery of L-DOPA ratio was increased in both rat strains with aging. LAT2 abundance was increased in
aged WKY and SHR. The expression of 4F2hc was markedly elevated in aged SHR but not in aged WKY.
ASCT2 was upregulated in both aged WKY and SHR. Plasma aldosterone levels and urinary noradrenaline
levels were increased in aged WKY and SHR though levels of both entities were more elevated in aged
SHR. Activation of the renal dopaminergic system is more pronounced in aged SHR than in aged WKY and
is associated with an upregulation of renal cortical ASCT2 in WKY and of LAT2/4F2hc and ASCT2 in SHR.
This activation may be the consequence of a counter-regulatory mechanism for stimuli leading to sodium
reabsorption.
 2011 Elsevier Ireland Ltd. All rights reserved.
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Dopamine is a major regulator of mammalian proximal tubule
salt and water reabsorption. In the mammalian kidney, dopamine
is primarily produced in the proximal tubule (Aperia, 2000; Gomes
and Soares-da-Silva, 2008; Soares-da-Silva and Vieira-Coelho,
1998). The dopamine precursor L-dihydroxyphenylalanine (L-
DOPA) is filtered at the glomerulus and is taken up by the
proximal tubule via luminal transporters and converted to
dopamine by aromatic L-amino acid decarboxylase (AADC), which
is highly expressed in the proximal tubule (Soares-da-Silva and
Fernandes, 1991). The regulation of this non-neuronal dopaminer-
gic system depends mainly on the availability of L-DOPA, on itsAbbreviations: 4F2hc, 4F2 heavy chain; ANOVA, one-way analysis of variance;
COMT, catechol-O-methyl-transferase; Ccr, creatinine clearance; DOPAC, 3,4-
dihydroxyphenylacetic acid; FENa+, fractional excretion of Na
+; GAPDH, glyceralde-
hyde-3-phosphate dehydrogenase; GFR, glomerular filtration rate; L-DOPA, L-
dihydroxyphenylalanine; LAT1, L-type amino acid transporter 1; LAT2, L-type amino
acid transporter 2; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel
electrophoresis; SEM, standard error of the mean; SHR, spontaneously hypertensive
rat; WKY, Wistar Kyoto rat.
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67decarboxylation into dopamine and on cell outward amine transfer
mechanisms (Pestana and Soares-da-Silva, 1994; Soares-da-Silva
and Fernandes, 1991). In the kidney, dopamine is metabolized
predominantly by catechol-O-methyl-transferase (COMT) and
monoamine oxidase to 3,4-dihydroxyphenylacetic acid (DOPAC),
and to homovallinic acid (HVA) (Pestana and Soares-da-Silva,
1994; Soares-da-Silva and Fernandes, 1991). A considerable
amount of evidence favours the view that dopamine of renal
origin plays a role in the regulation of central blood volume by
reducing the tubular reabsorption of sodium as a paracrine or
autocrine substance (Jose et al., 2003). The mechanisms through
which renal dopamine is thought to produce natriuresis involve
the activation of D1-like receptors that inhibit the activity of both
apical (e.g., Na/H exchange and chloride–bicarbonate exchange
and Na–P cotransport) and basolateral (Na–K-ATPase and NaHCO3
cotransport) transporters (Aperia et al., 1987; Felder et al., 1990;
Jose et al., 1992; Lokhandwala and Amenta, 1991). The availability
of dopamine to activate its specific receptors is determined by
factors affecting renal synthesis, mainly the amounts of L-DOPA
and sodium delivered to the kidney and the degree of degradation
of the amine (Soares-da-Silva et al., 1993).
The spontaneously hypertensive rat (SHR) is a genetic model of
hypertension characterized by the resistance to the natriuretic
effect of dopamine and D1-like receptor agonists, as a result of a
defective transduction of the D1 receptor signal in renal proximal
V. Pinto et al. / Mechanisms of Ageing and Development 132 (2011) 298–304 299tubules (Jose et al., 2010; Sanada et al., 1999; Zeng and Jose, 2011).
It has been suggested that increased oxidative stress in renal
proximal tubules of the SHR could be a mechanism for defective
dopamine D1 receptor/G-protein coupling (White and Sidhu,
1998). Moreover, recent studies have shown the overexpression
of Na+-independent and pH-sensitive amino acid transporter LAT2
(Slc7a8) in the SHR kidney, which might contribute to enhanced L-
DOPA uptake in the proximal tubule and increased dopamine
production (Pinho et al., 2004), as an attempt to overcome the
defect in D1 receptor function.
The aging kidney undergoes structural changes that result in
quantitative alterations in some renal functions, such as a decline
in renal blood flow and glomerular filtration rate (Zhou et al.,
2008). An increasing number of studies have shown that old
animals may present particular deficiencies in the renal handling
of L-DOPA, its subsequent conversion to dopamine (Armando et al.,
1995; Soares-da-Silva and Fernandes, 1991) and at the level of
receptor number or coupling to G proteins (Kansra et al., 1997). In
the presence of age-related diseases, such as heart failure and
hypertension, these changes can be aggravated (Fischer and
O’Hare, 2010).
This study was aimed at evaluating age-related changes in the
activity of the renal dopaminergic system and the regulation of the
amino acid transporters that are potentially involved in the uptake
of L-DOPA: Na+-independent LAT1 and LAT2 and Na+-dependent
ASCT2 in SHR and their normotensive Wistar Kyoto (WKY)
counterparts.
2. Materials and methods
2.1. Animal preparation and experimental design
Five-week old male WKY and SHR were obtained from Harlan-Interfauna Ibe´rica
(Barcelona, Spain). The rats were housed under controlled conditions (12 h light/
dark cycle and room temperature at 22  2 8C) and had free access to tap water and
standard rat chow (PANLAB, Barcelona, Spain). The animals were carefully maintained
and monitored until 13 or 91 weeks of age. Blood pressure (systolic and diastolic) and
heart rate were measured in conscious animals using a photoelectric tail-cuff detector
(LE 5000, Letica, Barcelona, Spain). A minimum of 5 measures were made each time and
the mean values were used for further calculations. All rat interventions were
performed in accordance with the European Directive number 86/609, and the rules of
the ‘‘Guide for the Care and Use of Laboratory Animals’’, 7th edition, 1996, Institute for
Laboratory Animal Research (ILAR), Washington, DC.
2.2. Metabolic study
Forty eight hours before experiments, 13- and 91-week old rats were placed in
metabolic cages (Tecniplast, Buguggiate, Italy) for a 24 h urine collection. The urine
samples were collected in vials containing 1 ml of 6 M HCl to prevent spontaneous
decomposition of monoamines and amine metabolites. After completion of this
protocol, rats were anesthetized with sodium pentobarbital (60 mg/kg, i.p.). The
animals were then sacrificed by exsanguination using cardiac puncture and the
blood collected into tubes containing K3 EDTA for later determination of plasma
biochemical parameters. Before excising the kidneys, a cannula was inserted in the
right ventricle of the heart and animals were perfused with ice-cold saline (0.9%
NaCl) to remove all blood from the kidneys. The kidneys were then excised,Table 1
Cardiovascular and physiological parameters in 13- and 91-week old WKY and SHR.
Parameter WKY 
13 weeks
n = 6
Systolic blood pressure (mm Hg) 122  6 
Diastolic blood pressure (mm Hg) 97  3 
Pulse pressure (mm Hg) 25  2 
Creatinine clearance (ml/min) 2.64  0.26 
Urinary protein excretion (mg/24 h) 14.01  0.80 
FENa+ (%) 0.38  0.04 
Kidney weight/tibia length (% of control) 100  2 
* Significantly different from corresponding values in 13-week old animals (P < 0.05
# Significantly different from age-matched WKY (P < 0.05).
68weighed, decapsulated, and the renal cortex and medulla rapidly separated by fine
dissection. Tissue pieces were immediately frozen in liquid nitrogen and stored at
80 8C for Western blot analysis.
2.3. Plasma and urine biochemistry
The quantification of sodium and potassium in plasma and urine was performed
by ion-selective electrodes. Creatinine was measured by the Jaffe´ method (Chromy
et al., 2008). All assays were performed by Cobas Mira Plus analyzer (ABX
Diagnostics, Switzerland). Creatinine clearance (in ml/min) was calculated using
the formula Ccr = (Ucreat  Vu)/(Pcreat  24 h  60) where Ucreat and Vu are the
urinary creatinine concentration and urinary 24 h volume and Pcreat is the plasma
creatinine concentration. Aldosterone in plasma samples was performed by
radioimmuno assay (Diagnostic Products Corporation; Los Angeles, CA).
2.4. Assay of catecholamines
The assay of catecholamines in urine (L-DOPA, dopamine, DOPAC and
norepinephrine) and plasma samples (L-DOPA, dopamine and DOPAC) was
performed by HPLC with electrochemical detection, as previously described
(Soares-da-Silva et al., 1994, 1993). The lower limit of detection of L-DOPA,
dopamine, norepinephrine, and DOPAC ranged from 350 to 1000 fmol.
2.5. Western blotting
Renal cortices from 13- and 91-week old WKY and SHR, were lysed in RIPA
buffer containing 150 mM NaCl, 50 mM Tris–HCl, pH 7.4, 5 mM EDTA, 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 100 mg/ml PMSF, 2 mg/ml leupeptin
and 2 mg/ml aprotinin. Protein concentration was determined using a protein
assay kit (Bio-Rad Laboratories, Hercules, CA), with bovine serum albumin as
standard. Lysates were boiled in sample buffer (35 mM Tris–HCl, pH 6.8, 4% SDS,
9.3% dithiothreitol, 0.01% bromophenol blue, 30% glycerol) at 95 8C for 5 min.
Samples containing 50–75 mg of protein, were separated by SDS-PAGE with 10%
polyacrylamide gel and then electroblotted onto nitrocellulose membranes (Bio-
Rad). Blots were blocked for 1 h with 5% non-fat dry milk in PBS (10 mmol/l
phosphate-buffered saline) at room temperature with constant shaking. Blots
were then incubated with the antibodies rabbit polyclonal anti-LAT1 (1:500;
Serotec); goat polyclonal anti-LAT2 (1:500; Santa Cruz Biotechnology); rabbit
polyclonal anti-4F2hc (1:500; Santa Cruz Biotechnology); rabbit polyclonal anti-
ASCT2 (1:500; Chemicon International); mouse monoclonal anti-b-actin
(1:20,000; Santa Cruz Biotechnology) or mouse monoclonal anti-GAPDH
(1:60,000; Santa Cruz Biotechnology) in 5% non-fat dry milk in PBS-T overnight
at 4 8C. The immunoblots were subsequently washed and incubated with
fluorescently labeled goat anti-rabbit (1:20,000; IRDyeTM 800, Rockland);
fluorescently labeled donkey anti-goat (1:10,000; IRDyeTM 800, Rockland); or
the fluorescently labeled goat anti-mouse secondary antibody (1:20,000;
AlexaFluor 680, Molecular Probes) for 60 min at room temperature and
protected from light. The membrane was washed and imaged by scanning at
both 700 and 800 nm, with an Odyssey Infrared Imaging System (LI-COR
Biosciences).
2.6. Drugs
All chemicals were obtained from Sigma (St. Louis, MO) unless otherwise stated.
2.7. Data analysis
Arithmetic means are given with standard error of the mean (SEM). Statistical
analysis was performed by one-way analysis of variance (ANOVA) followed by
Newman–Keuls test. A P value less than 0.05 was assumed to denote a significant
difference.SHR
91 weeks
n = 6
13 weeks
n = 6
91 weeks
n = 6
148  3* 191  2# 224  5*,#
88  3 165  2# 132  3*,#
60  1* 26  2 92  7*,#
3.9  0.23* 1.85  0.15# 2.05  0.18#
14.77  1.21 26.02  1.60# 41.06  3.38*,#
0.23  0.01* 0.37  0.04 0.23  0.04*
114  1* 100  1 122  2*,#
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3.1. Blood pressure data and renal function
As expected, the systolic and diastolic blood pressures (SBP and
DBP) determined by the tail-cuff method were significantly higher
in both 13- and 91-week old SHR than in age-matched WKY (Table
1). Moreover, aging was accompanied by increases in SBP in both
WKY and SHR. DBP remained unaltered in aged WKY, but a
significant decrease was observed in aged versus young SHR (Table
1). No difference in pulse pressure (defined as SBP minus DBP) was
found between young WKY and SHR. Pulse pressure increased with
age in both WKY and SHR but at 91 weeks of age SHR had higher
pulse pressure than age-matched WKY (Table 1). Creatinine
clearance (Ccr) levels were decreased in SHR in comparison to
age-matched WKY (Table 1). Urinary protein excretion was
significantly higher in SHR than in age-matched WKY at 13 and
91 weeks of age and increased significantly with age (Table 1).
Moreover, evaluation of FENa+ in WKY and SHR showed a
significant decrease in this parameter at the age of 91 weeks in
both rat strains (Table 1). Kidney/tibia length ratios were assessed
for WKY and SHR (Table 1). Aging was associated with increases in
kidney/tibia length ratio in both WKY and SHR. However, increases
in kidney size were more marked in SHR (Table 1).
3.2. Activity of the renal dopaminergic system
In the present study, the urinary excretion of dopamine and its
metabolite DOPAC was evaluated in 13- and 91-week old WKY and
SHR (Fig. 1). No changes were found in urinary L-DOPA indexed to
urinary creatinine in aged WKY. However, L-DOPA excretion was
decreased in aged SHR, though the difference did not reach
statistical significance (Fig. 1A). Aging was accompanied by slight
increases in urinary dopamine in WKY and SHR, though not
statistically significant. However, urinary dopamine in 91-week
old SHR was higher than that in age-matched WKY (Fig. 1B).
Urinary DOPAC was significantly increased in aged SHR but not in
aged WKY rats (Fig. 1C). More complete information on the L-DOPAWKY SHR
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Fig. 1. Urinary excretion of L-DOPA (A), dopamine (B), DOPAC (C), and sum of urinary dopa
SHR. Each bar represents the mean  SEM of 6 rats. Significantly different from correspo
matched WKY (#P < 0.05) using the Newman–Keuls test.
69renal turnover is obtained when the sum of urinary dopamine and
DOPAC is considered. The sum of urinary dopamine and DOPAC
was found to be increased in aged SHR but not in aged WKY
(Fig. 1D). Furthermore, urinary dopamine + DOPAC was markedly
increased in aged SHR in comparison to age-matched WKY
(Fig. 1D).
The enhanced urinary excretion of dopamine and DOPAC in the
SHR may reflect their enhanced ability to synthesize dopamine.
The urinary dopamine/L-DOPA ratio (a measure of renal L-DOPA
utilization and of renal dopamine-synthesis efficiency) in 91-week
old SHR was markedly higher than in young SHR (Fig. 2A). The
dopamine/L-DOPA ratio was also greater in 91-week old SHR than
in age-matched WKY (Fig. 2A). No differences were detected with
aging in the WKY (Fig. 2A). On the other hand, the ratio between
urinary dopamine and the renal delivery of L-DOPA (another index
of renal dopamine production) was greater in aged WKY and SHR
than in young animals (Fig. 2B). However, the dopamine/renal
delivery of L-DOPA ratio was significantly increased in aged SHR
when compared to age-matched WKY (Fig. 2B). The renal delivery
of L-DOPA, which considers L-DOPA plasma levels and creatinine
clearance (plasma L-DOPA  creatinine clearance), decreased with
age in WKY and SHR, though the difference did not reach statistical
significance in WKY (Fig. 2C). Moreover, the renal delivery of L-
DOPA in 91-week old SHR was significantly lower than in age-
matched WKY (Fig. 2C). As depicted in Table 2, aging was
accompanied by decreases in plasma levels of L-DOPA, dopamine
and DOPAC in both WKY and SHR.
3.3. Renal expression of LAT1, LAT2, 4F2hc and ASCT2
Age-related changes in the amino acid transporters that are
potentially involved in the uptake of L-DOPA were evaluated in the
renal cortex of 13- and 91-week old WKY and SHR. As depicted in
Fig. 3A LAT1 expression levels were downregulated in 91-week old
WKY and SHR rats when compared to young animals. On the other
hand, LAT2 abundance was significantly upregulated in 91-week
old WKY and SHR, as compared to young animals (Fig. 3B). Aging
had no effect on 4F2hc protein abundance in WKY, whereas 4F2hcWKY SHR
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Fig. 2. Urinary dopamine/L-DOPA ratios (A), dopamine/renal delivery of L-DOPA
ratios (B) and renal delivery of L-DOPA (C) in 13- and 91-week old WKY and SHR.
Each bar represents the mean  SEM of 6 rats. Significantly different from
corresponding values in 13-week old animals (*P <0.05) and significantly different
from age-matched WKY (#P < 0.05) using the Newman–Keuls test.
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SHR when compared to 13-week old SHR (Fig. 3C). ASCT2 was
increased at 91 weeks of age in both WKY and SHR when compared
with 13-week old animals (Fig. 3D).
3.4. Neurohumoral parameters
Aging was accompanied by increases in plasma aldosterone
levels in both WKY and SHR. However, at 91 weeks of age SHR had
increased circulating aldosterone levels when compared to age-Table 2
Plasma levels of L-DOPA, dopamine and DOPAC in 13- and 91-week old WKY and SHR
Parameter WKY 
13 weeks
n = 6
91 w
n = 6
L-DOPA (pmol/ml) 4.07  0.31 2.00
Dopamine (pmol/ml) 10.67  1.02 0.56
DOPAC (pmol/ml) 4.62  0.58 1.75
* Significantly different from corresponding values in 13-week old animals (P < 0.05
# Significantly different from age-matched WKY (P < 0.05).
70matched WKY (Fig. 4A). Plasma aldosterone levels were accompa-
nied by decreases in the UNa+/K+ ratio in both WKY and SHR
though the mineralocorticoid response to endogenous aldosterone
was markedly greater in 91-week old SHR than in age-matched
WKY rats (Fig. 4B). Similar to plasma aldosterone levels, urinary
excretion of noradrenaline was also greater in aged WKY and SHR
than in young animals, but levels in 91-week old SHR were higher
than in age-matched WKY rats (Fig. 4C).
4. Discussion
The present study evaluated age-related changes in dopami-
nergic activity and amino acid transporter expression in WKY and
SHR. The results indicate that aged SHR have increased renal
cortical LAT2/4F2hc and ASCT2 abundance and increased efficien-
cy in the formation of renal dopamine. Moreover, activation of the
renal dopaminergic system is accompanied by an increase in the
activity of the sympathetic and renin–angiotensin–aldosterone
systems.
There are conflicting results concerning the effect of age on
renal dopamine production. Although several studies have shown
an association between age and deficiencies in the renal handling
of L-DOPA (Armando et al., 1995; Kansra et al., 1997; Soares-da-
Silva and Fernandes, 1991; Vieira-Coelho et al., 1999), other
authors have reported no alterations in renal dopamine production
with aging (Komori et al., 1997; Lehmann et al., 1985; Nicolau
et al., 1985). In the present study, no significant changes with aging
were found in urinary excretion of L-DOPA, dopamine and DOPAC
or in the urinary dopamine/L-DOPA ratio in WKY. However, results
indicated that young WKY had increased renal delivery of L-DOPA
when compared to aged rats though the urinary excretion of L-
DOPA was the same. This may have led to the accumulation of
plasma levels of L-DOPA in young WKY. Since the urinary
dopamine/L-DOPA ratio only takes into account levels of urinary
dopamine and L-DOPA no differences were found between young
and aged WKY, regarding the ability to form dopamine. However, a
significant increase in the dopamine/renal delivery of L-DOPA ratio
in aged WKY indicates that the ability to produce dopamine may be
increased in aged WKY.
In comparison to aged WKY, aged SHR had increased urinary
excretion of dopamine and DOPAC. Additionally, urinary dopa-
mine/L-DOPA and urinary dopamine/renal delivery of L-DOPA
ratios were increased in aged SHR, indicating that aged SHR may
have an enhanced ability to produce dopamine than aged WKY.
Previous reports by other authors have shown that dopamine
production and excretion in the SHR were normal or increased
when compared with those in WKY, though most studies were
conducted in young animals (Herlitz et al., 1982; Kuchel et al.,
1987; Racz et al., 1985; Yoshimura et al., 1990). Our group reported
that SHR maintained on a normal-salt diet had, at 4 weeks of age
but not at 12 weeks, overexpression of LAT2 and increased tubular
uptake of L-DOPA (Pinho et al., 2007). Accordingly, the enhanced
ability to take up L-DOPA in the pre-hypertensive SHR was
suggested to take place as an attempt to overcome the deficient
dopamine-mediated natriuresis generally observed in this genetic.
SHR
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Fig. 3. Expression of LAT1 (A), LAT2 (B), 4F2hc (C) and ASCT2 (D) in the renal cortex of 13- and 91-week old WKY and SHR. Representative immunoblots are depicted on top of
the bar graphs. Values are normalized to the level of GAPDH expression in each condition and expressed as % of 13 week-old rats. Each bar represents the mean  SEM (n = 4
per group). Significantly different from values in 13-week old animals (*P <0.05) using the Newman–Keuls test.
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Moreover, at 4 and 12 weeks of age no differences in the urinary
excretion of dopamine or DOPAC, or in plasma aldosterone levels
were found between age-matched WKY and SHR (Pinho et al.,
2007).
The renal cortical abundance of Na+-independent LAT1 and
LAT2, 4F2hc and Na+-dependent ASCT2, amino acid transporters
potentially involved in renal tubular uptake of L-DOPA, was
evaluated in 13- and 91-week old WKY and SHR rats. The system L-
type amino acid transporters is a major route for providing living
cells with neutral amino acids including several essential amino
acids that cells are unable to synthesize such as leucine, isoleucine,
valine, phenylalanine, tryptophan, methionine and histidine
(Christensen, 1990; Silbernagl, 1979). Although the transport of
leucine by LAT1 in pig LLC-PK1 renal cells has been previously
described (Soares-da-Silva and Serrao, 2004), LAT1 has a very
limited tissue distribution in the kidney (Pinho et al., 2007). Global
gene expression monitoring by cDNA microarrays showed a
decline in the expression of y+LAT1 and B0AT1 with age in the renal
cortex (Melk et al., 2005). Similarly, in the present study aging was
accompanied by decreases in LAT1 abundance in WKY and SHR.
LAT2 is a major Na+-independent amino acid transporter expressed
mainly in transporting epithelia, such as in the kidney and
intestine (Broer, 2008), and its functionality is dependent on the
abundance of 4F2hc (Pineda et al., 1999). The heterodimerization71of LAT2 with 4F2hc is necessary for the transporter to reach the cell
surface (Nakamura et al., 1999). Therefore, increases in 4F2hc and
LAT2 abundance may translate in increases in LAT2 functionality in
aged SHR. On the other hand, the abundance of 4F2hc does not vary
with age in WKY, which would limit the translocation of LAT2 to the
cell surface. At the apical membrane of renal proximal tubule cells
only Na+-dependent amino acid transporters ASCT2 and B0AT1 are
capable of transporting amino acids with similar characteristics to
substrates transported through system L. Analogous to the LAT2
abundance profile, ASCT2 was found to be upregulated in aged WKY
and SHR. Overall, these results suggest that activation of the renal
dopaminergic system is accompanied by increases in LAT2/4F2hc
functionality and ASCT2 overexpression in aged SHR. In contrast,
LAT2/4F2hc functionality may not have a role in L-DOPA uptake in
the renal cortex of aged WKY.
Plasma aldosterone and renal noradrenaline levels were
higher in aged SHR than in aged WKY, indicating a marked
neurohumoral activation in aged SHR. The result of these
hemodynamic and neurohumoral alterations was an increase in
renal sodium transport (as indicated by a decrease in urinary
UNa+/K+ ratio), proteinuria and reductions of the renal delivery
of L-DOPA in aged SHR. Another indication of aldosterone actions
is the marked increases in kidney size in aged SHR rats.
Aldosterone directly modulates renal cell proliferation and
differentiation via stimulation of rapidly activated protein
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Fig. 4. Plasma levels (pmol/l) of aldosterone (A) changes in urinary Na+/K+ ratio (B) and urinary noradrenaline levels (nmol/mg creatinine) in 13- and 91-week old WKY and
SHR. Each column represents the mean  SEM of 6 rats. Significantly different from corresponding values in 13-week old animals (*P <0.05) and significantly different from age-
matched WKY (#P < 0.05) using the Newman–Keuls test.
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et al., 2010). The renal dopaminergic and renin–angiotensin–
aldosterone systems (RAAS) control renal electrolyte balance
through various receptor mediated pathways with counter-
regulatory interactions. In order to conserve sodium during low
sodium intake, the RAAS is upregulated in order to produce
angiotensin II (Ang II). Stimulation of the principal membrane
bound cell surface receptor for Ang II, the AT1R, leads to sodium
reabsorption. In order to eliminate sodium during high sodium
intake the local renal production of dopamine is increased
leading to inhibition of sodium reabsorption (Felder and Jose,
2006). The natriuretic renal dopaminergic system opposes the
anti-natriuretic activity of the RAAS by downregulating the
AT1R, upregulating the AT2R and inhibiting ROS generation. Each
of the individual dopamine receptors has been shown to oppose
the activity of the AT1R, with the D1R, D3R, and D5R physically
interacting with the AT1R (Gildea, 2009). Taken together, it is
suggested that the renal dopaminergic system might be a
compensatory mechanism activated by stimuli that lead to
sodium reabsorption in aged WKY and SHR. However, this
counter-regulatory mechanism is considerably more enhanced
in aged SHR. A similar mechanism has been shown in patients
with heart failure. Stimuli leading to activation of anti-
natriuretic systems and sodium retention are accompanied by
activation of the renal dopaminergic system characterized by an
increase in the renal utilization of filtered L-DOPA (Alvelos et al.,
2004; Ferreira et al., 2001, 2002).
The specific effects of aldosterone on the expression of 4F2hc
and LAT2 have recently been explored by our group (Pinho et al.,
2009). Eight-week old Wistar rats were submitted to high salt
intake (1% NaCl in their drinking water) and treated chronically
with aldosterone and/or spironolactone, a mineralocorticoid72receptor (MR) antagonist. Treatment with aldosterone signifi-
cantly increased LAT2 mRNA expression via the MR (abolished
by spironolactone), though protein levels remained unchanged.
On the other hand, aldosterone treated rats had decreased 4F2hc
protein expression in a spironolactone-independent manner.
These effects of aldosterone were accompanied by decreases in
urinary dopamine and DOPAC in a spironolactone-sensitive
manner (Pinho et al., 2009).
Studies have shown that cardiac function and coronary
hemodynamics progressively deteriorate with aging in both SHR
and WKY and that very old WKY tend to develop a significant
degree of isolated systolic hypertension (Susic et al., 1998,
2001). In the present study SBP was found to be increased in
aged WKY and SHR, displaying the same trend as the plasma
aldosterone levels. Pulse pressure has been reported to increase
significantly with age in SHR but not in WKY (Chamiot-Clerc
et al., 2001). However, these studies were conducted in rats
between 3 and 78 weeks of age. The findings show that aged
SHR has in fact an intense dopaminergic response but SBP and
pulse pressure values remain increased. The cause for this
outcome is possibly related to the defective transduction of the
D1 receptor signal in renal proximal tubules usually attributed
to this strain (Jose et al., 2010). On the other hand, the activation
of the renal dopaminergic system is not as effective in aged WKY
and SBP and pulse pressure are increased in these animals.
In conclusion, aging in WKY and SHR is accompanied by
increases in renal cortical ASCT2 abundance in the former and in
increases in LAT2/4F2hc and ASCT2 abundances in the latter.
Moreover, the dopaminergic response is more enhanced in aged
SHR than in aged WKY and this is probably a result of a
compensatory mechanism activated by stimuli leading to sodium
reabsorption.
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Aging is associated with alterations in renal physiology which may be aggravated by diseases such 
as hypertension. In the present study we hypothesised that age-associated changes in the renal 
aldosterone/mineralocorticoid receptor (MR) system may differ between spontaneously 
hypertensive rats (SHR), and Wistar-Kyoto rats (WKY). WKY became obese; body mass index 
(BMI) significantly increased with age. Fat mass accumulation may operate as a confounding factor 
therefore WKY were submitted to 15% food restriction (WKY-FR). Renal oxidative stress was 
increased in aged WKY and SHR. Long-term FR significantly reduced the BMI and decreased renal 
oxidative stress when compared to age-matched WKY and SHR. The renal medulla of aged WKY 
and SHR had increased MR action, assessed by the urinary Na+/K+ ratio which correlated positively 
with increased plasma aldosterone levels, nuclear MR content and expressions of Na+,K+-ATPase 
α1
 
-subunit and the α-subunit of the epithelial sodium channel (αENaC). In contrast, when compared 
to aged WKY and SHR, aged WKY-FR had decreased plasma aldosterone levels and decreased 
activation of the aldosterone/MR system in the renal medulla. Systolic and diastolic blood pressures 
in SHR increased with age and were significantly higher than that in age-matched WKY. In 
conclusion, renal oxidative stress and plasma aldosterone in aged WKY increased to levels 
observed in SHR but were not sufficient to result in sustained increases in blood pressure. 
Activation of the aldosterone/MR system is intensified by aging in SHR whereas 
hyperaldosteronism in WKY is associated with increases in body fat mass and not with aging per 
se.  
 
 
A broad-spectrum of physiological, 
functional and morphological changes in the 
kidney is associated with age, resulting in an 
almost inevitable decline of renal function 
(Kielstein et al. 2003; Epstein 1996). 
Previous studies have shown renal function 
decline to be associated with both structural 
(glomerulosclerosis, tubular atrophy and 
interstitial fibrosis) and functional (decreases 
in glomerular filtration rate (GFR), 
proteinuria, reduced ability to concentrate or 
dilute urine, impairment of electrolyte and ion 
transport, alteration in hormonal functions, 
reduced drug excretion) changes in the 
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kidney (reviewed in refs (Martin and Sheaff 
2007) and (Zhou et al. 2008)). 
In the presence of age-related 
diseases, such as heart failure and 
hypertension, these changes can be 
accelerated (Fischer and O'Hare). The 
prevalence of hypertension increases with age 
(Mosterd et al. 1999). Hypertension also 
correlates with altered kidney function and 
structure, which has been suggested to play a 
role in the development of this disorder 
(Mullins et al. 2006). This became 
particularly evident with renal cross-
transplantation between normotensive and 
hypertensive strains. Normotensive rats 
receiving a kidney from hypertensive rats 
were found to develop hypertension (Bianchi 
et al. 1974). The spontaneously hypertensive 
rat (SHR) is a genetic model of hypertension 
characterized by the resistance to the 
natriuretic effect of dopamine and D1-like 
receptor agonists, as a result of a defective 
transduction of the D1 receptor signal in renal 
proximal tubules (Jose et al. 2010). It has 
been suggested that increased oxidative stress 
in renal proximal tubules of the SHR could be 
a mechanism for defective dopamine D1 
receptor/G-protein coupling (White and 
Sidhu 1998). Moreover, recent studies have 
shown the overexpression of Na+
Aldosterone is a major regulator of 
extracellular fluid (ECF) volume and is the 
principal determinant of K
-independent 
and pH-sensitive amino acid transporter 
LAT2 (Slc7a8) in the SHR kidney, which 
might contribute to enhanced L-DOPA 
uptake in the proximal tubule and increased 
dopamine production (Pinho et al. 2004), as 
an attempt to overcome the defect in D1 
receptor function. 
+ homeostasis 
(Bhargava et al. 2004). Acting on the 
mineralocorticoid receptors (MR) it 
stimulates Na+ reabsorption, K+ and H+ 
secretion by the distal nephron, particularly in 
the collecting duct (O'Neil 1990). The MR is 
primarily localized in the cytosol of the cell 
in the absence of ligand (Nishi et al. 2001). 
Binding of aldosterone to the MR triggers its 
nuclear translocation and activity as a 
transcription factor (Fuller and Young 2005; 
Loffing et al. 2001). Inappropriate 
aldosterone secretion in relation to sodium 
balance leads to hypertension in the case of 
hyperaldosteronism, or to hypotension in the 
case of hypoaldosteronism (Epstein 2001). 
Although we recently showed that plasma 
aldosterone levels are increased in aged 
WKY (Pinto et al. 2011) the available data on 
the relationship between age and the function 
of the renin-angiotensin-aldosterone system 
in normotensive healthy adults are 
conflicting. Some authors noted diminished 
urinary aldosterone or plasma renin and 
aldosterone values (Weidmann et al. 1975), 
but others reported that plasma aldosterone 
remains unchanged with aging (Abd-Allah et 
al. 2004). Our group has recently reported the 
effects of aging (from 13- to 91-weeks of 
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age) on Na+,K+
 
-ATPase expression and 
activity in the kidney of WKY rats (Silva et 
al. 2010). Furthermore, Simão et al., reported 
that aged WKY and SHR display increased 
levels of oxidative stress in renal tissue that 
were suggested to be related to increases in 
body weight (Simao et al. 2011). In the 
present study we investigated age-related 
changes in the renal regulation of the 
aldosterone/MR system in normotensive 
Wistar-Kyoto (WKY) and spontaneously 
hypertensive rats (SHR). In comparison with 
SHR, aging in WKY was accompanied by 
marked increases in body weight, renal 
oxidative stress and a relative greater increase 
in plasma aldosterone levels. In WKY these 
changes were attenuated by long-term food 
restriction. 
Materials and Methods 
Animal preparation and experimental 
design 
All rat interventions were performed 
in accordance with the European Directive 
number 86/609, and the rules of the “Guide 
for the Care and Use of Laboratory Animals”, 
7th edition, 1996, Institute for Laboratory 
Animal Research (ILAR), Washington, DC. 
Five-week old male WKY and SHR rats were 
obtained from Harlan-Interfauna Ibérica 
(Barcelona, Spain) and carefully maintained 
and monitored until 13 and/or 52 weeks of 
age. One group of WKY rats were either fed 
ad-libitum or subjected to 15% food 
restriction (FR) until 13 weeks of age while 
another group was fed ad-libitum or subjected 
to 15% FR until 52 weeks of age. The rats 
were housed under controlled conditions (12 
h light/dark cycle and room temperature at 
22±2 ºC) and had free access to tap water and 
fed standard rat chow (PANLAB, Barcelona, 
Spain). Blood pressure (systolic and diastolic) 
was measured using a photoelectric tail-cuff 
detector (LE 5000, Letica, Barcelona, Spain). 
Body mass index (BMI) was determined in 
all animals as reported previously by other 
authors (Novelli et al. 2007), using the 
formula: BMI = body weight (g) / length2 
(cm2
 
), where “length” corresponds to the 
“nose-to-anus” length. 
Metabolic study 
Forty-eight hours before the 
experiments, 13- or 52-week old rats were 
placed in metabolic cages (Tecniplast, 
Buguggiate, Italy) for a 24 h urine collection. 
The urine samples were collected in vials that 
were subsequently stored at -80 ºC until 
assayed. After completion of this protocol, 
rats were anesthetized with sodium 
pentobarbital (60 mg/kg, i.p.). The animals 
were then sacrificed by exsanguination using 
cardiac puncture and the blood collected into 
tubes containing K3 EDTA for later 
determination of plasma biochemical 
parameters. Before excising their kidneys, a 
cannula was inserted in the right ventricle of 
the heart and animals were perfused with ice-
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cold saline (0.9 % NaCl) to remove all blood 
from the kidneys. The kidneys were then 
excised, weighed, decapsulated, and the renal 
cortex and medulla rapidly separated by fine 
dissection. 
 
Plasma and urine biochemistry 
All biochemical assays were 
performed by Cobas Mira Plus analyzer 
(ABX Diagnostics for Cobas Mira, 
Switzerland). Plasma aldosterone was 
assayed by radioimmunoassay (Diagnostic 
Products Corporation; Los Angeles, CA).  
 
H2O2
  H
 production by renal medulla and 
cortex 
2O2 was measured fluorometrically 
using the Amplex Red Hydrogen Peroxide 
Assay kit (Molecular Probes Inc., Eugene, 
OR, USA). Amplex Red is a fluorogenic 
substrate with very low background 
fluorescence that reacts with H2O2 with a 1:1 
stoichiometry to produce a highly fluorescent 
reagent. Renal cortex and medulla were cut 
into square pieces and incubated at 37 ºC in 
Krebs-HEPES buffer (in mM: NaCl 118, KCl 
4.5, CaCl2 2.5, MgCl2 1.20, K2HPO4 1.2, 
NaHCO3 25.0, Na-HEPES 25.0, and glucose 
5; pH 7.4) for 90 min. H2O2 released from 
the tissue was detected using the Amplex Red 
Hydrogen Peroxide Assay kit. Fluorescence 
intensity was measured in a multiplate reader 
(Spectromax Gemini Molecular Devices) at 
an excitation wavelength of 530 nm and 
emission wavelength of 590 nm at room 
temperature. After subtracting background 
fluorescence, the concentrations of renal 
cortical and medullary H2O2 (in pmol/mg) 
were calculated using a resorufin–H2O2 
standard calibration curve generated from 
experiments using H2O2
 
 and Amplex Red. 
Malondialdehyde (MDA) determination 
Briefly, urine samples were combined 
with 8.1% SDS for 10 min. Equal volumes of 
28% trichloroacetic acid (TCA) and 0.6% 
thiobarbituric acid (TBA) were added and 
heated at 95 ºC during 1 hour. After cooling 
at room temperature, a mixture of 
chloroform/methanol (2:1) were added and 
centrifuged at 5000 rpm for 10 min. 
Supernant absorbance was measured at 532 
nm. The content of urinary malondialdehyde 
MDA was calculated using a MDA standard 
calibration curve and results were expressed 
as nanomoles of MDA per 24 h urine volume.  
 
Western Blotting 
Isolated renal cortex and medulla of 
13- and 52-week old WKY, WKY-FR and 
SHR were sliced very thinly and lysed by the 
addition of RIPA buffer containing 150 mM 
NaCl, 50 mM Tris–HCl, pH 7.4, 5 mM 
EDTA, 1% Triton X-100, 0.5% sodium 
deoxycholate, 0.1% SDS, 100 µg/ml 
phenylmethylsulfonyl fluoride (PMSF), 2 
µg/ml leupeptin and 2 µg/ml aprotinin, as 
described previously (Amaral et al. 2009). 
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Nuclear protein was prepared as described by 
other authors (Kanematsu et al.). Briefly, 
renal medullary and cortical tissues were 
homogenized in ice-cold buffer (A) 
containing 10 mM HEPES (pH 7.9), 1.5 mM 
MgCl2, 10 mM KCl, 0.5 mM dithiothreitol 
(DTT), 0.5 mM PMSF, 2 µg/ml leupeptin, 2 
µg/ml aprotinin and 10% Nonidet P-40. After 
centrifugation of the homogenate at 1,000 x g 
for 5 min at 4°C, the supernatants and pellets 
were collected separately. The supernatants 
were centrifuged again at 6,000 x g for 10 
min. For nuclear fraction isolation, the pellets 
from the first centrifugation, which contain 
cell nuclei, were washed with buffer A and 
then incubated with ice-cold buffer (B) 
containing 5 mM HEPES (pH 7.9), 1.5 mM 
MgCl2, 300 mM NaCl, 400 mM KCl, 0.2 
mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 2 
µg/ml leupeptin, 2 µg/ml aprotinin, and 26% 
glycerol for 30 min to release nuclear 
proteins. Next, the reaction mixtures were 
centrifuged at 24,000 x g for 30 min, and the 
supernatant (containing nuclear-enriched 
protein fraction) was collected and frozen in 
liquid nitrogen until use as nuclear extracts 
for western blot analysis. Protein 
concentrations in nuclear protein enriched 
fractions and homogenates of total protein 
were determined by the Bradford assay. 
Proteins were subjected to SDS-10%PAGE 
and then electroblotted onto nitrocellulose 
membranes (Bio-Rad). Blots were blocked 
for 1 h with 5% non-fat dry milk in TBS (10 
mmol/l tris-buffered saline) at room 
temperature with constant shaking and 
subsequently incubated with antibodies 
mouse polyclonal anti-MR (1:500,(Gomez-
Sanchez et al. 2006); kindly supplied by Dr 
Elise Gómez-Sánchez, (University of 
Mississippi Medical Center, Jackson, 
Mississippi); rabbit polyclonal anti-αENaC 
(1:500, Chemicon); rabbit polyclonal anti-
NHE3 (1:200) (Xu et al. 2000); kindly 
supplied by Dr Pedro A. Jose, (George 
Washington University School of Medicine & 
Public Health, Washington, D.C.); mouse 
monoclonal anti-α1-subunit of Na+,K+-
ATPase (1:1000, Santa Cruz Biotechnology) 
and mouse monoclonal anti-GAPDH 
(1:20,000, Santa Cruz Biotechnology) in 5% 
non-fat dry milk in TBS-T overnight at 4 ºC. 
Mouse monoclonal anti-β-actin (1:20,000, 
Santa Cruz Biotechnology) was used as an 
internal loading control for homogenates of 
nuclear proteins as previously described by 
other authors (Kariagina et al. 2005; Olave et 
al. 2002). Since β-actin expression did not 
vary between the different groups it was 
regarded as a safe loading control. The 
immunoblots were subsequently washed and 
incubated with fluorescently labeled goat 
anti-rabbit (1:20,000; IRDyeTM 800, 
Rockland) or the fluorescently labeled goat 
anti-mouse secondary antibody (1:20,000; 
AlexaFluor 680, Molecular Probes) for 60 
min at room temperature and protected from 
light. The membrane was washed and imaged 
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by scanning at both 700 and 800 nm, with an 
Odyssey Infrared Imaging System (LI-COR 
Biosciences).  
 
Drugs 
All chemicals were obtained from Sigma (St. 
Louis, MO) unless otherwise stated. 
 
Data analysis 
Arithmetic means are given with 
standard error of the mean (SEM). One-way 
ANOVA followed by the Newman–Keuls test 
for multiple comparisons test was used to 
determine differences between single groups 
when more than 2 groups were represented. A 
P value less than 0.05 was assumed to denote 
a significant difference. 
 
Results 
Physiological parameters in aged WKY, 
WKY-FR and SHR 
As expected, systolic (SBP) and 
diastolic (DBP) blood pressures in the SHR 
were significantly higher than that in age-
matched WKY (Figure 1A and 1B). Blood 
pressure in the SHR was found to increase 
with age, whereas SBP and DBP in WKY 
were not significantly affected by aging 
(Figure 1A and 1B). Body weight of WKY 
and SHR increased steadily until 52 weeks of 
age (Figure 1C). By 52 weeks of age WKY 
had significantly greater body weight than 
SHR (Table 1). Moreover, at 52 weeks of age 
WKY had a BMI (g/cm2
FR resulted in a 14% body weight 
reduction at the age of 52 weeks in WKY-FR 
compared to WKY fed ad libitum and in a 
significant decrease in the BMI value (Table 
1). As electrolyte excretion may be 
conditioned by food ingestion, all groups 
were placed in metabolic cages and fed ad 
libitum 48 hours before experiments. No 
differences in the amount of food ingested 
during this time period were observed 
between groups (data not shown). 
) of 0.80±0.01, 
significantly above the considered “normal” 
range (0.45±0.02 to 0.68±0.05) determined 
by other authors for adult Wistar rats (Novelli 
et al. 2007). For this reason WKY were 
submitted to 15% FR (WKY-FR) from 5 to 
13 or 52 weeks of age. WKY-FR had at 13 
weeks of age, similar body weight to those 
fed ad libitum (Table 1).  
Urinary Na+ was lower in 13-week-
old SHR than in age-matched WKY. At 13 
weeks of age WKY-FR had increased urinary 
Na+ when compared to age-matched WKY. 
On the other hand, aging had no effect on 
urinary Na+ levels in WKY, WKY-FR and 
SHR (Table 1). No differences were found in 
urinary K+ levels between young WKY, 
WKY-FR or SHR. Aging was accompanied 
by increases in urinary K+
 
 in all groups.  
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Table 1. Physiological parameters in 13- and 52-week old WKY, WKY-FR and SHR. 
 
 WKY WKY-FR SHR 
 
13 weeks 
 
 52 weeks 
 
13 weeks 
 
52 weeks 
 
13 weeks 
 
 52 weeks 
 
       
Body weight (g) 321±12 578±9 324±8 * 498±10 272±5* # λ 392±6# 
BMI (g/cm
# 
2
 
) 0.60±0.01 
 
0.80±0.01 0.60±0.01 * 0.73±0.01 0.59±0.01 *# λ 0.68±0.01
UNa
*#  
+
 
 (mmol/24h) 1.77±0.11 
 
1.36±0.23 2.33±0.05 1.51±0.08 # 1.32±0.06 1.07±0.13 # 
UK+ 
 
(mmol/24h) 1.10±0.06 1.56±0.10 1.11±0.06 * 1.35±0.05 0.86±0.08 * # 1.30±0.07
 
* # 
      
Plasma cholesterol 
(mg/dl) 78±4 82±7 65±2 65±2# 50±2# λ 51±2# 
Plasma creatinine 
(mg/dl) 
# 
 
0.39±0.04 
 
0.50±0.01
 
* 0.43±0.03 
 
0.57±0.03 0.41±0.03 * 0.51±0.02
 
* 
      
Significantly different from corresponding values in 13-week old animals (*P<0.05).  Significantly different 
from age-matched WKY (#P< 0.05). Significantly different from 52-week old SHR (λP< 0.05). 
 
 
At 52 weeks of age urinary K+
Cholesterol levels were unaffected by 
aging in all WKY groups although levels 
were decreased in young and aged WKY-FR 
animals when compared to age-matched 
WKY (Table 1). Plasma creatinine levels 
increased with age in WKY, WKY-FR and  
 was 
significantly lower in WKY-FR and SHR 
than in age-matched WKY (Table 1). SHR 
had increased levels of urinary protein 
(UPRT) when compared to age-matched 
WKY. Furthermore, while no changes in 
UPRT were observed in aged WKY or WKY-
FR, urinary protein excretion in SHR 
increased with age (Table 1). 
SHR, although no differences were observed 
between age-matched animals (Table 1). 
 
Renal oxidative markers in aged WKY, 
WKY-FR and SHR 
In order to examine the renal 
oxidative status with aging, H2O2 production 
and lipid peroxidation levels were measured 
in the medulla and cortex of 13- and 52-week 
old WKY, WKY-FR and SHR (Figure 2). 
Aging was associated with increases in H2O2 
production in the renal medulla of all rats, 
however, at 52 weeks of age, WKY-FR had 
lower H2O2 production than age-matched 
WKY and SHR (Figure 2A). The production 
of H2O2
 
 in the renal cortex of WKY, WKY-
FR and SHR was similar to that observed in 
the renal medulla (Figure 2B).  
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Figure 1. Changes in systolic (A) and diastolic (B) blood pressure of 13- and 52-week old WKY and SHR. 
Significantly different from values in 13-week old rats (*P<0.05) and significantly different from age-
matched WKY (#P< 0.05) using the Newman–Keuls test. (C) Changes in body weight of WKY, WKY-FR 
and SHR rats as a function of time. Significantly different from WKY at 52 weeks of age (*P<0.05) using the 
Newman–Keuls test. Each bar represents the mean ± SEM of 6-12 rats. Each point represents the mean ± 
SEM of 6–12 rats. 
 
Young WKY-FR had decreased 
H2O2 production in comparison to age-
matched WKY and SHR. Aging was 
accompanied by increases in H2O2 
production in all groups. By 52 weeks of age 
no differences were found between age-
matched WKY and SHR, but WKY-FR had 
lower H2O2
We next measured the concentration 
of urinary malondialdehyde (MDA), a marker 
of lipid peroxidation (Figure 2C). Lipid 
peroxidation levels were similar in 13-week 
old WKY, WKY-FR and SHR. MDA levels 
increased with age in both WKY and SHR, 
but not in WKY-FR. No differences in MDA 
levels were observed between aged WKY and 
SHR. In contrast, lipid peroxidation levels 
were lower in 52-week old WKY-FR than in 
age-matched WKY and SHR 
 production levels than WKY and 
SHR (Figure 2B). 
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Figure 2. Production of H2O2 
 
by renal medulla (A) and cortex (B) of 13- and 52-week old WKY, WKY-FR 
and SHR. Urinary levels of lipid peroxidation (MDA levels) in 13- and 52-week old WKY, WKY-FR and 
SHR (C). Each bar represents the mean ± SEM of 3-7 rats. Significantly different from 13-week old WKY 
(τP< 0.05), significantly different from 13-week old SHR (βP< 0.05), significantly different from 
corresponding values in 13-week old animals (*P<0.05), significantly different from 52-week old WKY (#P< 
0.05) and significantly different from 52-week old SHR (λP< 0.05) using the Newman–Keuls test. 
Plasma levels of aldosterone and the 
urinary Na+/K+ ratio (UNa+/K+
Plasma aldosterone levels were 
greater in 13-week old SHR when compared 
to age-matched WKY (Figure 3A). At this 
age, no differences were found between 
WKY and WKY-FR. Aging was 
accompanied by marked increases in plasma 
aldosterone levels in all groups. By 52 weeks 
of age no differences were observed between 
WKY and SHR. However, WKY-FR had 
significantly lower plasma aldosterone levels 
when compared to age-matched WKY and 
SHR (Figure 3A). The mineralocorticoid 
) 
effect was assessed by the urinary Na+/K+ 
(UNa+/K+) ratio (Figure 3B). The UNa+/K+ 
ratio was significantly increased in 13-week 
old WKY-FR in comparison to age-matched 
WKY and SHR. Aging decreased the 
UNa+/K+ ratio in all animal groups, however, 
at 52 weeks of age WKY-FR had higher 
UNa+/K+ ratio when compared to age-
matched WKY and SHR. No differences in 
the UNa+/K+
 
 were observed between 52-week 
old WKY and SHR (Figure 3B). 
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Figure 3. Plasma levels of aldosterone (pmol/L) (A) and changes in urinary Na+/K+ (UNa+/K+
 
) ratio (B) in 
13- and 52-week old WKY and SHR. Each column represents the mean ± SEM of 6-12 rats. Significantly 
different from 13-week old WKY (τP< 0.05), significantly different from 13-week old SHR (βP< 0.05), 
significantly different from corresponding values in 13-week old animals (*P<0.05), significantly different 
from 52-week old WKY (#P< 0.05) and significantly different from 52-week old SHR (λP< 0.05) using the 
Newman–Keuls test. 
Renal abundance of total and nuclear MR 
in aged WKY, WKY-FR and SHR 
Aldosterone regulates sodium 
reabsorption in epithelial tissues such as the 
kidney via the activation of intracellular MR. 
Therefore, total and nuclear abundance of 
MR was measured in the renal medulla and 
cortex of 13- and 52-week old WKY, WKY-
FR and SHR (Figure 4 and 5). In the renal 
medulla, no differences in total MR 
abundance were found between 13-week old 
WKY, WKY-FR and SHR (Figure 4A). 
Total MR abundance was similar in WKY 
and SHR at 52 weeks of age. Aged WKY-FR 
had higher total MR abundance than age-
matched WKY and SHR (Figure 4A). The 
nuclear content of MR in the renal medulla 
was increased in 13-week old SHR in 
comparison to age-matched WKY (Figure 
4B). Aged WKY, WKY-FR and SHR had 
significantly increased MR nuclear 
abundance when compared to 13-week old 
animals. However, MR nuclear abundance 
was significantly greater in 52-week old SHR 
than in age-matched WKY. Aged WKY-FR 
had lower MR nuclear abundance in 
comparison to age matched WKY and SHR 
(Figure 4B). 
In the renal cortex, no differences 
were observed in the abundance of total or 
nuclear MR between 13-week old WKY, 
WKY-FR and SHR (Figure 5A and 5B). 
Total MR abundance decreased in the renal 
cortex of aged WKY, but increased in aged 
SHR (Figure 5A). In WKY-FR, no age-
related changes in total MR abundance were 
observed. Total MR was greater in 52-week 
old WKY-FR than in WKY. Conversely, total 
MR levels were lower in aged WKY-FR than 
in age-matched SHR (Figure 5A). Nuclear 
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MR content was decreased in the renal cortex 
of aged WKY, WKY-FR and SHR (Figure 
5B). No differences were observed between 
52-week old WKY and SHR. In contrast, 
WKY-FR had significantly higher nuclear 
MR content than age-matched WKY and 
SHR (Figure 5B). 
 
 
 
Figure 4. Total mineralocorticoid receptor (MR) expression (A) and nuclear MR content (B) in the renal 
medulla of 13- and 52-week old WKY, WKY-FR and SHR. Values are normalized to the level of GAPDH or 
β-actin expression for each protein of interest and expressed as percentage of control (13-week old WKY). 
Each column represents the mean ± SEM (n=4 per group). Significantly different from 13-week old WKY 
(τP< 0.05), significantly different from corresponding values in 13-week old animals (*P<0.05), significantly 
different from 52-week old WKY (#P< 0.05) and significantly different from 52-week old SHR (λP< 0.05) 
using the Newman–Keuls test. 
 
The effect of aging on the renal expression 
of aldosterone effectors in WKY, WKY-FR 
and SHR  
We evaluated the expression of 
several sodium transport proteins that have 
been reported  to be regulated by aldosterone, 
such as NHE3, Na+,K+-ATPase α1-subunit, 
and αENaC in the renal medulla and renal 
cortex of 13- and 52-week old WKY, WKY-
FR and SHR. No differences in the renal 
medullary abundance of NHE3, Na+,K+-
ATPase α1
between WKY, WKY-FR, and SHR at 13 
weeks of age (Figure 6). Moreover, no 
significant differences in NHE3 expression 
were found between age-matched WKY, 
WKY-FR and SHR in the renal medulla nor 
did NHE3 abundance change with aging 
(Figure 6B). Expression of Na
-subunit and αENaC were found 
+,K+-ATPase 
α1-subunit in the renal medulla was 
significantly increased in aged WKY and 
SHR, but not in WKY-FR (Figure 6C). No 
differences were found between age-matched 
WKY and SHR (Figure 6C). 
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Figure 5. Total mineralocorticoid receptor (MR) expression (A) and nuclear MR content (B) in the renal 
cortex of 13- and 52-week old WKY, WKY-FR and SHR. Values are normalized to the level of GAPDH or 
β-actin expression for each protein of interest and expressed as percentage of control (13-week old WKY). 
Each column represents the mean ± SEM (n=4 per group). Significantly different from 13-week old WKY 
(τP< 0.05), significantly different from corresponding values in 13-week old animals (*P<0.05), significantly 
different from 52-week old WKY (#P< 0.05) and significantly different from 52-week old SHR (λP< 0.05) 
using the Newman–Keuls test. 
 
Similar to what other authors have 
observed (Tiwari et al. 2009), we identified 
the presence of 3 different MW bands for 
αENaC expression in the renal medulla of 
WKY and SHR (Figure 6). The 65 kDa band 
density for αENaC was greater in aged WKY, 
WKY-FR and SHR than in young rats. 
Furthermore, at 52 weeks of age, WKY-FR 
had significantly decreased 65 kDa band 
density in comparison to age-matched WKY 
and SHR (Figure 6D). Aging was associated 
with decreases in the 75 kDa band density in 
both WKY and SHR, but not in WKY-FR, 
and no differences were found between age-
matched WKY and SHR (Figure 6E). At 52 
weeks of age WKY-FR had significantly 
increased 75 kDa band density in comparison 
to age-matched WKY and SHR (Figure 6E). 
No age-related or strain-related changes in 90 
kDa band density for αENaC in the renal 
medulla were observed (Figure 6F). 
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Figure 6. Representative immunoblots of renal medullary homogenates from 13- and 52-week old WKY, 
WKY-FR and SHRs probed with NHE3, α1-subunit Na+,K+-ATPase, αENaC and GAPDH antibodies (A). 
Protein expression of NHE3 (B) and α1-subunit Na+,K+
 
-ATPase (C). D-F, Quantification of several bands of 
αENaC: 65 kDa (D), 75 kDa (E) 90 kDa (F). Values are normalized to the level of GAPDH expression for 
each protein of interest and expressed as percentage of control (13-week old WKY). Each column represents 
the mean ± SEM (n=4 per group). Significantly different from corresponding values in 13-week old animals 
(*P<0.05), significantly different from 52-week old WKY (#P<0.05) and significantly different from 52-week 
old SHR (λP< 0.05) using the Newman–Keuls test. 
The renal cortical expression profiles of 
NHE3, Na+,K+-ATPase α1
abundance in WKY and SHR but not in 
WKY-FR (Figure 7B). At 52 weeks of age 
WKY-FR had significantly increased NHE3 
abundance in comparison to age-matched 
WKY and SHR (Figure 7B). No significant 
-subunit and 
αENaC of WKY, WKY-FR and SHR were 
also evaluated (Figure 7). Aging was 
associated with decreases in NHE3 
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differences in Na+,K+-ATPase α1-subunit 
abundance in the renal cortex were found 
between WKY and SHR at any age nor did 
FR have an effect on Na+,K+-ATPase α1
decreases in cortical abundance of NHE3 in 
WKY and SHR (Figure 7B) correlated 
positively with the decreases of the 75 and 
90kDa band densities of αENaC (Figure 7D 
and 7E, respectively). 
-
subunit expression (Figure 7C). Age-related 
 
 
 
Figure 7. Representative immunoblots of renal cortical homogenates from 13- and 52-week old WKY, 
WKY-FR and SHRs probed with NHE3, α1-subunit Na+,K+-ATPase, αENaC and GAPDH antibodies (A). 
Protein expression of NHE3 (B) and α1-subunit Na+,K+
 
-ATPase (C). Quantification of αENaC: 75 kDa (D) 
and 90 kDa (E). Values are normalized to the level of GAPDH expression for each protein of interest and 
expressed as percentage of control (13-week old WKY). Each column represents the mean ± SEM (n=4 per 
group). Significantly different from corresponding values in 13-week old animals (*P<0.05), significantly 
different from 52-week old WKY (#P<0.05) and significantly different from 52-week old SHR (λP< 0.05) 
using the Newman–Keuls test. 
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 No differences in the 75 and 90kDa 
band densities of αENaC were found between 
age-matched WKY and SHR (Figure 7D and 
7E, respectively). Although the 90kDa band 
density of αENaC did not vary with age in 
WKY-FR (Figure 7E), the 75kDa band 
density was slightly, but significantly, 
decreased in 52-week old versus 13-week old 
WKY-FR (Figure 7D). In this study we 
found that the density of the 65 kDa band for 
αENaC in renal cortex was too low to be 
quantified accurately. 
 
The magnitude of the effect of aging in 
WKY, WKY-FR and SHR  
The modifying effect of age on the 
expression levels of NHE3, α1-subunit 
Na+,K+-ATPase and αENaC in the renal 
medulla and renal cortex of WKY and SHR 
was summarized in Fig 8A and 8B. The data 
was analyzed and plotted as a percent of 
control (respective young animals). The 
effect of age on the renal medullary and 
cortical expression profiles of αENaC, NHE3 
and the α1-subunit Na+,K+-ATPase were very 
similar between WKY and SHR (Figure 8A 
and 8B). On the other hand, in the renal 
medulla, aging was accompanied by greater 
increases in αENaC (65 kDa band) and the 
α1-subunit Na+,K+
 
-ATPase abundances in 
SHR than in WKY-FR (Figure 8A). In the 
renal cortex, age-related decreases in αENaC 
and NHE3 abundances were more 
accentuated in SHR than in WKY-FR 
(Figure 8B).  
 
Discussion 
The findings reported here 
demonstrate that aging in WKY and SHR is 
accompanied by exacerbated oxidative stress 
at the kidney level and increased 
aldosterone/MR system activation. Despite 
similar oxidative stress status and plasma 
aldosterone levels in aged WKY and SHR, 
aged WKY did not develop hypertension. 
Moreover, long-term FR reduced age-related 
increases in renal oxidative stress and 
circulating aldosterone.  
Similarly to results obtained by other 
authors (Natalucci et al. 2003; Ruetten et al. 
1999), this study showed that WKY rats 
become obese with age, which mainly results 
from the accumulation of fat mass. Studies 
have shown that body weight of aging WKY 
rat increases significantly when compared 
with age-matched SHR (Natalucci et al. 2003; 
Ruetten et al. 1999). A 63% weight gain from 
the ages of 12 weeks to 40 weeks in WKY 
rats has been reported while body weight 
remained unaltered in aging SHR (Natalucci 
et al. 2003). SHR are considered hyperactive 
compared to WKY (Hendley et al. 1992). 
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Figure 8. Differences in the magnitude of the effect of aging on the expression of several aldosterone 
effectors in WKY, WKY-FR and SHR in the renal medulla (A) and the renal cortex (B). Each column 
represents the mean ± SEM (n=4 per group). Significantly different from WKY (*P<0.05), significantly 
different from WKY-FR (#P< 0.05) using the Student’s t-test. 
 
In contrast, WKY is particularly 
inactive compared to other often-used rat 
strains and has even been proposed as an 
animal model of endogenous depression 
(Wieland et al. 1986; Will et al. 2003). 
Therefore, the greater increase in body weight 
observed in WKY may be due to reduced 
physical activity energy expenditure, slow 
metabolism and decreased resting energy 
expenditure. In contrast, SHR may burn more 
calories than WKY through increased 
physical activity energy expenditure and an 
increased resting metabolic rate. There is an 
increasing amount of evidence that body fat 
mass is associated with increased aldosterone 
levels (Bomback and Klemmer 2009). Two 
mechanisms have been suggested to explain 
elevated aldosterone levels in obesity. First, 
that human adipose tissue produces several 
components of the renin-angiotensin-
aldosterone system, mainly adipose tissue-
derived angiotensinogen. In line with this 
view, it has been shown that weight loss 
reduces systemic RAS activity (Goossens et 
al. 2007). Second, that increased fatty acid 
production in obese humans, especially 
nonesterified fatty acids, might stimulate 
aldosterone production, in a renin-
independent manner (Goodfriend et al. 1999). 
Adipocyte-derived aldosterone-releasing 
factors, although not yet identified, have been 
found to stimulate aldosterone secretion from 
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adrenocortical cells (Ehrhart-Bornstein et al. 
2003).  
Increased production of H2O2 was 
observed in the medulla and cortex of 52-
week old WKY and SHR, which is in 
agreement with growing evidence implicating 
an age-related decline in activity of 
antioxidant systems (Harman 1998). 
However, no differences in H2O2 production 
in the renal medulla and cortex were observed 
between 52-week old WKY and SHR. 
Moreover, aged WKY and SHR also 
exhibited significantly increased urinary 
MDA levels, a frequently used index of cell 
lipid peroxidation. Several reports have 
shown an age-associated increase in the 
concentrations of lipid peroxidation products 
(Pratico 2002). We propose that oxidative 
stress in WKY may be associated with their 
age-related weight gain. Production of ROS is 
increased in adipose tissue of obese mice, 
accompanied by augmented expression of 
NADPH oxidase and decreased expression of 
antioxidative enzymes (Furukawa et al. 
2004). Accordingly, our results demonstrated 
that renal H2O2
The mineralocorticoid response was 
assessed via the UNa
 levels were decreased WKY-
FR when compared to age-matched WKY 
and SHR fed ad libitum. As previously 
reported, SBP and DBP were significantly 
increased in SHR in comparison to age-
matched WKY (Gerova and Kristek 2008). 
Studies have suggested that hypertension 
might result from increased levels of 
oxidative stress in the renal medulla (Makino 
et al. 2002). Reduction of SOD activity in the 
renal medulla by the chronic infusion of the 
SOD inhibitor DETC into the renal medullary 
interstitium resulted in an increase of 
medullary superoxide anion concentrations, a 
reduction of blood flow to the renal medulla, 
and a sustained increase of blood pressure 
(Makino et al. 2002). Our findings 
demonstrate that despite similar increases in 
renal oxidative stress and plasma aldosterone 
levels, SBP and DBP in WKY were 
significantly lower than age-matched SHR 
and that renal oxidative stress and increases 
in sodium reabsorption may not be sufficient 
to cause hypertension.  
+/K+ ratio in WKY, 
WKY-FR and SHR. The UNa+/K+ ratio has 
been used previously by other authors to 
examine long-term changes in the aldosterone 
response (Hanukoglu et al. 2008). All groups 
were placed in metabolic cages and fed ad 
libitum 48 hours before sacrifice and no 
differences in the amount of food ingested 
during this time period were observed 
between groups. Given that food 
consumption was similar between groups we 
assumed that any potential changes in urinary 
Na+ and K+ excretion would be a result of 
dysregulated renal ion transporters. In our 
study we found that aging from 13 to 52 
weeks was accompanied by a decrease in the 
UNa+/K+ ratio in WKY and SHR and an 
increase in plasma aldosterone levels. This 
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decrease was mainly due to an increase in 
urinary K+ excretion (Na+ remained constant 
with aging). When aldosterone levels are 
elevated the kidney can overcome 
aldosterone's Na+-retaining action by 
activation of the so-called "aldosterone 
escape" mechanism, in which renal tubule 
Na+ reabsorption decreases despite the 
continued presence of aldosterone (Schrier 
2010). Aldosterone initially decreases urinary 
Na+ by increasing sodium retention. 
However, urinary Na+ quickly returns to 
baseline levels through pressure natriuresis 
and decreased proximal Na+
The role of aldosterone in
 reabsorption 
(Schrier 2010).  
 the 
pathogenesis of hypertension is gaining wider 
recognition with the finding that nearly 1 in 
10 hypertensives has 
inappropriate aldosterone activity (Lim 2002). 
In this study we report that SHR, a well 
known experimental model for 
human essential hypertension, develops 
hyperaldosteronism with age which is 
accompanied by increases in MR nuclear 
trafficking at the renal medulla level and 
decreases in the UNa+/K+ ratio. Studies have 
shown that aldosterone induces a rapid 
nuclear accumulation of the MR (Fejes-Toth 
et al. 1998). Aldosterone-bound MR acts as a 
transcription factor, therefore, the 
measurement of nuclear MR content may 
indicate the level of MR signalling. 
Moreover, this method has been used by 
other authors to evaluate MR- and GR 
(glucocorticoid receptor)-mediated signalling 
(Nagase et al. 2007; Kariagina et al. 2005). 
Our results suggest that aging is accompanied 
by increases in nuclear MR trafficking at the 
renal medullary level, as a consequence of 
increased plasma levels of aldosterone. These 
findings correlate with increased expression 
of Na+,K+-ATPase α1-subunit and 65 kDa 
αENaC in the renal medulla of aged rats. In 
agreement with other studies, we observed 
the presence of several MW bands for renal 
αENaC (Tiwari et al. 2009). It has been 
suggested that higher MW bands for αENaC 
may represent immature, uncleaved forms of 
the protein and that the lower bands may be 
“active” forms of the protein (Ergonul et al. 
2006; Guipponi et al. 2002) and that unique 
MW bands for αENaC may be due to 
differential activation by steroids (Tiwari et 
al. 2009). No differences in NHE3 expression 
were found between age-matched WKY and 
SHR, although we had previously reported an 
increase in NHE3 expression in SHR in renal 
proximal tubule epithelial cells at 4 and 12 
weeks of age (Pinho et al. 2007; Pedrosa et al. 
2004) that could be related to differential 
expression in nephron segments other than 
the proximal tubule. We found that aging is 
associated with decreases in MR nuclear 
content, and NHE3 and αENaC expression in 
the renal cortex. These findings may 
correspond to a counter-regulatory 
mechanism activated by increased plasma 
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aldosterone levels. Potentially counteracting 
protective mechanisms may be activated via 
the reduction of cortical nuclear MR and 
ultimately through the reduction of cortical 
αENaC and NHE3 expression in an effort to 
maintain sodium balance in aged WKY and 
SHR. The dramatic decrease in NHE3 protein 
expression levels concurs with previous 
studies that show a decrease in activity and 
abundance of NHE3 in the kidney of aged 
rats (Mac Laughlin et al. 2001). We have 
reported previously that 
immortalized proximal tubular epithelial 
(PTE) cells from 4-12 week old SHR have 
higher Na+-K+ ATPase activity and 
expression than PTE cells from 4-12 week 
old WKY (Pedrosa et al. 2007). However, the 
abundance of the renal α1-subunit of Na+,K+-
ATPase in freshly isolated renal proximal 
tubules from 12-week old SHR was found to 
be similar to that in WKY (Pinho et al. 2007). 
Likewise, in the present study, no differences 
in α1-subunit Na+,K+-ATPase expression 
between 13- and 52-week old age-matched 
WKY and SHR in the renal cortex were 
found. However, confirming our previous 
studies (Silva et al. 2010), α1-subunit of 
Na+,K+
Plasma aldosterone levels and MR 
signalling and functionality in the renal 
medulla were decreased in aged WKY-FR in 
comparison to age-matched WKY and SHR. 
Therefore, it is suggested that in WKY, the 
activation of the aldosterone/MR system is 
related to increases in body fat mass, and not 
to the aging process. On the other hand, 
despite normal body fat mass, SHR already 
had increased plasma aldosterone levels at 13 
weeks of age when compared to age-matched 
WKY, and the aldosterone/MR system was 
further intensified by aging in these animals.  
-ATPase expression was increased in 
the renal medulla with aging.  
In summary, our findings show that age-
related increases in body fat mass may be 
responsible for exacerbated renal oxidative 
stress, hyperaldosteronism, and increased 
renal medullary MR trafficking in WKY. 
Interestingly, despite the existence of 
multiple independent studies suggesting that 
aldosterone and ROS broadly contribute to 
the development of hypertension, blood 
pressure in WKY remained unaltered 
throughout this study. Nevertheless, long-
term FR in WKY had the beneficial effect of 
mitigating ROS production, reducing plasma 
aldosterone levels, and decreasing 
aldosterone/MR system activation in the renal 
medulla. These findings shed light on the 
importance of FR in controlling oxidative 
stress and the renal aldosterone/MR system. 
Additionally, we report the aldosterone/MR 
system is intensified by aging in SHR. The 
importance of aging in the development of 
hyperaldosteronism in SHR is undermined. 
Aging is accompanied by increases in 
oxidative stress levels and renal 
aldosterone/MR system activation, which 
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may play a role in the progression and 
worsening of hypertension in these animals.  
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DISCUSSION AND CONCLUSIONS 
Despite the progress made in the molecular identification of cell membrane 
transport systems, there is still a lack of information on the regulation of renal amino acid 
transporters. In this study we hypothesised that oxidative stress could modulate the 
amino acid transporters that are potentially involved in the uptake of L-DOPA, the 
precursor of dopamine. ROS, originally considered to cause cell damage, are now 
recognized to be key signaling molecules that mediate diverse biological responses such as 
induction of host defense genes, activation of transcription factors, phosphorylation of 
kinases and mobilization of ion transport systems (Droge 2002). On the other hand, it has 
been suggested that ROS are associated with hypertension, at least in animal models and 
that a greater understanding of the (patho)biology of ROS may lead to new mechanistic 
insights and novel diagnostics and treatments for hypertension. The data presented in this 
work suggests that L-DOPA transporters can be regulated by oxidative stress, mainly in the 
SHR, possibly as an adaptive mechanism to maintain sodium homeostasis and decrease 
ROS levels.  
In Chapter I we addressed the question of whether oxidative stress has a role in 
the regulation of ASCT2 in immortalized PTE cells from WKY and SHR. Several established 
cell lines of renal origin have been used previously in our laboratory for analyzing the 
function of renal amino acid transporters that can potentially transport L-DOPA, such as 
opossum kidney (OK) cells (Gomes et al. 1997), LLC-PK1 cells (Soares-da-Silva et al. 2004) 
and immortalized renal PTE cells from SHR and WKY (Pinho et al. 2004). LLC-PK1 cells, a 
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cell line derived from porcine renal tubule epithelial cells that retain several properties of 
proximal tubular epithelial cells in culture (Hull et al. 1976), express both LAT1 and LAT2 
transcripts (Soares-da-Silva et al. 2004). In this cell line, transport of [14C]-L-leucine occurs 
through the sodium-independent pH-insensitive and high-affinity LAT1 transporter, 
whereas [14C]-L-DOPA is mainly transported through the sodium-independent pH-
insensitive and low-affinity LAT2 transporter and a minor component through a sodium-
dependent transporter (Soares-da-Silva et al. 2004). Furthermore, in LLC-PK1 cells, LAT2 
gene silencing was shown to reduce markedly the inward and outward transfer of [14C]-L-
DOPA (Soares-da-Silva et al. 2004). Immortalized renal proximal tubular epithelial (PTE) 
cells from SHR and WKY have been used previously in an attempt to better characterize 
the differences in renal handling of L-DOPA and to evaluate the diversity and regulation of 
amino acid transport systems in hypertension (Woost et al. 1996; Pedrosa et al. 2004; 
Pedrosa et al. 2004). Immortalized renal PTE cells from SHR were found to overexpress 
LAT2 (Pinho et al. 2003). In immortalized WKY PTE cells L-DOPA uptake was almost 
exclusively through LAT2  whereas in immortalized SHR PTE cells 50% of L-DOPA uptake 
occurred through LAT1, 25% through LAT2, and 25% through sodium-dependent 
mechanisms, (Pinho et al. 2004). These sodium-dependent mechanisms may involve 
ASCT2 and B0AT1, which are the only transport systems that are capable of transporting 
amino acids with similar characteristics to substrates transported through system L. The 
rat SLC1A5 gene that codes for ASCT2, is located on chromosome 1 and was associated to 
hypertension by several linkage analysis studies (Clemitson et al. 2002; Lo et al. 2002). 
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Quantitative trait loci (QTLs) were identified in chromosome 1 accounting for salt loading-
induced variance of blood pressure (Yagil et al. 2003). Interestingly, previous studies 
showed that high salt intake-induced increases in urinary dopamine were not 
accompanied by increases in LAT1, LAT2 or 4F2hc expression in 4- and 12-week old WKY 
and SHR (Pinho et al. 2007). These results indicated that sodium-dependent transporters, 
such as ASCT2, may play an important role in the regulation of renal dopamine formation 
during high salt intake.  
As shown in Chapter I, the renal activity and expression of ASCT2 transporter were 
lower in SHR than in WKY PTE cells. In view of the fact that ASCT2 is regulated by NO in 
intestinal Caco-2 cells (Uchiyama et al. 2005), and that NO availability in the kidney is 
decreased in SHR (Adler et al. 2002), it was suggested that oxidative stress might be 
downregulating ASCT2 by decreasing intrarenal NO availability. In order to investigate this 
hypothesis we attempted to explore the short and long term effects of L-NAME (inhibitor 
of NO production), SNAP (NO donor) and carboxy PTIO (NO scavenger) on the inward 
transport of [14C]-L-alanine, an ASCT2 preferential substrate, in monolayers of 
immortalized renal PTE cells from WKY and SHR. No effects were observed with the tested 
concentrations and the treatment times (unpublished data) which may indicate that NO 
may not have a role in the regulation of ASCT2 in renal PTE cells.  
Previous studies in our laboratory have shown that apocynin, a NADPH oxidase 
inhibitor, decreased significantly Na+,K+-ATPase activity and Na+,K+-ATPase α1-subunit 
expression in OK cells (Silva et al. 2007). Furthermore, intracellular H2O2 can amplify the 
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response downstream of α1-adrenoceptor activation (Simao et al. 2008), α2-adrenoceptor 
activation (Simao et al. 2008) and Cl-/HCO3- exchanger activity (Pedrosa et al. 2008; Simao 
et al. 2010) in immortalized SHR PTE cells. Therefore, we hypothesized that H2O2 or O2 
could modulate ASCT2 activity. Lineweaver–Burk plots from data obtained in the present 
study revealed the presence of high- and low-affinity states for the sodium-dependent 
[14C]-L-alanine uptake processes in both cell lines. At low extracellular sodium 
concentrations, the sodium-dependent [14C]-L-alanine uptake in both WKY and SHR PTE 
cells is a high-affinity low-capacity process and increases in extracellular sodium reduced 
the affinity for the substrate, but increased the capacity to take up [14C]-L-alanine. In 
Chapter I we show that inhibition of H2O2 production by apocynin during cell growth 
significantly reduced Na+-Km and Vmax values of the low-affinity high-capacity component 
of sodium-dependent [14C]-L-alanine uptake in immortalized SHR PTE cells. Therefore, 
when H2O2 levels are reduced the sodium-dependent [14C]-L-alanine uptake by ASCT2 in 
SHR PTE cells functions predominantly as a high-affinity low-capacity transporter. It was 
suggested that oxidative stress may have an effect on the conformations of ASCT2 in SHR 
PTE cells as they proceed through the transport cycle, which may result in differential 
sodium binding and unbinding. In fact, in immortalized SHR PTE cells, H2O2 has been 
shown to stimulate Cl-/HCO3- exchanger activity via modification of thiol groups of 
intracellular and/or transmembrane proteins. In addition, the oxidized conformation of 
the exchanger enhanced the affinity for HCO3- in immortalized SHR PTE cells but not in 
WKY PTE cells (Simao et al. 2011). Cysteine residues of proteins are especially susceptible 
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to oxidative stress and, given the important role that disulfides play in protein structure 
and stability, alterations of reactive cysteine thiol groups may change protein function and 
activity. Therefore, we concluded that ASCT2 is expressed in immortalized WKY and SHR 
PTE cells and suggested that H2O2 may regulate the sodium binding process of this 
transporter in immortalized SHR PTE cells only. Further studies are required to determine 
the effect of apocynin on LAT1 and LAT2 in immortalized WKY and SHR PTE cells. 
As indicated in the Introduction section, the dopaminergic system has the ability to 
stimulate antioxidant activity. D1-like receptor agonists were found to suppress platelet-
derived growth factor (PDGF)-BB–mediated increases in oxidative stress in vascular 
smooth muscle cells (VSMCs). Furthermore, in HEK-293 cells heterologously expressing 
human D1 receptor (HEK-hD1), fenoldopam, a D1 receptor agonist was found to inhibit 
NADPH oxidase activity in a time- and concentration-dependent manner (Yu et al. 2011). 
On the other hand, several studies suggest that one of the mechanisms linking oxidative 
stress and hypertension is represented by activation of the RAAS (Fanelli et al. 2011). In 
Chapter I, we demonstrated that in SHR PTE cells, but not in WKY PTE cells, the 
aldosterone-induced increase in NHE1 activity was prevented by apocynin. Therefore, 
whereas H2O2 may have a “detrimental” role by acting with aldosterone to increase 
sodium reabsorption in SHR PTE cells, it concurrently contributes to the presence of a 
more “sophisticated” uptake process for the sodium-dependent [14C]-L-alanine uptake in 
SHR PTE cells. Although speculative, it is suggested that the presence of two components 
for the sodium-dependent [14C]-L-alanine uptake, with different affinities and capacities 
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that vary according to extracellular sodium concentrations, may be more favourable than 
one. Moreover, this potential adaptive mechanism in SHR PTE cells could be a means for 
the cell to take up L-DOPA more efficiently. 
Several factors may contribute to increases in oxidative stress such as the aging 
process and increased NADPH oxidase activity intrinsic to essential hypertension. In this 
setting, the next question we addressed was whether the regulation of the amino acid 
transporters that are potentially involved in the uptake of L-DOPA (LAT1, LAT2 and ASCT2) 
is altered in the kidney of aged WKY and SHR. Our group has reported previously that the 
enhanced ability to take up L-DOPA in the pre-hypertensive SHR was suggested to take 
place as an attempt to overcome the deficient dopamine-mediated natriuresis generally 
observed in this genetic model of hypertension (Jose et al. 2002; Pinho et al. 2003). The 
results presented in Chapter II show that aging, from 3 to 12 months of age, was 
associated with increases in H2O2 levels in renal tissue in both WKY and SHR. Furthermore, 
the abundance of p22phox and Nox4 proteins were increased in the renal cortex of aged 
WKY and SHR, as well as the expression of the antioxidant enzymes SOD2, SOD3 and 
catalase. In contrast to our studies, 22/24-week old SHR was reported to have increased 
plasma (Zhan et al. 2004) and urinary (Suzuki et al. 2008) H2O2  levels when compared to 
age-matched WKY. In 8-month old SHR, renal mitochondrial H2O2 production was also 
found to be increased in comparison to age-matched WKY (de Cavanagh et al. 2006). It 
was suggested that the apparent conflicting results may be related to the marked increase 
in body fat mass of aged WKY. The link between oxidative stress and obesity was further 
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investigated in Chapter IV. Nevertheless, in this pro-oxidative environmental milieu, the 
renal dopaminergic system was found to be activated in aged WKY and SHR as 
demonstrated in Chapter III, although the dopaminergic response is more enhanced in 91-
week old SHR than in aged-matched WKY. Moreover, aging was accompanied by the 
upregulation of renal cortical ASCT2 in WKY and of LAT2/4F2hc and ASCT2 in SHR.  
Given the pro-oxidant nature of the RAAS and the fact that the dopaminergic 
system can counter-regulate the RAAS by decreasing the production of ROS, another goal 
of this thesis was to evaluate age-related changes in the renal aldosterone/MR system in 
WKY and SHR. Plasma aldosterone increased with age in WKY and SHR (Chapter III and 
Chapter IV). Therefore it was suggested that the upregulation of ASCT2 in aged WKY and 
SHR and LAT2/4F2hc and ASCT2 in aged SHR could be an attempt to increase L-DOPA 
uptake, and consequently dopamine synthesis, in order to normalize sodium levels. There 
is accumulating evidence that supports the view that the dopaminergic system can 
directly counteract the RAAS. The natriuretic renal dopaminergic system opposes the anti-
natriuretic activity of the RAAS by downregulating the AT1 receptor and upregulating the 
AT2 receptor. Each of the individual dopamine receptors has been shown to oppose the 
activity of the AT1 receptor. D1, D3, and D5 receptors even interact physically with the AT1 
receptor (Gildea 2009). In Chapter IV we confirmed that aging in WKY and SHR is 
accompanied by exacerbated oxidative stress at the kidney level and increased 
aldosterone/MR system activation. Similarly to results obtained by other authors (Ruetten 
et al. 1999; Natalucci et al. 2003), this study showed that WKY become obese with age, as 
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a result of fat mass accumulation. In our study 15% food restriction resulted in significant 
weight loss at the age of 52 weeks, which was accompanied by a decrease in renal 
oxidative stress, plasma aldosterone levels and MR functionality. These results were found 
to be in agreement with studies by other authors that have demonstrated that adipose 
tissue can produce several components of the RAAS, mainly adipose tissue-derived 
angiotensinogen. Furthermore, adipocyte-derived aldosterone-releasing factors, although 
not yet identified, have been found to stimulate aldosterone secretion from 
adrenocortical cells (Ehrhart-Bornstein et al. 2003). Therefore, based on the results 
presented in Chapter III and Chapter IV it is proposed that the upregulation of amino acid 
transporters that may be involved in L-DOPA uptake, such as ASCT2 and LAT2/4F2hc, 
could be a counteractive mechanism to overcome increases in renal ROS levels and 
activation of the RAAS during the aging process. However, in aged WKY the exacerbated 
oxidative stress levels and aldosterone/MR activation may be related to increases in body 
fat mass and not with aging per se. Furthermore, our findings demonstrate that although 
52-week old WKY had renal oxidative stress and plasma aldosterone levels similar to those 
observed in age-matched SHR, blood pressure values were significantly lower. Therefore, 
it was suggested that increases in renal oxidative stress and sodium reabsorption may not 
be sufficient to cause hypertension.  
The relationship between aldosterone and the expression of amino acid 
transporters has been previously evaluated by our group in young WKY and SHR (Pinho et 
al. 2007). At 12 weeks of age, high salt intake for 24 hours increased urinary dopamine in 
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SHR, but not in WKY. Changes in urinary dopamine paralleled changes in the uptake of L-
DOPA in isolated renal tubules from 4- and 12-week old WKY and SHR on normal salt and 
high salt intake. At 12 weeks of age, high salt intake was accompanied by decreases in 
LAT1 and LAT2 transcript abundance in WKY and SHR. ASCT2 and B0AT1 expression was 
significantly decreased in both 4- and 12-week old WKY and in 4-week old SHR on high salt 
intake. By contrast, high salt intake increased ASCT2 and B0AT1 expression in 12-week old 
SHR (Pinho et al. 2007). We have demonstrated that 8-week old normotensive Wistar rats 
chronically treated during 8 days with aldosterone had increased renal cortical LAT2 
mRNA levels with no changes in LAT1, 4F2hc and ASCT2 transcript levels (Pinho et al. 
2009). The effect of aldosterone upon LAT2 mRNA levels was completely prevented by 
spironolactone, a mineralocorticoid receptor antagonist. At the protein level, aldosterone 
treatment did not significantly affect LAT1 and LAT2 expression, but markedly reduced the 
abundance of 4F2hc, although levels were not reversed by spironolactone. The decrease 
in LAT2 functionality (related to the decrease of 4F2hc abundance) correlated well with 
the reduction in urinary dopamine (Pinho et al. 2009). Taken together, these results 
suggested that the transcript abundance of amino acid transporters is age dependent and 
that can be modulated by aldosterone levels.  
There is accumulating data supporting a role for oxidative stress in experimental 
hypertension; however, it is suggested that increases in ROS at the renal level may not be 
sufficient to cause hypertension. Moreover, the fact that oxidative stress may have a role 
in the modulation of the amino acid transporters that are potentially involved in the renal 
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tubular uptake of L-DOPA could be a defence mechanism activated in response to 
increases in aldosterone and oxidative stress levels. All together, the work presented in 
this thesis suggests that amino acid transporters can be regulated directly or indirectly by 
the oxidative damage that is associated with hypertension and aging.  
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RESUMO 
 
O papel do stress oxidativo na regulação dos transportadores de aminoácidos renais na 
hipertensão e no envelhecimento 
 
O sistema dopaminérgico renal opõe-se à actividade anti-natriurética do sistema renina-
angiotensina-aldosterona (SRAA) e inibe a formação de espécies reactivas de oxigénio 
(ERO). Neste estudo, colocou-se a hipótese de que o stress oxidativo possa desempenhar 
um papel na regulação dos transportadores de aminoácidos envolvidos na captação de L-
DOPA na hipertensão e no envelhecimento. Verificou-se que a expressão e a actividade do 
ASCT2 são menores nas células epiteliais dos túbulos proximais renais (TPR) imortalizadas 
provenientes de ratos espontaneamente hipertensos (SHR) do que nas dos TPR de ratos 
Wistar-Kyoto (WKY). Nas duas linhas celulares, foram identificados componentes, um de 
alta e outro de baixa afinidade do processo de captação de [14C]-L-alanina (um substrato 
preferencial do ASCT2), dependente de sódio. O tratamento com apocinina, um inibidor 
da NADPH oxidase, inibiu o componente de baixa afinidade do processo de captação de 
[14C]-L-alanina dependente de sódio. Este efeito foi reversível e ocorreu exclusivamente 
nas células dos TPR dos SHR. Estudos in vivo com ratos WKY e SHR indicaram que o 
envelhecimento estava associado a um aumento dos níveis de H2O2 no rim de WKY e SHR. 
As quantidades de p22phox e de Nox4 estavam aumentadas no cortex renal de WKY e SHR 
envelhecidos, bem como a expressão das enzimas antioxidantes SOD2, SOD3 e catalase. O 
processo de envelhecimento também foi acompanhado pelo aumento da expressão de 
ASCT2 no cortex renal dos WKY e de LAT2/4F2hc e ASCT2 nos SHR. Subsequentemente, foi 
demonstrado que o sistema aldosterona/receptor mineralocorticoide estava activado de 
forma semelhante no WKY e SHR envelhecidos mas que a pressão arterial dos WKY 
continuava a ser inferior às dos SHR.  Nos WKY envelhecidos, a restrição alimentar 
prolongada resultou em perdas significativas de peso, diminuição do stress oxidativo renal 
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e redução no nível de aldosterona plasmática. No WKY e SHR a modulação dos 
transportadores de L-DOPA pode ser uma reacção de compensação de activação do SRAA 
e do aumento nos níveis renais de ERO durante o processo de envelhecimento. Os 
resultados apresentados podem contribuir para uma melhor compreensão da regulação 
dos transportadores de aminoácidos renais e do papel das ERO na hipertensão.  
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ABSTRACT 
 
Oxidative stress on the regulation of renal amino acid transporters in hypertension and 
aging 
 
The renal dopaminergic system opposes the anti-natriuretic activity of the renin-
angiotensin-aldosterone system (RAAS) and inhibits reactive oxygen species (ROS) 
generation. In this study we hypothesized that oxidative stress could play a role in the 
regulation of the candidate amino acid transporters for L-DOPA uptake, in hypertension 
and aging. The activity and expression of ASCT2 transporter were found to be lower in 
immortalized renal proximal tubular epithelial (PTE) cells from spontaneous hypertensive 
rat (SHR) than in Wistar-Kyoto (WKY) PTE cells. In both cell lines, high- and low-affinity 
components were identified for the sodium-dependent [14C]-L-alanine (an ASCT2 
preferential substrate) uptake process. In SHR PTE cells, treatment with apocynin, a 
NADPH oxidase inhibitor, inhibited the low affinity component for the sodium-dependent 
[14C]-L-alanine uptake. This effect was found to be reversible and exclusive to SHR PTE 
cells. In vivo studies showed that aging was associated with increases in renal H2O2 levels 
in WKY and SHR. The abundance of p22phox and Nox4 proteins were increased in the renal 
cortex of aged WKY and SHR, as well as the expression of the antioxidant enzymes SOD2, 
SOD3 and catalase. Aging was also accompanied by the upregulation of renal cortical 
ASCT2 in WKY and of LAT2/4F2hc and ASCT2 in SHR. Subsequently, it was shown that the 
renal aldosterone/mineralocorticoid receptor system was activated in aged WKY and SHR. 
However, although renal oxidative stress and plasma aldosterone levels were similar to 
that observed in age-matched SHR, blood pressure values were significantly lower in aged 
WKY. Moreover, in aged WKY long-term food restriction resulted in significant weight loss 
which paralleled decreases in renal oxidative stress and reductions in plasma aldosterone 
levels. In WKY and SHR the modulation of amino acid transporters may be an attempt to 
overcome activation of the RAAS and increases in renal ROS levels during the aging 
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process. The data presented in this thesis may contribute to a better understanding of the 
regulation of renal amino acid transporters and the role of ROS in hypertension.  
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